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The relevant literature on the physiology and pathophysiology
of the intracranial contents, the effects of anaesthetic agents on
intracranial pressure (ICP) and cerebral blood flow (CBP) and the
methodology of measurement of ICP is reviewed. The author's
original work on the effect of anaesthetic agents and manoeuvres
on ICP and cerebral perfusion pressure (CPP) in patients with intra¬
cranial pathology is described. The following results were
obtained in patients who were about to undergo intracranial operations.
The changes in ICP associated with intubation were small and were
similar when thiopentone or Althesin were used together with d-tubo-
curarine for induction of anaesthesia even in patients with elevated
ICP. Etomidate 0.2 m^Kg intravenously caused a significant
reduction in ICP (0.01_>P > O.OOl) but caused no significant change
in CPP. Tubocurarine ;+5 mg when given in combination with thio¬
pentone or Althesin caused significant reductions in ICP (0.05^>P.>
0.02), mean arterial pressure (MAP) (P < O.OOl) and CPP (P<L O.OOl)
and tubocurarine 15 to 20 mg caused a significant reduction in ICP
(0.05 C> P >0.02) but caused no significant change in MAP or CPP.
In hypocapnic patients fentanyl 0.2 mg caused small changes in ICP
which could be in either direction and significant decreases in MAP
(0.01 > P> 0.001) and CPP (0.01> P > O.OOl). ' Enflurane also
caused small changes in ICP which could be in either direction,and
significant reductions in MAP (P< O.OOl) and CPP (P < O.OOl).
In mechanically ventilated patients with head injury 50%> nitrous
oxide in oxygen increased ICP (P < O.OOl) and exaggerated the
increases in ICP associated with chest physiotherapy. Thiopentone
and Althesin reduced the increases in ICP associated with chest
i
physiotherapy but did not prevent them. The relevance of these
results to the anaesthetic and intensive care management of neuro¬
surgical patients is discussed, and it is concluded that the
information obtained helps the neuroanaesthetist to decide which
anaesthetic agents are best used during intracranial surgery and
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In order to make a rational choice of which anaesthetic
agents to use during intracranial operations, the anaesthetist
needs a thorough knowledge of the physiology and pathophysiology
of the cranial contents, and of how they are affected by anaesthetic
agents. The physiological parameters which are most important to
the neuroanaesthetist are intracranial pressure (ICP), cerebral
blood flow (CBF), cerebral blood volume (CBV),mean arterial pressure
(MAP), cerebral perfusion pressure (CPP) and cerebral metabolic rate
for oxygen (CMR02). In patients with intracranial pathology high
ICP can cause brain shifts or reduction in CPP sufficient to cause
cerebral ischaemia, thus it is necessary to minimise ICP changes
during the anaesthetic and surgical care of such patients. In this
thesis I will discuss the physiology and pathophysiology of the
cranial contents, the effect of anaesthetic agents on ICP, CBF and
CBV, the mechanisms whereby anaesthetics affect these parameters,
and the influence on ICP of interactions between intracranial
pathology and anaesthetic agents. Because the original work is
concerned only with the measurement of ICP and MAP I will describe
and discuss the methodology of ICP monitoring in detail and only
briefly mention methods of measurement of CBF and CBV. I will then
describe the original work and conclude by discussing the validity
and clinical relevance of this work.
The original work deals with the effects of the intravenous
anaesthetic agents thiopentone and Althesin on the changes in ICP
and CPP during induction of anaesthesia and endotracheal intubation,
and the effects of the intravenous induction agent etomidate, the
narcotic analgesic fentanyl, the muscle relaxant d-tubocurarine and
the volatile anaesthetic agent enflurane on ICP and CPP in patients
who were about to undergo intracranial surgery. It also includes
investigations in patients with severe head injury who were being
mechanically hyperventilated in which 5tfo nitrous oxide in oxygen
(Entonox), thiopentone and Althesin have been used in an attempt
to reduce the increase in ICP associated with chest physiotherapy,
and the effect of Entonox on ICP has been measured in the absence
of stimulation.
The aim of these investigations was to establish or confirm
whether the anaesthetic agents investigated were suitable for use
during intracranial surgery, and to determine whether particular
anaesthetic agents were useful in preventing or attenuating changes
in ICP associated with essential manoeuvres during anaesthesia and
intensive care such as endotracheal intubation and chest physio¬
therapy. In the studies concerning fentanyl, d-tubocurarine and
enflurane the worto was done to clarify areas where the literature
was contradictory, and the purpose of the other investigations was
to provide information which was not available in the literature.
The work described in Chapters ;u, 5, 7 and 9 has been
published in the British Journal of Anaesthesia and Acta
Anaesthesiologica Belglca. and reprints of these publications are
included at the end of the thesis.
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CHAPTER 1
FACTORS WHICH INFLUENCE INTRACRANIAL PRESSURE
(EXCLUDING DRUGS)
A
In order to make a rational assessment of studies of the
effects of drugs on the cranial contents it is necessary to have
a full understanding of the physiology and pathophysiology of the
brain, cerebral circulation and cerebrospinal fluid. In this
chapter I will therefore discuss the relevant physiology and
pathophysiology of the cranial contents.
THE PHYSIOLOG-Y OF THE CRANIAL CONTENTS
The Contents of the Cranium
The adult cranium forms an almost rigid container which is
in direct communication with the vertebral canal. It contains
1400 g. of brain, 130 ml. of blood (Hedlund and Nylin, 19^2) and
about 75 ml. of cerebrospinal fluid. About ll$ of the brain
volume is extracellular fluid (V.'oodward et al,, 1967)* 50^ of
the CSF is contained in the ventricles and cisterns and the rest
covers the surfaces of the brain.
CSF is formed mainly in the choroid plexuses, which are
present in all four ventricles, at a rate of about O.k ml./min.
The rate of formation of CSF is independent of the age of the
subject and of the level of ICP up to 15 mm Hg (Rubin et al.,
1966; Cutler et al., 1968), except when autoregulation of CBF
is impaired when the CSF formation rate may passively follow
changes in CBF and CPP (Sklar et al., 1980). It is formed by
an active secretion from the choroid plexus which is villous,
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highly vascularised, and covered by a single layer of cuboidal
cells supplied with various membrane elaborations and numerous
mitochondria. Transependymal water follows the pumping of sodium
(Pollay, 1975)# This active transport of sodium into the CSF is
inhibited by frusemide (Buhrley and Reed, 1972). CSF production
is an energy-requiring secretory process involving at least two
enzymes, carbonic anhydrase and an ouabain-sensitive sodium-potassium
activated ATPa.se. The choroid plexus is supplied with an extensive
system of autonomic nerves. Sympathetic stimulation causes a 32%
reduction in the net rate of CSF production while sympathectomy gives
a 33% increase (Lindvall et al., 1978). It is suggested that the
sympathomimetic reduction in the rate of CSF production is the result
of a combined {}-receptor mediated inhibition of the secretion from
the plexus epithelium, and a reduced blood flow in the choroid plexus
tissue resulting from stimulation of the vascular ©^.-receptors.
CSF production rate is also reduced by cholinomimetic agents acting
at receptors which appear to be of the muscarinic type (Lindvall et al.
1980).
The rate of CSF production is reduced by acetazolamide
(Oppelt et al., 1963; Rubin et al., 1966; Cutler et al., 1968;
Domer, 1969), frusemide (Reed, 1969; Buhrley and Reed, 1972),
ethacrynic acid, triamterene and thiazide diuretics (Domer, 1969).
Spironolactone significantly increases the rate of CSF formation
(Domer, 1969)* Metabolic and respiratory alkolosis reduce CSF
production by 23% and r6% respectively, but metabolic and respiratory
acidosis have no constant effect on CSF production (Oppelt et al.,
1963).
CSF is mainly reabsorbed into the blood at the arachnoid
villi which consist of coiled microtubules without any membrane
separating b^ood from CSF (Welch and Friedman, i960). The process
is mechanical depending on a pressure gradient between CSF and the
blood of the venous sinuses. The minimum pressure gradient
required for absortition is 5 mm Hg and at pressure gradients above
this the rate of absorption is linearly related to the gradient
(Rubin et al., 1966; Cutler et al., 1968). The absorption capacity
exceeds the CSF production rate by at least four times (Rubin et al.,
1966; Katzman and Hussey, 1970).
The resting level of CSF pressure is determined by the badance
between formation and reabsorntion. The rigid walls of the venous
sinuses provide a resistance to blood flor/ and thus the venous sinus
pressure is always greater than the intrathoracic pressure. The
normal ICP is 0 to 10 mm Hg (Lundberg, i960) and is the sum of the
venous sinus pressure and the CSF to venous sinus pressure gradient.
This pressure range is only valid for the horizontal position;if the
head is on a pillow it is reduced by up to 2 mm Hg. Miller (1975)
states that the normal ICP usually ranges between 0 and 10 mm Hg
with an upper limit of 15 mm Hg, and Cilland and colleagues (l97'i)
found an average lumbar CSF pressure in the horizontal position in
young normal volunteers of 11.5 mm Hg (S.D. 2.7) with a maximum
value of 17»7 mm Hg. Thus the upper limit of normal ICP can be
taken to be approximately 15 mm Hg. The pressure fluctuates
around the mean value.
The CSF pressure fluctuates with the heart beat and
respiration. The transmission of the arterial pulse wave is
believed to be produced partly by the pulsation of the intracranial
arteries, particularly those at the base of the brain, and partly
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"by the pulsatile movements of the choroid plexuses. The
amplitude of these pulsations increases when mean ICP is increased
and when cerebral arterial vasodilatation occurs (both conditions
may be present in diseased or damaged brain). The a-wave of the
cerebral venous pressure (CVP) curve can also be identified in the
CSF pressure curve as a small peak just before the arterial peak
(Ponssen and Van den Bos, 1971)» The height of the CSP pressure
wave is dependent on the mean arterial blood pressure whilst the
contour of the CSP pulse wave is shaped by rapid changes of cerebral
blood volume (CBV) in the post-capillary cerebral vascular bed
(Hamer et al., 197k)*
The respiratory fluctuations in CSP pressure are in the
same direction as the changes in intrathoracic pressure.
Transmission of the intrathoracic pressure changes to the CSP may
be partly through associated changes in systemic arterial pressure
with respiration, but mostly via. the jugular and vertebral veins
because in animals CSF pressure variations continue with IPPV after
death (Levinger and Kedem, 1972). Even after brain death when there
is no blood flow through the brain, intracranial pulsations, with an
amplitude as high as 10 to 30 mm Hg, may be seen in the ICP trace
(Jorgensen et al., 1972).
A change in volume of any one of the intracranial contents
must lead to a change in ICP unless compensatory changes in the
volumes of the other constituents occur. Under noima.1 circumstances
compensation occurs and returns ICP to normal. The compensatory
mechanisms include a reduction in intracranial blood volume due to the
pressure exerted by the CSP on the thin-walled cerebral veins,
displacement of CSF into the spinal subarachnoid space (which leads
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to displacement of epidural venous blood from the vertebral canal),
and increased reabsorption of CSF across the arachnoid villi. In
dogs, yOfo of the variation in volume in the craniospinal system was
related to the spinal section and 30/° to the cranial section, with
the spinal compartment acting as an expansion vessel coupled to the
rigid skull cavity (Lofgren and Zv/etnow, 1973)*
Interrelations between TCP, CBF and CBV
There is a linear correlation between changes in cerebral
blood flow (CBF) and cerebral blood volume (CBV) (Risberg, 1969a;
Smith et al., 1971; Phelps et al., 1973) • Changes in CBF cause
changes in CBV partly by changing the diameter of the arterioles
and thus the volume of arterial blood in the brain, and partly by
changing the volume of venous blood inside the cranium. The volume
of venous blood will change because the resistance to flov/ through
the almost rigid dural sinuses is virtually fixed. The cortical
veins are readily distensible and if the outflow resistance remains
constant whilst the blood flow changes, it follows that the pressure
and thus the volume of blood in these veins will change. This
explanation is supported by the observation of McDowall and
colleagues (1966) that superior saggittal sinus pressure rises in
parallel with ICP when halothane is administered to dogs. This
change in volume of the venous blood in the cranium is the major
cause of the change in CBV when CBF changes. If CBV increases
then so will ICP, because the volume of one of the contents of the
non-expansile cranium has increased. This increase in ICP will
last until compensatory mechanisms can return the volume of the
intracranial contents to normal. A definite correlation between
C3F and CSF pressure has been demonstrated (Shenkin et al., 1952;
Hamer et al., 197k) • Thus changes in CBP are accompanied by
changes in CBV and ICP.
Physiological Influences on TCP
Changes in various physiological parameters may cause changes
in CBF and ICP. Therefore, in order to study the effect on ICP of
anaesthetic agents or techniques, it is necessary to know how these
physiological influences may alter ICP and if possible eliminate
their effects.
Arterial Blood Gas Tensions
Effect of PaCOp on ICP
CBF is very sensitive to changes in PaCOg (Smith et al.,197l).
Hypocapnia causes a reduction and hypercapnia causes an increase in
CBF (approximately 3Q"°/KPa change in PaCOg (Okuda et al .,197k) Hauge
et al., 1980) ). The relationship appears to be linear over the
physiological range (3«3 to 7*3 KPa) with a levelling off at very low
PaC02 values (Hauge et al.,1980; Thoresen & Walloe,1980; Rhodes et al.,
1981), although Brown and Donaldson (1978) found that the relationship
was exponential. These latter authors reported that the response of
CBF to changes in PaC02 was almost linear in the physiological range
(li.8 to 5.3 KPa). Further evidence against a linear relationship
between PaC02 and CBF is provided by Hayes and Tindall (1969), who
10
found only a small increase in CSF pressure between PaC02 values
of 2./j_ and A.5 KPa, and the steepest increase between PaC02 values
of A .5 and 5.6 KPa in patients with cerebral tumours. Briggs and
Adams (1973) found also that ICP changes may not always be linearly
related to PaC02 in neurosurgical patients. No further increase
in CBF occurs at a PaC02 greater than 10.6 KPa when CBF is increased
by about 10Cfc> from normocapnia levels, and very little further
decrease occurs at PaC02 values below 2.6 KPa, at which values CBP
is reduced by about ;L0/o from normocapnia (Harper, 1965; Harper and
G-lass, 1965; Thoresen and Walloe, 1980). This inability to reduce
overall CBP below a certain level in response to a reduction in
PaC02 may be due to blood flow levels being insufficient to remove
acid metabolites (Cervos-Navarro et al., 1971-2). Alternatively,
they may be explained by the exponential relationship between PaC02
and CBP, because the vessels have reached the limit of their
responsiveness at such PaC02 values.
These CBP changes are accompanied by linearly related
changes in CBV of approximately 3.75 ml/100 g./KPa change in PaC02
(Loehning et al., 1962; Greenberg et al., 1978), and these changes
in CBV will in turn cause changes in ICP. Thus hypocapnia reduces
ICP (Shenkin et al., 1952; Rich et al., 1953; Halldin and Wahlin,
1959; Lundberg et al., 1959; Greenbaum et al., 1975; Smith et al.,
198l), and hypercapnia increases ICP (White et al., 19J+2; Shenkin
et al., 1952; Rich et al., 1953; Small et al., I960; Loehning et al.,
1962; Hamer et al., 197A; Smith et al., 1981). Moderate hyper¬
ventilation in brain-injured patients or normal man causes a reduction
in CBP and an increase in the cerebral arterio-venous oxygen
difference, but causes no change in cerebral oxygen consumption
I (
(McHenry/,1965; G-ordon and Bergvall, 1973) • The reduction in ICP
with hypocapnia is a temporary effect lasting only 30 to 60 minutes
in dogs (Rosomoff, 1963; Ueyama and Loehning, 1963) because reduced
reabsorption of CSF returns the volume of the intracranial contents
to normal. But the longer-lasting reductinn in CBV tends to
produce good neurosurgical operating conditions (Furness-, 1957;
Hayes and Slocum, 1962; Marrubini et al., 196)4.; Stern, 1972).
Thus hyperventilation is routinely used for intracranial surgery
today. During prolonged hyperventilation there is restoration of
CSF pH to normal values and CBF to near normal values after 2 and
3-5 days respectively of hyperventilation produced by the hypoxia
of altitude (Severinghaus et al., 1963, 1966). Normalisation of
CBF therefore occurs within 3 days but the exact time course is
unclear. In goats and baboons Alexander et al. (1968b)and McDowall
and Harper (1968, 1970) found no return of CBF or cerebrovascular
resistance (CVR.) towards control values during 3 to /, hours of
hypocapnia despite return of CSF pH towards normal, while Raichle
et al. (1970) showed that in conscious man CBF had returned to 9C%
of control values after hours of hyperventilation, which is still
considerably longer than the 30 minutes required for the restoration
of normal ICP (Rosomoff, 1963). CBF overshot the control value by
a calculated 31% when the original PaC02 was restored. It must be
stressed that these observations were made in the absence of intra¬
cranial pathology and caution must be exercised in applying them in
the presence of intracranial compression. Christensen (1973) showed
that during controlled hyperventilation in patients with stroke, the
CSF pH adapted with an estimated half time of 6 hours and was
complete within 30 hours and the ICP changes showed a similar time
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course, indicating that rapid normalisation of ICP does not occur
during hyperventilation in patients with stroke.
Possible disadvantages of hyperventilation are that a high
minute volume may increase ICP (Schettini et al., 19°7) and extremely
low PaC02 values ( <12.67 KPa) may cause cerebral ischaemia as
demonstrated by an increase in CSF lactate (Plum and Posner, 1967;
Alexander et al., 1968c;Miller and Ledingham, 1971) and a reduction
of cerebral venous P02 to less than 2.67 KPa in man(V/ollman et al.,1965)
and significant cerebral lactate production in children (Settergren
et al., 1973) and in dogs (Albert! et al,197?)•There is limited
evidence that extreme hyperventilation may increase the susceptibility
to cerebral hypoxia when CPP is lower than 50 mm Hg (Harp and V/oilman,
1973)- Alexander and G-ranholm (1968) state that there seems to be
conclusive evidence that hyperventilation to PaC02 values below
2.67 KPa causes a lowering of CBF of such a degree that tissue
hypoxia ensues. Campkin et al. (197k) found no biochemical evidence
of cerebral ischaemia at a PaC02 of 3«21 - 0.39 KPa in normothermic
neurosurgical patients receiving 50^ oxygen, whereas Cohen et al.
(1968) found that changes in cerebral metabolism indicative of
cerebral hypoxia were beginning during mild hypocapnia, and that there
was a significant degree of anaerobic metabolism during severe hypo¬
capnia (PaC02 1.35 KPa). Thus from the evidence currently available
there appears to be little danger of cerebral hypoxia at PaC02 values
of 3«3 KPa and above (Harp and Wollman, 1973).•
During hypercapnia, as during hypocapnia, CSF pH and CBF adapt
to the new PaC02 value, and this adaptation can be detected within 8
to 11 hours (Agnoli, 1968). After a brief period of uncomplicated
hypercapnia a return of PaC02 to normal produces immediate restoration
of normal ICP, but if acute hypertension occurs during hypercapnia
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cerebral oedema may be produced causing a more prolonged elevation
of ICP (Marshall et al., 1969).
Effect of PaOp on TCP
There is no change in CBP until the Pa02 falls below 6.67 KPa,
but major increases occur if the Pa02 is reduced further (McDowall,
1966a; Kogure et al., 1970b) • ISP changes will show a similar
pattern with an increase occurring during severe hypoxia (Small et al.,
i960). At a Pa.02 of about A.67 KPa in conscious human volunteers OBF
is nearly doubled (Cohen et al., 1963). The relationship between CBF
and Sa02 is linear in the hypoxic range of Pa02 values £Stoyka et al.,
1978), and maximum vasodilatation occurs at an arterial oxygen
saturation of about 25% in dogs (Ekstrom-Jodal et al., 1979)•
Following hypoxia CBV and ICP may not return to normal
immediately after the restoration of normoxia (Freeman and Ingvar,
1968) because of cerebral hyperaemia, and even if ICP returns to normal
values on restoration of normoxia it can increase again in the
following few hours due to developing brain oedema (Loehning et al.,
1962). Autoregulation to blood pressure changes may be impaired after
hypoxia (Freeman and Ingvar, 1968; Kogure et al., 1970a).
SO/o oxygen did not significantly alter CBF from its value at
normoxia in man (Turner et al., 1957), but lOCP^ oxygen at 1 atmosphere
pressure reduced CBF by 11 to 12%> (Jacobsen et al., 1963; McDowall,
1966a) and ICP by 2j% (Miller et al., 1970).
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Combined hypoxia and PaCO? changes
In cats hypercapnia increases the sensitivity of the cerebral
vessels to hypoxia with an increase in CBF occurring at higher Pa02
values (Flohr et al., 1970)» and combined hypoxia and hypercapnia
has been shown to cause damage to the blood-brain barrier, cerebral
oedema production and thus a sustained elevation in brain surface
pressure (Schettini et al., 1972).
Conversely mild hyperventilation can completely overcome the
vasodilator effect caused by a Pa02 of 5.3 KPa (Shapiro et al., 1970)•
Cerebral Perfusion Pressure
Before discussing autoregulation it is necessary to discuss
the concept of cerebral perfusion pressure (CPP). Blood flows
through the brain because there is a difference in pressure between
the arteries and the veins. The veins on the brain surface are
thin-walled and the pressure in these veins must closely approximate
to CSF pressure, otherwise they would collapse. G-reenfield and
Tindall (1965) have shown that the cerebral veins within the sub¬
arachnoid space are not collapsed at a CSFP of 73.5 mm Hg in man.
Thus in discussing cerebral perfusion the venous pressure in the
thin-walled cerebral veins which drain into the venous sinuses must
be considered. As this pressure approximates to CSF pressure it
follows that CPP should be calculated by subtracting mean CSF pressure
from mean arterial pressure (MAP). This concept of CPP has been
confiimed by Johnston and Rowan (l97?f.b)in studies on baboons. The
normal cerebral perfusion pressure in man is approximately 85 to
95 mm Hg.
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The concept of an overall CPP is prohablv too simplified
particularly in patients with expanding intracranial space-occupying
lesions. In such patients local tissue pressure will not be
constant throughout the brain and thus local cerebral perfusion
pressure will vary in different areas of the brain.
Autoregulation of CBF
CBF remains constant in normotensive man between mean
arterial pressure values of approximately 60 and 130 mm Hg (Lassen,
et al.
1959; Strandgaarcj/, 1973> Lassen, 1978). Above and below these
limits CBF becomes pressure passive. When the MAP is 29 to 55 mm Hg
and CBF is reduced to approximately 30 ml/100 g./min. clinical signs
of cerebral ischaemia occur (sighing, syncope, dizziness, restlessness,
disorientation and confusion) (Finnerty et al., 195AJ Moyer et al.,
195Mb). During hypocapnic nitrous oxide halothane anaesthesia CBF can
be reduced to 13 ml./lOO g./min. before neurological damage can be
demonstrated (Boysen et al., 197-0 • C3F also autoregulates in
response to increasing levels of ICP with an increase in postcapillary
resistance and a decrease in precapillary resistance (Shulman and
Verdier, 19&7) an& does not become pressure passive until the cerebral
perfusion pressure is reduced below 30 to 50 mm Hg in animals
(Jennett et al., 1970; Johnston et al., 1972; Miller et al., 1972,
et al.
1973; Zwetnow, 1970a; Hamer et al., 1973; Haggendal/, 1970a, 1970b),
but in damaged brain when autoregulation is lost CBF will fall at
lower levels of raised ICP (Miller et al., 1973)» Jennett et al.
(1970) found that the lower limit of autoregulation in baboons was
the same regardless of whether the CPP was reduced by decreasing MAP
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or "by increasing ICP, whereas in monkeys G-rubb et al. (1975)
found that the limit was lower if CPP was decreased by increasing ICP
(CPP of less than 30 mm Hg) than if it was reduced by decreasing MAP
(CPP of 80 mm Hg). The difference in findings might be explained by
the different methods used to reduce the MAP, as the former author
used trimetaphan whilst the latter used trimetaphan in 5&fa of the
animals and haemorrhage in the others and it is known that auto-
regulation is lost at a higher CPP during haemorrhagic hypotension
than during drug-induced hypotension (Pitch et al., 1976).
Autoregulation fails in baboons during haemorrhagic hypotension at an
MAP of 65% o£ baseline whereas in drug-induced hypotension it fails
at 35~b-5% of baseline (Pitch et al., 1976). After chemical or
surgical sympathectomy autoregulation persists to significantly lower
levels of MAP (approximately 35% of the baseline value) during
haemorrhagic hypotension (Fitch et al., 1975)* It is postulated
that under conditions of haemorrhagic hypotension constriction of the
extraparenchymal cerebral vessels in response to sympathetic
stimulation reduces the possible range of autoregulation. This
effect is less noticeable in hypertensive baboons (Fitch et al.,1978).
In man G-reenfield and Tindall (1965) found that CBP was
maintained up to CSP pressures of about 28 mm Hg which indicated a
lo?;er limit of autoregulation of 55 to 60 mm Hg. The rate of
increase of ICP is important because if ICP is rapidly increased CBF
declines immediately, but if the ICP increase is gradual no change in
CBP will occur up to an ICP of 30 to 50 mm Hg (Langfitt, 1965a).
Elevation of the internal jugular venous pressure to 12.;+ to
30 cm H20 had no significant effect on CBP but caused a marked
increase in ICP (Moyer et al., 195t.a). Raisis et al. (1979) found
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that monkey pial vessels dilated as cerebral venous pressure was
increased and CBF remained constant up to a cerebral venous pressure
of 75 mm Hg so there is autoregulation to an increase in cerebral
venous pressure.
Several authors have reported a delayed response to a change
in CPP of from 10 to 120 sees (but probably less than 60 sees)
(Kogure et al., 1970a; Lassen and Agnoli, 1972; Ekstrom-Jodal, 1970;
Symon et al., 1973)* Lassen and Agnoli (1972) found that a sudden
increase in B.P. may overcome autoregulation temporarily, while the
same elevation more sl07/ly does not overcome autoregulation. Thus
autoregulation to a change in CPP is not immediate.
There are no significant biochemical changes suggestive of
tissue hypoxia in the rat or dog brain until intracranial hypertension
reduces CPP below 30 to AO mm Hg (Siesjo and Zwetnow, 1970; Zwetnow,
1970a, 1970b; Hamer et al., 1973; Locke et al., 1971)•
In dogs autoregulation was achieved in the major arteries
supplying the circle of Willis and only when alterations of perfusion
pressure were too large for the disturbance to be eliminated by the
major arteries did resistance changes in smaller brain arteries
become evident (Mchedlishvili et al., 1973)•
Autoregulation of CBF occurs in all regions of the brain and
spinal cord (including the brain stem and cerebellum) and during
severe haemorrhagic hypotension redistribution of CBF occurs with
preservation of flow to the cortical grey matter and brain stem
(Heistad et al., 1977).
In hypertensive patients the CBF is the same as in normotensive
patients but the CVR is increased in both grey and white matter, and
the upper limits of autoregulation are shifted to a higher level,
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with an upper limit of up to 160 mm Hg MAP (Strandgaard et al.,
1973)j depending on the severity of the hypertension. The range of
blood pressure over which autoregulation occurs may be somewhat less
in hypertensive patients than in normotensive individuals and the
less distensible vessels in the elderly patient may reduce the range
still further (Jones and G-raham, 1978). A sudden reduction in blood
pressure in the hypertensive patient may cause a marked reduction in
C3F (Hansson, 1979), but if the blood pressure is gradually reduced
over several months the autoregulation curve will tend to shift back
towards normal (Hansson, 1979; Pistolese et al., 1977; Strandgaard,
1978). Some hypertensive patients, however, do not readapt their
autoregulation towards normal during treatment (Strandgaard, 1978).
Brain hypoxia occurs at an MAP of about ~/0 mm Hg in untreated hyper¬
tensive patients compared with A-0 mm Hg in norinotensives (Strandgaard
et al., 1973)«
An increase in MAP above the autoregulatory limit in animals,
particularly during hypercapnia (which reduces the autoregulatoiy
pressure range (Harper, 1966; Eckstrom-Jodal et al., 1971-2) ) may
cause distension of the cerebral arterioles and a large increase in
CBF causing an increase in hydrostatic pressure in the capillaries
and venules, focal disruption of the blood-brain barrier and oedema
formation (Schutta et al., 1968). This has been termed 'breakthrough'
of cerebral autoregulation by Lassen and Agnoli (1972). If the blood
pressure increase is abrupt it may cause dysfunction of the blood-
brain barrier and cerebral oedema even when the change is within the
limits of autoregulation, and if autoregulation is impaired or
abolished such damage could occur with less pronounced pressure changes
(Haggendal and Johansson, 1971-2). The upper limit of autoregulation
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may be lowered in the early stages of development of brain pathology,
thus aoute hypertension should be avoided during neurosurgical
anaesthesia (Alexander and Lassen, 1970; Shapiro et al., 1972c;
Leech et al., 197a)«
During stimulation of cervical sympathetic nerves the upper
limit of autoregulation is shifted upwards (Bill and Linder, 1976;
Mackenzie et al., 1977) thus protecting against the increase in blood
pressure during increased sympathetic activity, and preventing or
reducing breakdown of the blood-brain barrier and formation of cerebral
oedema (Beausang-Linder and Bill, 1981).
Fitch et al. (1976) showed that autoregulation was lost during
haemorrhagic hypotension at a higher MAP (approximately 65 mm Hg)
than with drug-induced hypotension (approximately 35 mm Hg) and
^-adrenergic receptor blockade reduced the lower limit of auto¬
regulation during haemorrhagic hypotension (Fitch et al., 1975)
suggesting that cerebral vasoconstriction, due to sympathetic activity
during haemorrhagic hypotension, reduces the range of autoregulation.
This observation was confirmed by Hamar et al. (1979) •
Hypercapnia narrows the range of autoregulation (Ekstrom-Jodal,
1971~2; Harper, 1966; Parolla and Beer, 1975), and autoregulation is
lost at PaC02 values of 9 to 12 KPa in dogs (Harper, 1966).
Autoregulation may be restored by hypocapnia (Paulson et al., 1972).
Autoregulation is impaired following hypoxia (Freeman and
Ingvar, 1968) being lost only when Pa02 is maintained below 3*3 KPa
for A to 6 minutes (Kogure et al., 1970a). The fact that auto¬
regulation is maintained even after hypoxia has produced an increase
in CBF and decrease in cortical pH suggests that autoregulation is
not due to parenchymal acidosis (Kogure et al., 1970a).
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When hypotension is extreme and prolonged autoregulation may
be abolished whether the hypotension is caused by bleeding (Freeman
and Ingvar, 1963), by halothane anaesthesia (Keaney et al., 1973b),
by nitroprusside infusion (Keaney et al., 1973a) or by trimetaphan
infusion (Gamache et al., 1976) and impairment of autoregulation
may last for more than 2 hours.
Dilatation of cerebral vessels in response to mass-induced
intracranial hypertension has been demonstrated angiographically in
dogs (Goodman and Wilson, 197'l), anc^ such hyperaemia may persist when
the ICP is returned to normal after intracranial hypertension has
caused a reduction of CPP to levels at which CBF was reduced
(Haggendal et al., 1970b ;Grubb etal.1975). This hyperaemia lasts for
up to 90 minutes and grossly coincides with the time taken for the
disturbance of the energy metabolites to be corrected (Zwetnow, 1970a).
Mean CBF must be decreased to levels as low as 39?° of normal
for as long as 30 minutes in order to produce conditions which lead
to brain oedema (Gamache et al., 1976).
There is a widespread clinical impression that 'brain bulk*
is reduced by only moderate decreases in blood pressure during intra¬
cranial surgery (Mazzia et al., 1956). This is probably due to
disturbance in autoregulation, caused by brain pathology or surgical
manipulation, which allows the CBF, at least regionally, to follow
the arterial pressure passively.
2.1
Neurogenic Influences on CBV
Stimulation of the sympathetic nerves supplying the cerebral
vessels causes vasoconstriction and a reduction in CBV (Hdvinsson,
1971-2; Harper et al.,1972; D'Alecy et al.,1979) and acetylcholine
causes vasodilatation (Nielsen et al.,1973; Edvinsson and Oman,1973;
Aoyagi et al.,1975; Matsuda et al.,197^; Toda,1979) as does stimulation
of VII nerve when the centripetal effects of such stimulation are
prevented (Salanga and Waltz, 1973)* The extent of the change in CBF
due to sympathetic stimulation is no more than 10fo (Harper et al.,
1972). Sympathetic stimulation increases the upper level of auto-
regulation (Bill and Linder, 1976).
On morphological grounds and from physiological data it appears
that there is a dual control of the cerebral circulation, the extra-
parenchymal vessels being influenced by the sympathetic nervous
system while the intraparenchymal vessels are under local intrinsic
metabolic regulation. The pial vessels are possibly influenced by
both systems (Harper et al.,1972; Ishii et al.,1975). It is possible
that the increase in CBV which occurs in the early stages of brain
swelling in patients with cerebral trauma is neurogenic in origin.
The Effects of CVP Changes
Changes in CVP or intrathoracic pressure can affect ICP
by two mechanisms: firstly the increased pressure may be trans¬
mitted through the jugular and vertebral veins, thus increasing
cerebral venous pressure, CBV and ICP; and. secondly the pressure
may be transmitted to the epidural veins in the thoracic
vertebral canal, the distension of these veins may elevate CSP
2.2.
pressure and displace CSF from the spinal to the cranial compartment
(Hamilton et al., 1936; Williams, 1970, 1976). The latter mechanism
is probably the most important particularly during rapid changes in
intrathoracic pressure, for example due to coughing, which can cause
significant increases in ICP (Brennan, 1938; Hunter, 1952; Stephen et
al., 195;+; Lundberg, I960). Coughing causes CSF pressure below the
foramen magnum to increase before ICP in the posterior fossa, and CSF
pressure can exceed 100 mm Hg in the lumbar region (Williams, 1970,
1976). Thus the increase in ICP is probably caused by a wave of CSF
passing upwards in the subarachnoid space, but part of the increase
may be due to an increase in venous pressure around the cistern
(Williams, 1976). Increases in intra-abdominal pressure, for
example, due to incorrect prone positioning or straining due to
inadequate doses of muscle relaxants, also act mainly through changes
in epidural venous pressure and volume.
Lofgren (1976) has analysed the intracranial effects of central
venous pressure changes. When the skull is closed isolated short-
term increases in intrathoracic and systemic venous pressure may be
of little consequence, because cerebral venou3 pressure and CSF
pressure increase in parallel and the system remains balanced.
If CPP is not significantly reduced there is no change in the
relationshipsbetween the volumes of the cranial contents and there
will be no volume displacements. The increase in CSF pressure will
be slightly less than that in the central veins as there is a gradient
of pressure along the veins. The head-down posture will similarly
produce a balanced system when the cranium is closed because the
effects on CVP and CSF pressure will balance each other. Elevation
of the head of the bed leads to a decrease in ICP in most patients
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with brain oedema (Shalit and Umansky, 1977; Abbushi, 1980).
However, any manoeuvre which increases intracranial venous
pressure alone, for example compression of the neck veins, will
cause the system to become unbalanced, there is a localised expansion
of the veins, an increase in ICP (Moyer et al., 195Aa> Stephen et al.,
195AJ Shalit and Umansky, 1977), and dislocation of CSF to the spinal
compartment. Thus obstruction of the great veins of the neck, for
example by extreme positions of the head, elevates cerebral venous
and Cooper
pressure, CBV and ICP (Brennan, 1938; Hulrae/, 1976). Head rotation
of 90° to either side may partially or totally occlude the ipsilateral
internal jugular vein, whereas flexion of the neck does not appear to
affect internal jugular vein blood flow (Lipe and Mitchell, 1980).
The increase in ICP on rotation of the head is associated with an
increase in jugular venous pressure (Shalit and Unansky, 1977)•
In addition, when the craniotomy bone flap has been removed the
balancing effect of the associated CSF pressure increase is removed,
and changes in systemic venous pressure will produce changes of the
relative volumes of the cranial contents. The cerebral congestion
induced by coughing and straining when the cranium is open may
persist for at least 30 minutes (Hunter, 1952).
When the cranium is closed an increase in CVP displaces the
CSP pressure-volume curve in parallel along the pressure axis in
proportion to the increase in venous pressure, but the elastance of
the system is not appreciably affected. The volume change
consequent upon an increase in systemic venous pressure results in
a transient and reversible change in IGP, the magnitude of which
depends on the value of the elastance at the pre-existing pressure
level. The ICP then decays exponentially at a rate which is a
Zk-
function of the ratio between the outflow resistance and the
elastance of the system. If the elastance of the system is
increased, an increase in CVP may cause very large increases
in ICP which may be further augmented by transtentorial or
foraminal herniation which shuts off the volume buffering action
of the spinal compartment.
The different modes of controlled ventilation can alter CVP
in different ways. Intermittent positive pressure ventilation
(IPPV) causes an increase in intrathoracic pressure and CVP, and
ventilation with excessive tidal volumes may lead to increases in
ICP (Schettini et al., 1967). Negative phase can be used to
achieve a lower CVP and ICP (Schettini et al., 1967), but Lundberg
and colleagues (1959) suggest that it probably makes very little
difference in practice. High frequency positive pressure ventilation
has little effect on mean ICP or CPP even when ICP is high, but does
reduce ventilator linked fluctuations in ICP and arterial pressure and
thus may facilitate microsurgery (Todd et al., 1981). Positive end
expiratory pressure (PEEP) increases systemic venous pressure which
will tend to increase ICP, tends to reduce arterial pressure which
reduces ICP, and causes cerebral vasodilatation because of the auto-
regulatory response to the decrease in arterial- pressure and increase
in ICP. Several authors have shown significant increases in ICP when
PEEP was applied (Apuzzo et al., 1977; Shapiro and Marshall, 1978;
Abbushi, 1980; Kikuta et al., 1980), although the increases can be
reduced or abolished by a head-up tilt (Frost, 1977;- Abbushi,
1930). Decreases in CPP have also been reported (Apuzzo st al.,1977;
et al.
Shapiro and Marshall, 1978; Kikuta/ 1980; Doblar et al., 198l). By
increasing ICP PEEP may produce a critical reduction in blood flow in
25"
regions of the brain where marginal conditions for tissue perfusion
exist, for example, in focal expanding lesions caused by trauma or
ischaemia in which existing vasodilatation reduces the capacity for
further compensatory dilatation when the local tissue pressure is
increased. This is particularly likely to occur if the PEEP causes
hypotension. The presence of intracranial hypertension diminishes
the increases in TCP seen at a given level of PEEP because there is
greater compression of the cerebral veins as they enter the dural
sinuses, thus the effect of an increase in CVP will be less (Huseby
et al., 1981). Termination of PEEP tends to cause an overshoot in
ICP because the arterial pressure increases and temporarily overcomes
the autoregulation mechanisms. Neurological dysfunction has been
demonstrated in cats during the application of PEEP (Aidinis et al.,
1976). This could be explained by brain displacement or cerebral
ischaemia.
The Influence of Hypothermia
Hypothermia lowers CBE and CMR02 (Stone et al., 1956;
Rosomoff and Holaday, 195^; Michenfelder and Theye, 1968), brain
volume (Rosomoff and Gilbert, 1955), and ICP (Rosomoff and Gilbert,
1955; McQueen and Jeanes, 1962).
Pain or Peripheral Stimulation
Pain and anxiety induce a marked increase in CBF and CMR02
(ingvar, 1975; Kety, 1975). These effects are of an arousal
nature and are probably related to enhanced neuronal function and
catecholamine release in the brain, because in rats stress causes
a marked catecholamine mediated increase in CBF and CKR02 (Carlsson
et al., 1977). ICP increases can be seen in head injured patients
during painful stimulation such as arterial blood sampling and
during application of a facemask to neurosurgical patients
(dreenbaum et al., 1975)• These increases are presumably due to
arousal.
Surgical Manoeuvres
Surgical manoeuvres such as insertion of the G-igli saw guide
and application of a head clamp can cause marked increases in ICP
without increases in arterial or central venous pressures (Shapiro
et al., 1972a, 1972c). Pressure on the brain substance during
removal of the bone flap can also increase CSP pressure (Stephen
et al., 195/4-).
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Thus during investigations into the effects on ICP of
anaesthetic agents and techniques it is important to keep the
PaC02, Pa02, temperature, posture and inflation pressures
constant, and to avoid surgical stimulation, because alteration
of any of these factors will alter the ICP response. In the
interpretation of the results it is important to take into
account changes in CVP, arterial pressure and CPP.
0.7
PATHOPHYSIOLO&Y OF THE INTRACRANIAL CONTENTS
Raised Intracranial Pressure
There is no evidence that increased hydrostatic pressure
has a direct effect on neuronal function or structural integrity in
the train. The adverse effects of raised ICP produce neuronal
damage indirectly, through cerebral ischaemia or because of brain
shift, and in each of these mechanisms elevated ICP is only one of
several factors that interact to injure the brain (Miller, 1975;
Miller, 1979b). When the brain and cerebrovascular system are
relatively normal, central nervous system function can continue in
some patients despite ICP values in excess of 100 mm Hg and cerebra.l
perfusion pressures of 10 mm Hg or less (Miller et al., 1972).
In dogs , when CBP is reduced by elevating ICP, a CBF of LO to 5Cffo
of control appears to be adequate to maintain normal brain energy
metabolites while a lower CBP is not(Bruce et al J972). When the brain
is deformed and the cerebrovascular bed is structurally or function¬
ally compromised much smaller increases in ICP may be associated
with neurological deterioration. Chawla, Hulme and Cooper (1975)
have reported that there is a decrease in CBP and cortical available
oxygen ?/hen ICP is greater than 1,0 mm Hg, but this varies from
patient to patient. Thus the level of ICP at which reduction should
be attempted is uncertain. Repeated insults to the brain in the
form of elevations of ICP ultimately impair autoregulation, even if
none of the individual rises of pressure has been sufficient to
cause cerebral ischaemia (Miller et al., 1973)> and if autoregulation
is impaired any increase in ICP will cause a fall in CBP (Miller et
al., 1972). Locally expanding mass lesions may affect local CBP by
producing tissue pressure differentials.
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The Pressure-Volume Curve
The pressure-volume curve of the intracranial contents
describes the ICP changes associated with increasing volume of one
of the intracranial contents. Due to compensation for the change
in volume the pressure remains fairly constant until all the
compensation is used up when there is a steep rise in pressure.
Even before the compensation is used up a rapid increase in volume
of any one of the contents, for example an increase in CBV due to
halothane administration, may cause a steep increase in ICP.
Thus when a space-occupying lesion begins to enlarge, there
is little change in ICP, due to compensatory shifts of venous blood
and CSP out of the skull. While this is occurring, however, the
reserve of compensation is being used up, and any additional volume
results in a large ICP increase. Most patients with intracranial
pathology are on the flat compensated part of the pressure volume
curve, though they are at various stages on the way to exhaustion
of the compensating reserve. It is only at a very late stage, when
all the compensation is used up, that patients (usually those with
rapidly expanding space-occupying lesions) reach the steep section
of the curve and ICP rises rapidly. At this stage there is
cerebral vasomotor paralysis with loss of both autoregulation and
responsiveness to PaC02 changes (Langfitt et al., 1965b) and ICP
follows the arterial pressure passively.
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Pressure Gradients arid Brain Shifts
With any stimulus which causes an increase in ICP, pressure
gradients must exist until equalisation of CSF pressure occurs and
such gradients have "been demonstrated between the supratentorial and
spinal CSF spaces in patients with intracranial disease, particularly
in relation to temporal lobe herniation through the tentorium (Smyth
and Henderson, 1938; Kaufmarm and Clark, 1970)• Pressure gradients
have also been demonstrated between the supratentorial and infra-
tentorial CSF spaces in dogs (Fitch and McDowall, 1971) and in
baboons (Johnston and Rowan, 197ha). Usually these gradients are
compensated for by CSF pressure equalisation because this pressure
remains essentially the same throughout the CSF sp&oe, but a point
eventually occurs when CSF pathways become obstructed due to brain
shift and impaction of the brain occurs. Brain shift occurs
because the local tissue pressure around an expanding space-occupying
lesion is greater than the pressure in other areas of the brain.
This pressure is dissipated throughout the surrounding brain and CSF,
and gradients are difficult to measure until brain shift has caused
interruption of the CSF pathways. For brain shift to occur,however,
there must be some pressure gradient and differential pressures must
exist in relation to a rapidly expanding intracranial mass whose rate
of expansion exceeds the rate of adjustment of the intracranial
compensating mechanisms. As well as generating shearing forces and
brain shift, such pressure gradients will favour propagation of
oedema (Paulson, 1972). Actual shift of brain tissue may cause
brain damage by direct compression, will lead to distortion of local
blood supply and may cause obstruction of cerebral venous drainage by
kinking of the cortical veins as they enter the venous sinuses.
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In addition to pressure cones occurring through the foramen
magnum (Cushing, 1902) and through the tentorium (Jefferson, 1938)
when the cranium is intact, there is the danger of external
herniation and upward shifts through the tentorium when external
decompression is performed.
Intracranial Pressure Waves
Lundherg (i960) described three types of variations of ICP
or pressure waves: A-waves or plateau waves which have an amplitude
of 50 to 100 mm Hg lasting for 5 to 10 minutes (although it is now
more generally accepted that these waves can last up to 20 minutes);
B-waves, or one per minute waves (usual range | to 2 per minute)
with an amplitude of 20 to 25 mm Hg; and C-waves, or 6 per minute
waves, which are related to rhythmic variations of the systemic
arterial blood pressure (Traube-Hering waves). Risberg and
colleagues (1969b) suggest that plateau waves are caused by an
initial limited increase in ICP which may have been precipitated by
a spontaneous variation in cerebrovascular resistance (Kjallquist
et al., 196a) which in turn causes an increase in CBV and thus in
ICP (Lundberg, 1972). This increase in ICP cannot be compensated
for because of existing compression and leads to a further decrease
in cerebrovascular resistance which in turn leads to a further
increase in CBV and ICP. The cerebral vasodilatation allows the
blood pressure to be transmitted straight through to the cerebral
capillaries causing cerebral oedema and a further increase in ICP.
Thus dilatation of the cerebral vessels seems to be of primary
importance in the production of a plateau wave. The initial
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limited increase in ICP will also induce compression of the
outlets of the leptomeningeal veins (Laas and Arnold, 19Sl) which
will lead to cerebral venous distension and contribute to the increase
in CSV.
Tindall et al. (1972b)reported that a transient PaC02 increase
often preceded the development of a plateau wave. This could be
the cause of the initial decrease in CVR which precipitates the
plateau wave.
Johnstone etal. (1975) found that CBF remained at control
levels despite falling cerebral perfusion pressures during plateau
waves, and that there was a marked cerebral hyperaeraia between
pressure waves.
Global Effects of Cerebral Pathology on the Circulation
If ICP is increased rapidly (for example by expanding an
intracranial balloon) CBF declines (Langfitt, 1965a), and ceases
when ICP exceeds the MAP, but with a gradual rise in ICP there is
a minimal change in CBF until the CPP is reduced below the lower
level of autoregulation. As ICP increases cerebral vasodilatation
occurs (Goodman and Wilson, 197i) and eventually the associated
increase in CBF increases CBV and thus ICP, so that a vicious circle
develops until ICP equals MAP. Restoration of ICP to normal after
a period of intracranial hypertension, for example by removal of an
intracranial mass, may also cause cerebral vasodilatation (Langfitt
et al., 1965a; Grubb et al., 1975; Zwetnow, 1970a) which usually
lasts for 30 to 90 minutes.
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Langfitt et al. (1965b) have described /,. stages of cerebro¬
vascular compensation and decompensation in response to increasing
intracranial space occupation:- Stage 1: a period of spatial-
compensation, loss of CSF and possibly blood from the cranium;
Stage 2: when the intracranial volume is sufficiently increased to
cause an increase in ICP leading to vascular dilatation which further
increases volume and pressure; Stage 3" failure of the vasopressor
mechanism (i.e. the increase in MAP in response to the increase in
ICP) with a terminal pressure wave causing the arterial pressure to
fall to the level of the, ICP; Stage h_: vasomotor paralysis is
complete with ICP and MAP becoming inseparable (which can only occur
if respiration is being supported because apnoea occurs).
Trauma to the cat brain impairs cerebral autoregulation and
under these conditions an increase in MAP is transmitted straight
to the capillary bed producing acute cerebrovascular congestion and
oedema (Marshall et al., 1969). Similar changes can occur when
hypertension is combined with hypercapnia or follows a period of
profound hypotension in the absence of trauma to the brain.
Impairment of autoregulation which may be global or localised is also
found in patients with head injuries (Enevoldsen and Jensen, 1973),
ischaemic brain lesions (Pieschi et al., 1968; Hoedt-Rasmussen et al.,
1967; Paulson, 1970; Zinke et al., 1979), subarachnoid haemorrhage
(Heilbrun et al., 1972), cerebral tumours (Palvolgyi, 1969), except
for meningiomas in which autoregulation is usually well preserved
(Schmiedek et al., 1975) and during seizure activity (Plum et al.,
apparently
1968). In severe head injury/preserved autoregulation is not
always a good sign because it may not be a true autoregulation.
It may be due to an increase in tissue pressure caused by raised
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arterial pressure in the absence of normal autoregulation
(Enevoldsen and Jensen, 1978). There is evidence that, in the
presence of space-occupying lesions, there is more rapid exhaustion
of autoregulatory capacity in the hemisphere subjected to greater
compression (Symon et al., 197A) •
Carbon dioxide reactivity is also altered in the presence
of intracranial pathology. It is less commonly altered than
autoregulation in patients with ischaemic lesions (Hoedt-Rasmussen
et al., 1967; Fieschi et al., 1968; Paulson, 1970; Zinke et al.,1979).
It is also altered in severe head injury, returning to normal as
recovery occurs (Cold et al., 1977a, 1977b; Enevoldsen and Jensen,
1978; Nyary and Pasztor, 1973), in cerebral tumours (Palvolgli,19£>9;
Schmeidelc et al., 1975), and experimental subarachnoid haemorrhage
(Hashi et al., 1972). Loss of autoregulation and cerebrovascular
reactivity to C02 may not always occur in the same areas of brain
(Fieschi et al., 1968). Acute brain injury tends to affect auto¬
regulation first and all vasomotor control later (Alexander and
Lassen, 1970).
This loss of autoregulation and carbon dioxide reactivity
in relation to cerebral pathology has been termed the 'luxury
perfusion syndrome' by Lassen (1966), because the CBF is in excess
of that required to satisfy the metabolic requirements of the area
of brain tissue involved. It may be due to the expanding mass
lesion compressing vessels which leads to ischaemia and lactic
acidosis which in turn causes vasoparalysis. It could, however,
be due to abnormal brain metabolism leading to accumulation of
acid metabolites.
It is of special practical importance that only very mild
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local compression of brain tissue seems able to elicit the
vicious circle of acidosis, hyperaemia, blood brain barrier damage,
oedema, and local compression which creates further acidosis and so
on. Thus, during neurosurgery, gentle retraction and manipulation
Cerebrovascular carbon dioxide reactivity can also be
significantly impaired in hypertensive patients (Griffith et al.,
1978) and diabetics (Dandona et al., 1978).
In diffuse chronic brain diseases, e.g., senile dementia,
cortical blood flow is reduced (Bower et al., 1970; Ingvar and
Gustafson, 1970) but cerebrovascular control is unaltered (Lassen,
1971; Simard et al., 197l) and in diffuse cerebrovascular disease
the cerebrovascular response to C02 is largely maintained (McHenry
et al., 1972).
Focal Effects of Cerebral Pathology on the Cerebral Circulation
Focal loss of autoregulation and carbon dioxide reactivity
in the region of a cerebral tumour, infarct or area of oedema may
lead to intracerebral steal when there is cerebral vasodilatation
in normal brain tissue. This is a paradoxical decrease in flow
through the damaged region when C3F through normal brain is
increased for example by an increase in PaC02 (Fieschi et al., 'I968;
Palvolgyi, 1969; Paulson, 1970; Waltz, 1970). Several authors
could not demonstrate intracerebral steal with volatile agents
(Smith et al., 1973b; McKay et al., 1976). These authors showed
an increase in CBF with halothane and enflurane in the ischaemic
territory, but Hanson and colleagues (1975) and De Rood and co-workers
of the brain is essential (Lassen, 1968a).
(l97t) showed that halothane caused steal phenomena in ischaemic
areas.
Conversely, if cerebral vasoconstriction is induced in
normal brain tissue in the presence of focal vasoparalysis an
increase in flow through the damaged region, which has been termed
inverse intracerebral steal, can occur. Inverse intracerebral steal
has been demonstrated during hypocapnia (Palvolgyi, 19^9; Paulson,
1970; Cold et al., 1977b) and when anaesthetic drugs (e.g., Althesin)
which cause cerebral vasoconstriction were administered (Renou et al.,
et al. .
1977a;Orgogozo et al., 1977; Rasmussen/,1978; Renou et al., 1978a).
It has been suggested that intracerebral steal is not caused
by dilatation of the cerebral vessels causing a diversion of blood
away from the diseased area, but by an increase in resistance to flow
through the vessels in the lesion because an increase in PaC02 causes
an increase in ICP and thus an increase in brain tissue pressure
(Welch and Meyer, 1970; Lassen, 1971; Meyer et al., 1972).
Therefore 'intracerebral squeeze' would be a better term. Inverse
intracerebral steal could similarly be explained by the cerebral vaso¬
constriction causing a reduction in brain tissue pressure.
Hypocapnia does not, however, always improve the blood supply
to an area of focal cerebral ischaemia. If the lesion is receiving
a collateral blood supply from vessels which are still sensitive to
carbon dioxide, hypocapnia may reduce the blood flow to the ischaemic
area (Yamamoto et al., 1971)•
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Effects of ICP on Venous Pressure Gradients
When ICP increases,the pressure in the cerebral cortical
veins increases and remains a few mm Hg above the ICP (Yada et al.,
1973; Johnston and Rowan, 197t-b). If this was not so these veins
would collapse and cerebral venous drainage into the dural sinuses
would be obstructed. The pressure in the superior sagittal . sinus
remains constant as ICP increases because it is virtually
incompressible (Yada et al., 1973; Johnston and Rowan, 197'jb).
In fact Bedford (191.2) described a small fall in sagittal . sinus
pressure when ICP was increased in dogs. The sagittal sinus pressure
increases to levels approaching ICP only during the later stages of
intracranial hypertension (Shulman et al., 196/+; Johnston and Rowan,
1971-b; Martins et al., 1971-)• The cavernous sinus in man cannot be
compressed by an increase in ICP (Muller and Deck, 1975)• Flow
through the lateral lacuna decreases as ICP increases due to gradual
stenosis of these vessels. Thus the regulatory mechanisms
controlling intracranial venous pressure is located in the intradural
portion of the drainage system next to the major dural sinuses. This
mechanism prevents collapse of thin-walled cortical vessels during
increased ICP but also leads to a decrease in CBF (Yada et al., 1973)*
Thus a considerable pressure gradient can develop between the cortical
veins and the draining sinuses.
Permutt and Riley (1963) discussed the physics of flo7/ through
collapsible tubes which have a higher pressure surrounding them than
their outllow pressure. These are the conditions which apply to the
cerebral cortical veins, because the ICP is higher than the sagittal
sinus pressure (Shulman et al., 1962,.), markedly so during intra¬
cranial hypertension. Under these circumstances a change in flow
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has no influence on the pressure drop across the end of the tube,
and a change in pressure drop across the end of the tube has no
influence on flow. These are the characteristics of a waterfall
and the effect has been termed a 'vascular waterfall'. The
Poiseuille equation still holds for flow through the arteriole up
to the vascular waterfall provided the proper driving pressure is
used, i.e., the pressure at the arteriole minus the critical closing
pressure of the cortical vein, thereafter the flow takes on the
characteristics of a waterfall. As ICP increases the cerebral
arterioles must dilate to maintain a constant cerebral blood flow
against the increased resistance in the cerebral veins (Bloor, 1972).
Brain Swelling due to an Increase in CBV
Vascular factors appear to be very important in the early
stages of brain swelling in patients with cerebral trauma, and the
onset of vasomotor paralysis may be the turning point between
reversible and irreversible swelling. The brain parenchyma becomes
oedematous in the latter stages of brain swelling (Langfitt and
Gennarelli, 1982). Barbiturate therapy may be effective when intra¬
cranial hypertension is due to vascular engorgement (Marshall et al.,
1979).
Cerebral Oedema
Several types of cerebral oedema have been described
(Miller, 1979a). Prom a neurosurgical point of view, the vasogenic
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type of oedema is more common and important, since it is usually
associated with brain tumours, head injury and brain inflammation
(Reulen, 1976).
Vasogenic cerebral oedema
In vasogenic cerebral oedema the starting point is related
to injury of the walls of cerebral blood vessels lead.ing to an
escape of water and plasma constituents into the surrounding
parenchyma (KLatzo, 1967). The injury to cerebral vasculature is
usually of a local character, such as occurs in the vicinity of
brain tumours, traumatic lesions and inflammatory foci. It seems
that in the majority of cases the vascular injury is severe enough
to allow an indiscriminate escape of plasma components including
serum proteins. The oedema is localised predominantly in the
white matter where there is enlargement of the extracellular spaces
which provide the pathway for the movement of oedema fluid. Any
cellular swelling predominantly affects the astrocytes. The oedema
is confined to the area of the lesion, and blood vessels outside
the area of the lesion but within the oedema territory do not show
an increased permeability. Oedema occurs because of damage to the
blood brain barrier with an opening of the tight junctions allowing
the passage of oedema fluid into the extracellular space. This has
been observed in a variety of neuropathological conditions, such as
malignant brain tumours, local injury, and experimental allergic
encephalomyelitis (Reulen, 1976). The driving force for the extra¬
vasation of fluid is the capillary transmural pressure gradient
(the difference between the intravascular and interstitial fluid
pressure). Thus an acute increase in the arterial pressure
results in a dramatic increase in oedema formation (Schutta et al.,
1968; Paulson, 1972) whilst a decrease in arterial pressure inhibits
the development of oedema.
Oedema fluid probably moves by bulk flow because measurement
of interstitial fluid pressure at various distances from the lesion
showed the existence of hydrostatic pressure gradients during oedema
with the highest pressure in the area of the lesion and decreasing
pressure along the oedema pathway towards the normal tissue
(Reulen, 1976).
An increasing interstitial fluid pressure, resulting from a
pathological accumulation of oedema fluid in the extracellular space,
may approach the intravascular pressure at the venous end of the
capillary thus tending to collapse the vessel, increasing resistance
to flow through it and decreasing local blood flow. Oedema per se
does not appear to interfere with brain function, which is only
disturbed when the volume of oedema is sufficient to reduce local
blood flow by the mechanism described above, or to produce a
generalised increase in ICP sufficient to reduce CPP to ischaemic
levels (Langfitt, 1965b).
Cytotoxic cerebral oedema
In cytotoxic cerebral oedema a noxious factor (hypoxia or
certain types of poisoning) directly affects the structural
elements of the parenchyma producing intracellular swelling,
vascular permeability remains relatively undisturbed (Klatzo, I967).
The cellular swelling itself is a non-specific reaction, which can
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be induced by agents of varying nature all of which disturb cell
osmoregulation. It may be caused by an interference with the
sodium pump. Cytotoxic brain oedema is localised in the grey or
white matter depending on the type of cytotoxic agent. Swelling
of necrotic cells following ischaemic or hypoxic insults occurs
in patients with cerebral infarcts. If vascular damage is also
present at the edge of the infarct, vasogenic and cytotoxic oedema
can co-exist.
Hydrostatic oedema
Thi3 type of oedema is produced by increases in intravascular
pressure which are transmitted to the capillary bed because there
is no compensatory increase in cerebrovascular resistance (Schutta
et al., 1968; Marshall et al., 1969). The failure of autoregulatory
compensation may be due to direct trauma, excessive arterial hyper¬
tension, hypercapnia or hypoxaemia. Water pours out into the
extracellular space in the absence of damage to the vascular endo¬
thelium. The fluid is thus not protein rich and is forced out of
the vessels by the high intravascular pressure which upsets the
Starling equilibrium. Hydrostatic oedema is generally diffuse
unlike vasogenic oedema which is focal. This form of oedema can
occur during craniotomy when a rise in intravascular pressure is not
balanced by an equivalent increase in ICP. It can also occur when
a surgical decompression is performed on a patient with a mass
lesion of long standing.
Interstitial oedema
This is a form of cerebral oedema which can be seen in the
periventricular area in patients with obstructive high pressure
hydrocephalus, and is caused by seepage of CSF through the
ependyma and into the periventricular white matter (Fishnan, 1975).
Hypo-osmotic oedema
This form of cerebral oedema, which is diffuse, occurs when
plasma osmolality is reduced, and is thought to develop under
circumstances in which hyponatraemia occurs, as in the syndrome
of inappropriate ADH secretion or when excessive amounts of intra¬
venous dextrose-water solutions have been infused.
Osmotic diuretics will help in the treatment of cytotoxic
cerebral oedema by reducing cellular oedema, but in vasogenic cerebral
oedema they will reduce ICP by reducing the size of normal cells and
may cause an increase in extracellular oedema by crossing the blood
brain barrier and dra?/ing in more water with them. Avoidance of
agents which cause cerebral vasodilatation (hypoxia, hypercarbia,
volatile anaesthetic agents and hyperthermia), control of hypertension,
steroid therapy, hyperventilation and diuretics such as frusemide




THE EFFECTS OF ANAESTHETIC AGENTS ON ICP AND CBF
A-3
MECHANISMS OF ANAESTHETICALLY-INDUCED CHANCES IN ICP
Some anaesthetic agents produce major changes in ICP.
Because of the speed of onset and the sise of these ICP changes the
only likely explanation for them is an alteration in CBV caused by
a change in CBF. The fact that anaesthetic agents which alter ICP
also alter CBF supports this explanation. No direct measurements
change*
of anaesthetically-induced CBi/have been made, but Risberg
has shown a very high linear correlation between changes in CBF and
CBV and a definite correlation between CBF and CSF pressure has been
demonstrated (Shenkin et al., 1952; Hamer et al., 197l)« As
described in Chapter 1, an increase in CBF will increase the intra¬
cranial arterial blood volume to some extent but will increase the
volume of blood in the readily distensible, thin-walled cerebral
veins to a much greater extent. Another possible explanation for
the ICP change associated v/ith the administration of anaesthetic
agents is a change in the rate of CSF formation. The rate of CSF
formation has been shown to be influenced by drugs (see p. 6),
cerebral blood flow changes, alterations in metabolic rate (Bering,
1959) and sympathetic activity (Lindvall et al., 1978). The rate
of CSF production is 0.35 to 0.37 ml./min.(Rubin, 1966; Cutler,1968)
and the resistance to reabsorption of CSF is so low that a three-fold
increase in CSF formation rate would only raise ICP to 1A.7 mm Hg
(Cutler et al., 1968). Thus this mechanism is too slow, and is
probably incapable of producing changes of sufficient magnitude, to




The most important mechanism whereby ICP can be increased
by anaesthetic agents is through a change in CBF and CBV, but there
are other possible mechanisms. Many anaesthetic drugs will depress
the myocardium and will increase central venous pressure and. thus
cerebral venous pressure which will lead to an increase in ICP.
Cyclopropane increases central venous pressure (Price et al., 1953;
Thompson et al., 1957);although deep halothane anaesthesia may
increase CVP, appreciable increases do not occur with the inspired
concentrations required for surgical anaesthesia (Adams et al.,1972).
Most anaesthetic agents cause central respiratory depression
and thus will cause an increase in PaC02. This PaC02 increase v:ill
in turn cause an increase in CBF and ICP.
In patients with cerebral pathology in which autoregulation
is defective, an increase in MAP caused by some anaesthetic agents
may lead to an increase in CBV, cerebral oedema and an increase in ICP.
One further mechanism by which the administration of an
anaesthetic agent leads to an increase in ICP is by the diffusion
of nitrous oxide into the ventricles when air has been used for
pneumoencephalography. The nitrous oxide increases ICP by causing
the air space to expand because nitrous oxide diffuses into the space
more ra.pidly than nitrogen diffuses out.
The mechanism whereby anaesthetic agents alter CBP is
uncertain. Considerable differences in CBF, which are closely
related to local increases in neuronal activity and metabolism, can
occur in localised areas (Olesen, 197l)» and there are increases in
regional oxygen uptake which parallel these changes in CBF (Raichle,
1975). In addition, abnormal increases in cerebral metabolism occur
during seizure activity (Plum et al., 1968; Sakabe et al., 197A;
Brodersen et al., 1973), and by producing an increase in CBF cause
an increase in CSF pressure (Stephen et al., 195a)» Thus changes
in cerebral metabolism can alter CBF. Anaesthetic agents have been
shown to alter CMR02 and this may be the mechanism whereby they alter
CBF.
The mechanism whereby CBF is controlled at cellular level is
uncertain. It is now accepted that the pH hypothesis (i.e., that a
change in hydrogen ion concentration in the cerebral extracellular
fluid around pial and parenchymal vessels will influence the tone of
the vascular smooth muscle), cannot explain all the experimental
observations, and that no simple hypothesis can be advanced to explain
the relationship between CBF and cerebral metabolism (Cameron, 1977;
Astrup et al., 1978; Purves, 1978). Purves (1978) suggests that in
addition to the system of rapid regulation of CBF in response to
systemic disturbances such as hypoxia, hypocapnia and hypotension,
which threaten the supply of oxygen and substrate and the immediate
chemical environment of the neurones, there could be a second system
which acts as a fine tuner to ma.ke local adjustments of perfusion to
metabolic rate. This system may involve factors very different from
those known to dilate pial or extraparenchymal vessels which include
potassium ions (Baldy-Moulinier, 1971-2; Kuschinsky et al., 1972;
Heuser et al., 1977; Astrup et al., 1978; Heuser, 1978), hydrogen ions
(Lassen, 1968b;Kuschinsky et al., 1972; Heuser et al., 1977; Astrup et
al., 1978), and adenosine (Wahl and Kuschinsky, 1976; Cameron, 1977;
Purves, 1978).
The effects of pH, potassium ions, and adenosine on the
vascular muscle may eventually be explicable in terms of their
influence on the entry of calcium ions into the cell, one of the
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essential steps in smooth muscle contraction (Cameron, 1977;
Purves, 1978).
Prostaglandin F„ causes cerebral vasodilatation and may be
involved in the control of CBF (Emerson et al., 1976; Vlahov, 1976).
It has been suggested that cyclic AMP may be involved in cerebro¬
vascular dilatation (Wahl and Kuschinsky, 1976), and MacMurdo and
colleagues (l98l) claim to show a dose-related increase in brain
cyclic AMP levels with the administration of ether and halothane, which
suggests a causal relationship between their effect on cyclic AMP and
their cerebrovascular effects. Scrutiny of the latter author's results,
however, reveals that the difference between the results with halothane
and pentobarbitone was small, and the results with halothane were of
borderline significance.
So there is a multifactorial control mechanism for CBF, with
the brain having at its disposal several potent and independent local
vasodilatory mechanisms including hydrogen ions and potassium ions
which, together with the perfusion pressure, control CBF.
Keaney and colleagues (1978) have shown that the cerebro¬
vascular response to Althesin occurred approximately 2 seconds after
the arrival of the drug in the brain, and within 1 second of the
onset of the electroencephalogram (EEG) depression. From calculations
of the change in cortical carbon dioxide tension and hence tissue/H^7
they concluded that this was too small to be the factor linking
metabolism and flow. By repeating the experiment in baboons after
acute cervical sympathectomy and ©(-adrenergic blockade, they also
excluded the involvement of the sympathetic nervous system in the
vasoconstrictor response. The calculations have been confirmed by
the measurement of cortical extracellular fluid pH during Althesin
administration (McDowall et al., 1979). Perhans the most likely
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mechanism causing the initial change in flow is a decrease in extra¬
cellular fluid potassium ion concentration due to depression of
neuronal function. The decrease in extracellular fluid pH may play
a part in the maintenance of the change in CBF. Another explanation
is the removal of tonic activity in a vasodilator pathway. Extra¬
cellular potassium ions also act as a vasodilator initiating hyperaemia
in seizures, and extracellular hydrogen ions seem to be important in
maintaining the hyperaeraia, but hyperaemia may be initiated and
maintained by other mechanisms as in amphetamine activation and
hypoglycaemia (Astrup et al., 1978).
Most inhalational anaesthetics uncouple the relationship between
cerebral metabolism and CBF so they cannot alter CBF by their effect on
cerebral metabolism. Stullken et al. (1977) have shown that, during
anaesthesia with enflurane, halothane, isoflurane and thiopental in
dogs, there is an abrupt metabolic depression when the EEG pattern
changes to an "anaesthetic" pattern, and that this change occurs at
concentrations well below 1 MAC. This indicates that the metabolic
depression is caused by the anaesthetic state. It is unknown whether
the increased CBF to CMR02 ratio with deep inhalation anaesthesia
indicates an improved safety margin or whether the higher tissue P02
is somehow necessitated by a block in oxygen utilisation or uptake
(Smith and V/oilman, 1972).
Because the maximum effect of halothane on CBF occurred A to 5
minutes after the arterial halothane concentration had reached a
maximum, Smith (1973a) suggested that the increase in CBF during
halothane anaesthesia is not due to a direct effect of halothane but
due to halothane altering PVo2, with an increase in CBF and a decrease
in CVR following as secondary effects. It seems more likely,
however, that the altered PV02 is just another manifestation
of altered cerebral metabolism.
TIME COURSE OF ANAESTHETICALLY-INDUCED CHANGES IN ICP
Compensatory mechanisms would be expected to return ICP to
its initial value and this can be shown to occur after 52 minutes
of 0.5/o halothane administration in dogs (McDowall et al., 1966),
after 10 to 30 minutes in man with halothane 0.5 to 1% (Adams et al.,
1972), after 10 to 20 minutes with isoflurane (Adams et al., 198l)
and after 10 to 15 minutes with ketamine (Sari et al., 1972).
EFFECTS ON ICP OF INTERACTION BETWEEN ANAESTHETICS AND
BRAIN PATHOLOGY
In the presence of an intracranial space-occupying lesion
the changes in ICP can be accentuated. Anaesthetic agents which
increase ICP have a greater effect when the ICP is elevated before
administration (Jennett et al., 1969), and those which reduce ICP
cause a greater reduction in patients with higher initial ICP values
(Turner et al., 1973)* This is due to the nature of the pressure
volume curve of the intracranial contents described on page 29.
If a standard volume increment is added to the intracranial contents
e.g., the administration of halothane, the increase in ICP is
gradually accentuated as the intracranial contents become more
compressed (Fitch and McDowall, 197l)» If halothane is given when
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compensation has been overcome/there is cerebral vasomotor paralysis,
the ICP will fall as the arterial pressure falls. Anaesthetic
agents do not appear to precipitate plateau waves (Jennettet al.,1969).
Al
INTERACTION O.F HYPERVENTILATION WITH ANAESTHETIC
DRUG-S
Adams and his colleagues (1972) showed that CSF pressure
increases associated with the administration of halothane 0.5 to
I% were small when hyperventilation (PaC02 less than A KPa) was
established for 10 minutes prior to the introduction of halothane,
but G-ordon (1970) found that hyperventilation did not fully
protect against increases in ICP during the administration of
halothane in patients with very high initial ICP values, a
finding which was supported by the work of Jennett and colleagues
(1969). Simultaneous introduction of isoflurane and hypervent¬
ilation (PeC02 3.3 to A KPa) prevented increases in lumbar CSP
pressure with this agent, and initiation of hyperventilation
during isoflurane anaesthesia reduced CSF pressure to control
levels (Adams et al., 1981). The influence of anaesthesia on
cerebrovascular reactivity to C02 will be discussed separately.
INTERACTION OF OSMOTIC AGENTS WITH
ANAESTHETIC DRUG-S
agents reduce the volume'of the intracranial
thus one would expect the effects of volatile agents
less after the osmotic agents have been given.
Osmotic
contents and
on ICP to be
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THE EFFECT OF ANAESTHESIA ON CEREBROVASCULAR REACTIVITY TO
CARBON DIOXIDE
The cerebral circulation retains its responsiveness to changes
in PaC02 during halothane anaesthesia (Alexander et al., 196k; McHerrry
et al., 1965; Christensen et al., 1967i Okuda et al., 197b) except
during profound hypotension (systolic B.P. = 60 mm Hg) (Okuda et al.,
1976), although Alexander and colleagues (196O found that the shape
of the PaC02 response curve was altered, showing an increase in cere¬
brovascular sensitivity to changes in PaC02, a finding confirmed by
Scremin and colleagues (1978). With 1.2% halothane the CBF response
to C02 tends to diminish at a PaC02 of about 6.7 KPa because the
cerebral vessels are nearly maximally dilated (Alexander et al.,196>,.).
Carbon dioxide reactivity is also markedly increased during 21/o
cyclopropane anaesthesia (Alexander et al., 1968a;Smith and Wollman,
1972).
Carbon dioxide reactivity is not altered by thiopental
anaesthesia deep enough to reduce CMR02 by iSffo (Schieve and Wilson,
1953; Pierce et al., 1962), by Althesin anaesthesia (Sari et al.,
1976), by ketamine anaesthesia (Sari et al., 1972a),or by etomidate
anaesthesia (Renou et al., 1978c). Carbon dioxide reactivity was
significantly greater in patients anaesthetised with methohexitone,
nitrous oxide, oxygen and neuroleptanalgesia than in awake subjects
(Iliff et al., 1976), and was reduced by a combination of diazepam
and fentanyl according to Renou and colleagues (l977b)but unchanged
by this combination according to Vernhiet and co-workers (1978).
Diazepam alone does not affect cerebral vaso-reactivity to carbon
dioxide (Cotev and Shalit, 1975)•
Reactivity to carbon dioxide is also preserved during
isoflurane (Cucchiara et al., 197;,), methoxyflurane (Michenfelder
and Theye, 1973), enflurane (Michenfelder and Cucchiara, 1971.;
De Rood et al., 1980a), trichloroethylene (McDowall et al., 196^),
and chloroform anaesthesia (McDowall, 1965). It is unaltered hy
70% nitrous oxide (Wollman et al., 1965) or nitrous oxide, oxygen
and neuroleptanalgesia (Wilkinson and Browne,1970). Fentanyl and
fentathienyl increase cerebral vascular reactivity to carbon
dioxide (Vernhiet et al., 1977)•
TH3 EFFECT 0? ANAESTHESIA ON AUT0R3GULATION OF CBF
Autoregulation is preserved during light general anaesthesia
with both nitrous oxide and cyclopropane, but impaired at deeper
levels of cyclopropane anaesthesia (20%) during arterial hypotension
(Smith et al., 1970; Smith and Wollman, 1972). It is also
preserved during nitrous oxide anaesthesia supplemented with
fentanyl, Althesin and halothane or enflurane (Farrar et al.,198l).
In baboons disturbance of autoregulation has been observed
following deep halothane anaesthesia when the blood pressure had
been restored to normal (Keaney et al., 1973b), and following the
restoration of the blood pressure after nitroprusside hypotension
(Keaney et al., 1973a)« This impairment of autoregulation can
last for at least 100 minutes. The slow return to normal could be
due to the gradual correction of an undetected cerebral extracellular
fluid acidosis. In the monkey autoregulation remained intact during
nitrous oxide/oxygen anaesthesia supplemented with 0.5% halothane,
but when the halothane concentration was increased to 1% autoregul¬
ation was impaired and with 2% halothane autoregulation was
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completely lost (Morita et al., 1977). Morphine 2 mg/Kg during
70% nitrous oxide administration does not affect cerebral auto-
regulation in man (Jobes et al., 1975).
Okuda and colleagues (1976) observed that after restoration
of the blood pressure to normal following deep halothane anaesthesia
in the baboon, the response to changes in PaC02 was still preserved,
which suggests that post-operative hyperventilation may protect
against cerebral hyperaemia and possible oedema formation.
Autoregulation fails in baboons during haemorrhagic hypo¬
tension at an MAP of 65% of baseline, whereas in drug-induced
hypotension it fails at 35 to 2,.Q% of baseline (Fitch et al., 1976).
After chemical or surgical sympathectomy autoregulation persisted to
significantly lower levels of MAP (approximately 35 mm Hg) during
haemorrhagic hypotension (Fitch et al., 1975). It is postulated
that, under conditions of haemorrhagic hypotension, constriction
of the extraparenchymal cerebral vessels in response to sympathetic
stimulation reduces the possible range of autoregulation. This
effect is less noticeable in hypertensive baboons (Fitch et al.,1978).
THE EFFECT OF ANAESTHESIA ON THE CEREBROVASCULAR
RESPONSE TO HYPOXIA
Anaesthesia with pentobarbitone, Althesin or 0.3% methoxy-
flurane did not interfere with the dogs' response to severe arterial
hypoxaemia to an extent that impaired cerebral oxygen transport
(Cohen et al., 1973). Gray and co-workers (1971a) found that
anaesthesia with low concentrations of volatile agents had very
little effect on the CBF response to hypoxia in dogs, but at high
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concentrations the response was variable and frequently resulted
in insufficient oxygen transport to maintain cerebral metabolism.
Halothane anaesthesia was associated with a better oxygen supply
to demand ratio than methoxyflurane or trichloroethylene anaesthesia,
when these agents were given in higher concentrations during
hypoxaemia.
THE EFFECT OF ANAESTHETIC A&ENTS ON OPERATING CONDITIONS
Anaesthetic agents which alter ICP do so by altering CBY,
so brain bulk is influenced by anaesthetic agents. When the
cranium is opened at craniotomy there is an external decompression
of the cranial contents and the ICP falls to zero. Thus the
balancing effect of the ICP is lost, so that when the initial ICP
is elevated, the decompression may lead to an increase in brain
bulk (due to the removal of the restraints of the intact cranium)
and the brain tissue will be forced against the edges of the
craniotomy defect, with the danger of herniation through the
craniotomy site (Jennett at al., 1969). These events will cause
trauma to the brain tissue. A lesser manifestation of the same
process is the greater difficulty the surgeon experiences in
retracting the brain, thus making the operation difficult or even
impossible. The greater the pressure required to retract the
brain, the greater the degree of ischaemia and trauma to the brain
underlying the retractor, and to the surface of the contralateral
hemisphere. If an anaesthetic agent produces arterial hypotension
as well as an increase in brain bulk and retraction pressure, the
risk of cerebral ischaemia will be even greater because the local
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CPP will be reduced further (Albin et al., 1930). In addition
the vascular congestion caused by those agents which increase CBF
will increase the amount of surgical bleeding. Thus operating
conditions can be affected by the anaesthetic agents given.
EFFECTS 0? INDIVIDUAL ANAESTHETIC AGENTS
ON CBF, ICP AND CPP
In this chapter I have discussed in general terms how
anaesthetic agents can affect CBF, ICP and CPP and the potential
harmful or beneficial effects of the changes produced. In order
to avoid repetition, the effects of individual anaesthetics on
CBF, ICP and CPP will be discussed in chapters K to 9j
which deal with the original work, the discussion sections of
which will include reviews of the relevant literature. Unless
otherwise stated, the literature quoted refers to investigations
in man, and when adequate information is available from




METHODS OF ASSESSING THE EFFECTS OF ANAESTHETIC AGENTS
ON THE DYNAMICS OF THE CRANIAL CONTENTS
S(o
MEASUREMENT OF TCP
Before G-uillaume and Janry (1951) described the
continuous measurement of ICP using transducers and Lundberg (i960)
comprehensively reviewed the technique, knowledge about ICP had been
obtained from discrete measurements of lumbar CSF and ventricular
fluid pressure performed during lumbar puncture or craniotomy. The
relative ease with which ICP can be measured, the continuous nature
of the information obtained, and the minimal risk to the patient have
made it a useful method for assessment of the effects of anaesthetic
agents and techniques on intracranial dynamics. Consequently, this
is the method of measurement which was used in the original work
described in this thesis.
Attempts have been made to record changes in ICP by non¬
invasive methods such as echoencephalography and impedance plethys¬
mography, but all techniques which give useful measurements require
the insertion of a measuring device into the cranial cavity.
There are four recognised sites for ICP monitoring; firstly
a lateral ventricle, secondly the intracranial subd.ural space,
thirdly the intracranial extradural space, and fourthly the intra¬
cranial subarachnoid space. In addition, CSP pressure can be
measured from the lumbar subarachnoid space. In steady state
conditions ICP measured outside the CSP space closely approximates
to CSP pressure, but under changing conditions this may not be the
case because of the viscoelastic nature of the brain tissue, its
membranes and blood vessels.
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ICP Measurement from a Lateral Ventricle
A catheter is introduced under sterile conditions into a
lateral ventricle through a burr hole or twist drill hole. Care
is taken to lose as little CSF as possible so that the baseline
ICP can be obtained accurately.
This method feives the most reliable readings of ICP, it
reflects global ICP, and is the standard by which the others
are judged. Other advantages include minimal damping of the
respiratory and pulse waveforms, and the ability to withdraw
CSF to improve surgical access, to reduce ICP, or to allow
biochemical or bacteriological examination.
The disadvantages are that the brain must be punctured
and thus it is more invasive than the other methods, it may cause
intracranial haemorrhage (less than 1% chance) (Fleischer et al.,
1976), and there is the danger of introducing infection into the
ventricular system. In addition, cannulation of a. lateral
ventricle can be technically difficult, and it can be difficult
to keep the catheter patent because of pa.rtial or complete blockage
by collapse of the ventricular surface with either damping or loss
of the pressure recording (Turner et al., 1975).
The ventricular catheter is connected to an electrical
transducer and the signal is amplified and recorded. Transducers
incorporated into the catheter tip are available, but have not yet
reached the required degree of reliability for long-term
measurements.
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TCP Measurement from the Intracranial Extradural Space
Dorsch and Symon (1975a) have discussed the theory of
extradural measurement of ICP. The pressure within a hollow
organ can be measured from outside its enclosing membrane provided
that the membrane is not indented by the pressure sensor (i.e., it
is coplanar with the outer surface of the membrane). Any forces
due to changes in the tension of the membrane which accompany changes
in intracavity pressure must act in the plane of the membrane, while
the force due to pressure inside the cavity can be taken to act along
a radius from the centre of the cavity. These two forces act at
right angles, so the force due to tension in the membrane has zero
component with regard to the pressure sensor because this has maximum
sensitivity along the line of action of the intracavity pressure.
However, if the surrounding membrane is indented by the pressure
sensor then the forces will not be at right angles and the tension
in the membrane will have an effect on the pressure recorded by the
sensor. Thus it is critical that the pressure sensor is correctly
placed. With an implanted transducer the sensing diaphragm must be
exactly flush with the inner surface of the skull and perpendicular
to a line extending from the centre of the brain. Provided that
the dural membrane is absolutely flat against the transducer sensing
surface, the internal pressure will be fully transmitted irrespective
of the tension in the membrane. To satisfy these conditions, Ream
and colleagues (1979) have developed an implantable transducer with
a guard ring which holds the membrane flat. This ring has to be
sufficiently distant from the sensing surface to avoid edge-loading.
The sensing area of the transducer must be large enough to average
out the effects of less than ideal smoothness and non-uniform
5^
thickness of the dura, and the maximal allowable transducer
displacement must be very small. , Any epidural transducer or
device must be rigidly fixed in place once in the correct position.
For measurement from this site one can use a fluid-filled
adaptor such as the device described by Coroneos et al. (l973)»
which is a hollow metal screw with a base-plate and side-holes
rather than an end-hole to minimise blockage of the measurement
holes by the dura mater, or a specially designed transducer which
lies against the dura mater. Many different devices have been
described for measurement of ICP from the extradural space (Nornes
and Serck-Hanssen, 1970; Dorsch and Symon, 1975b; Beks et a.l., 1977;
Levin, 1977; Wald et al., 1977; Ream et al«, 1979; G-jerris et al.,
1980; Koster and Kuypers, 1980; Corbin et al., 1980). The main
problem with an implanted transducer is zero drift, although some
transducers can be re-zeroed in situ. The measuring instrument
is inserted into a burr-hole or twist-drill hole, which must be at
right angles to the plane of the dura, and there must be a watertight
seal round, the bolt or transducer in order to obtain correct
measurements (Coroneos et al., 1972a).
The advantages of this site of measurement are that
insertion of the measuring implement is straightforward, the dura
mater is not breached so that infection, if it does occur, is less
serious (the dura is an excellent barrier against infection), and
patency can usually be maintained without difficulty for prolonged,
periods.
There are several disadvantages of this site of measurement.
CSF cannot be removed, implanted transducers may be subject to zero
drift (although some can be calibrated in situ) and there is also
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evidence of gradients of pressure occurring "between the ventricles
and the brain surface when there are acute relative changes of the
cerebral constituents. Thus values of extradural pressure should
be treated with caution (Cooper and Nornes, 1972), A further
disadvantage is that the dura mater tends to damp the pressure signal,
and although there is a linear relationship between extradural
pressure (EDP) and ventricular fluid pressure (VFP), the measurements
of pressure from the extradural space tend to be higher than the
pressures recorded simultaneously from a ventricular catheter,
particularly at high pressures (G-obiet et al., 1972; Coror.eos et al.,
1972a, 1972b, 1973; Jorgensen and Riishede, 1972; Nornes and Sundbarg,
1972; Sundbarg and Nornes, 1972; Turner et al., 1975; G-obiet et al.,
197A; Gjerris et al., 1980; Nagai et al., 1980), and high EDP has been
reported in the presence of a normal VFP (Turner et al., 1975). Some
hours may be needed after implantation before pressures are recorded
which are reasonably close to CSF pressure, and even then there is
still considerable scatter of VFP and EDP values, and VFP may exceed
EDP (Coroneos et al., 1973).
The VFP/EDP regression line does not pass through zero and
shows an error of the EDP reading up to 10 mm Hg when the VFP is
zero. Zattoni and colleagues (1973) state that EDP reads higher
than the pressure in the subdural space only when the epidural
devices are shaped or placed in such a way as to displace the
surrounding dura mater from the bone surface. However, possible
reasons for the EDP reading higher than the VFP include the following
methodological errors (Dorsch and Symon, 1975a). Firstly, the
construction of the measuring device may allow the sensing portion to
project beyond the rest of the device, thus indenting the dura, so
&(
that the additional stress force causes the measured extradural
pressure to read higher. Secondly, and for similar reasons,
implantation of the transducer at an angle to the dura mater or
indenting it will give a falsely high reading of EDP. An 8 degree
change in the angle of insertion of the transducer will produce
differences in pressure readings of more than 2Cfj (Zierski, 1980).
Thirdly, undue trauma during the insertion of the measuring device
may lead to a localised increase in pressure without affecting the
general ICP. Fourthly, in comparative studies if the zero reference
points for the two forms of measurement are different a constant
differential will occur. The existence of true pressure
differentials can he explained by the dura, because of its relative
thickness, causing a distortion of the pressure transmitted through
it (Cooper and Nornes, 1972; Zierski, I98O), so that, in disturbed
physiological conditions, the deviations between EDP and VFP may be
considerable (up to 20 mm Hg). In addition, factors causing an
increase in CBF which increase brain bulk and only increase VFP
secondarily may lead to pressure gradients which could explain the
difference between these two measurements (Schettini and Walsh, 197J+J
Dorsch and Symon, 1975a). The true extradural to ventricular pressure
differentials at higher ICP levels could be explained by increasing
contact of the dura with the sensor thus converting the system to a
stress/force rather than a fluid-filled system (Jennett, 1972); the
time at which this change occurs cannot be determined. The work of
Esparza et al. (1980), showing an EDP to VFP gradient only when CSF
circulation over the cerebral hemispheres was impeded, appears to
support this hypothesis. At low pressures the dura might not always
be pressed against the sensing membrane and would therefore record a
falsely low ICP.
Miniature transducers have been slipped under the inner
table of the skull for measuring extradural pressure, but sources
of inaccuracy must include indentation into the subarachnoid and.
subpial regions and the transducer not being flush with the inner
table of the skull. Guha and Anar.d (1979), however, have suggested
that their non-coplanar transducer of rectangular design, which is
inserted between dura and skull, will be more accurate than the
traditional coplanar transducer for long-term monitoring, because
its position will be more constant than that of a coplanar transducer.
Such a transducer must, however, be calibrated initially against the
reading from a coplanar transducer.
Zierski (1980) concluded that the range of discrepancies
between EDP and VPP was too disturbing for routine clinical use
because he could not confirm the tendency of SDP to read higher
at higher VFP values.
TCP Measurement from the Intracranial Subdural Space
IGP can be measured from this site using a 3~way tap or
the end of an intravenous giving set pushed into an appropriately-
sized hole in the skull after the dura has been incised (Gosch and
Kindt, 1972; Kindt, 1975), or a plastic catheter inserted below
the dura mater which can be made in a ribbon-shaped design
(V,*ilkinson, 1977), or a bolt (as described above for extradural
pressure measurement, the only difference being that the dura mater
is incised leaving the arachnoid mater intact). In addition,
transducers have been specially designed for insertion into a burr
hole for subdural pressure measurement (Eversden.,1970; Richardson
et al., 1970; Tindall et al., 1972a).
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The advantages of this site of measurement are that the
damping effect of the dura mater is removed but the arachnoid
mater is not breached, thus the chance of serious infection is
reduced, siting of the measuring device is technically easier
than placing a ventricular catheter, placement is independent
of brain shift or small ventricular size, the brain is not punctured
and the patency of the measuring device is maintained quite easily
(particularly if the Leeds bolt (Coronecs, 3-973) is used because it
has a footplate to protect the measuring holes from blockage).
The disadvantages are that CS? cannot be removed, blockage
may occur at high ICP levels, particularly when a catheter is used
because the arachnoid mater is forced against it by the underlying
brain, and surface bleeding may be caused by opening the dura.
In measuring subdural pressure I'endelow (1982) found that both the
single lumen screw as described by Vries and colleagues (1973) and
the Leeds type screw may give unreliable results which may differ
from VFP in either direction, more commonly by underestimating the
occurrence of high ICP. This tendency was seen more frequently
with the open ended screw than with the Leeds type screw, but both
can show errors which become grea.ter as ICP exceeds 20 mn Hg.
ICP Measurement from the Intracranial Subarachnoid Space
Sometimes it is technically impossible to avoid incising
the arachnoid mater along with the dura mater so that subarachnoid
pressure is measured. Some workers deliberately incise the
arachnoid mater in order to measure supratentorial subarachnoid
pressure. Vries and colleagues (1973) described a hollow screw
designed for measurement of pressure from the subarachnoid
space which gave pressure measurements which were identical with
VFP in 12 patients and gave satisfactory readings up to 100 mm Hg
in cats. The tip of the screw projected 1 mm "below the surface
of the dura mater. V/inn and colleagues (1977) found that sub¬
arachnoid pressure measurement through a screw was a reliable
method of recording ICP clinically with a low failure rate.
In patients VFP and convexity subarachnoid pressure were similar
except for a slight difference in waveform which could be partly
due to the distensibility of the ventricular catheter. In swine,
however, Davis et al. (1981) found that subarachnoid screw-type
devices consistently underestimated the brain tissue pressure
measured from an intracerebral microtransducer, which confirms
the findings of Schettini and Walsh (l97t)•
Measurement of ICP in Infants
In infants with an open fontanelle a transducer can be
applied directly over the fontanelle to measure ICP either using
pneumatic pressure to balance a mirror (Vidyasagar and Raju, 1977)
or the aplanation principle (Wealthall and Smallwocd, 1970•
pressures obtained correlate well with simultaneously measured CSF
pressure.
&S"
Measurement of CSF Pressure from the Lumbar Subarachnoid Space
In many studies of the effects of anaesthetic agents on
CSF pressure this pressure has "been measured by cannulation of
the lumbar subarachnoid space. However, the spinal CSF pressure
will only be the same as the ventricular CSF pressure under steady
state conditions, and when there is no obstruction to the flow of
CSF between the intracranial and the spinal CSF compartments
(Shenkin, 1952). In normal patients, and the majority of patients
with intracranial tumours, the lumbar and ventricular CSF pressures
are identical and show identical responses to jugular vein
compression and withdrawal of CSF, but in some there is a difference
of up to 7*5 mm Hg with VFP reading higher. In these latter
patients jugular compression revealed partial block between the
cranial and spinal compartments (Smyth and Henderson, 1958).
This is the least invasive method of measuring CSF pressure and the
only one justifiable in normal subjects, but it does penetrate the
subarachnoid space and there is a danger of meningitis. Free
communication between the cranial and spinal subarachnoid space
must be demonstrated before lumbar CSF pre sstore can be taken to
reflect ICP. When performing lumbar puncture in the presence of
intracranial space-occupying lesions and raised ICP, there is a
considerable danger of inducing brain shift and impaction at the
foramen magnum.
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Measurement of Lumbar Epidural Pressure
Recently it has been suggested that CSF pressure can be
measured from a catheter placed in the lumbar epidural space
(Shah, 198l). It seems unlikely, however, that lumbar epidural
pressure will accurately reflect CSF pressure.
From the above discussion it is obvious that there is no one
method of ICP measurement which is ideal in all circumstances, but
that measurement of the pressure from a lateral ventricle will give
the most accurate values. In the original work described in this
thesis a ventricular catheter was used for ICP measurement in patients
scheduled for craniotomy (with the exception of one patient), and an
extradural or subdural device (Coroneos, 1973) or subdural catheter
was used in the studies undertaken in patients with head injury.
The zero reference point for ICP was the external auditory meatus,
except in the patients with head injury in which the zero reference
point was the level of the transducer which was mounted on the patient's
If an implanted device (catheter, bolt or 3~way tap) is used
this is filled with sterile saline and. connected through a saline-
filled column to a suitably calibrated arterial range electrical
pressure transducer sited outside the cranium. The signal from
the external or internal transducer is amplified and recorded on a
chart recorder. All joints in the system must be watertight and
air:, must be completely removed from the system. The author used
head.
Recording the ICP
an externally mounted transducer connected to a Devices amplifier
and chart recorder which employs a heated stylus on a knife-edge
to provide a linear response. During the studies the chart was
set to run at an appropriate speed (usually 1 mm/second) and ICP
values were read directly from the analogue signal on the chart.
For clinical investigations the ICP range of the recording system
normally should be 0 to 50 mm Hg but if the pressure is very high
a range of 0 to 100 mm Hg is required. The transducer was
calibrated against a sterile saline column exerting a known pressure
(usually 3k cm H20 which equals 25 nan Hg) immediately before the
measurements were made, and the calibration was checked after the
period of measurement. Regular zero checks are necessary during
a long period of measurement to check that significant zero drift
has not occurred. The transducer is sterilised before use by
filling the dome with Cidex and waiting at least 2 hours. The
Cidex is then flushed out with liberal amounts of sterile saline.
In the results included in this thesis mean ICP has been
defined as half-way between the systolic and the diastolic
pressures. Figures so obtained were rounded to the nearest
0.5 mm Hg.
The recording system can be made more sophisticated by
feed.ing the amplified signal into an analogue-to-digital converter,
and from there into a suitably programmed computer or micro¬
processor where the data can be manipulated and stored.
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Telemetry
Telemetry allows continuous measurement o? ICP in ambulant
patients and many implantable devices have been developed for this
purpose. The technique is of use for long-term observations of ICP
in experimental situations but is not usually used for measurement
of the effects of anaesthetic agents on ICP.
Infection
Intracranial infection rarely occurs during short-term ICP
monitoring for studies of drug effects on ICP. It does, however,
occur during long-term monitoring particularly when this is
continued for more than 3 days (Rosner and Becker, 1976). Under
these conditions the incidence of infection is usually between
1 and (Lundberg, 1972; Sundbarg et al., 1972; Winn et al., 1977)
but can be as high as lCrt (Fleischer et al., 1976). In order to
reduce the incidence of infection during long-term ICP monitoring
from a ventricular^catheter, Fleischer and colleagues (1975)
developed a system in which an intraventricular catheter was
connected to an implanted Rickham reservoir, and a 23 gauge nefedle
was inserted percutaneously into the reservoir.
Volume-Pre3sure Testing
Another test relating to ICP which has been found useful
in the prediction of the response of ICP to increasing volume of
one of the intracranial components is the volume-pressure test
(Miller and Caribi, 1972). In this test a known volume of sterile
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saline (usually 1 ml) is injected into (or withdrawn from)
the CSF space through a ventricular catheter and from the height
of the resultant increase in ICP and the rate of decline towards
the baseline after injection indices can be derived which relate
both to absorption rates for CSF and brain stiffness (Marmarou et al.,
1975). There is a positive correlation between the height of the
resting level of ICP and the volume pressure response which supports
the concept of an exponential relationship between intracranial
volume and pressure (Miller and G-aribi, 1972). An increase or
decrease in ICP of 2 mm Hg or more is taken to indicate reduced
intracranial compliance and thus a reduced ability to compensate
for further changes in volume of the intracranial contents.
Pronounced enlargement of the ventricles interferes with the test
(Miller and Leech, 1975; Rowed et al., 1975).
The VPR is closely correlated with the ventricular fluid
pressure (VFP) immediately before the test and can be dissimilar
at the same VFP depending on whether the increase in VFP was
produced by a mass lesion or by a. diffuse process such as an increase
in MAP (Leech and Miller, 197a), a^d the test is useful in determining
which agents improve intracranial compliance (Miller and Leech, 1975).
An increase in pulse amplitude of the ICP trace occurs with
increasing ICP and is mainly explained by the decrease of the
intracranial compliance (Nornes et al., 1977). The increment of
blood volume that is added to the intracranial compartment with
each heart beat acts as the volume stress of a volume-pressure test.
Van Eijndhoven and colleagues (19S0) found that in individual
patients the CSF pulse pressure is a reliable parameter for monitoring
alterations in intracranial elastance, but that the volume change
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underlying the CSF pulse pressure varies considerably between
patients and may be affected by haemodynamic changes. According
to Szewczykowski et al, (1977) calculation of intracranial elastance
from the pulse pressure and the basic level of ICP needs an on-line
computer for clinical use. Ikeyama et al. (1980) suggest that the
function of the intracranial veno-sinus junction is the most
important factor in causing the increase in pulse pressure associated
with intracranial hypertension.
A further test of IGP reserve has been developed by Wilkinson
et al. (1978) in which increments of saline were injected subdurally
at one minute intervals for not more than 5 injections. Using this
test in dogs, baboons and man they found a linear response of ICP to
an increase in volume (V/ilkinson et al., 1981). They claimed that
the linear response was a response to intermittent injections
allowing compensation to occur in between injections, whereas
continuous or rapid infusion would be expected to cause an exponential
response because there was less time for compensation to occur.
A marked increase in CSF pulse pressure to ICP ratio may
indicate a loss of autoregulation and under these circumstances the
CSF pulse pressure is a better parameter of the clinical state than
the VPR (Avezaat et al., 1979).
M5ASUREMEI7T OF OTHER PRESSURES WITHIN THE CRANIAL CAVITY
Brain Tissue Pressure
Brain tissue pressure can be measured using Tricks which
consist of a thin polythene catheter with a wick of long-stranded
combed cotton wool at its tip preventing obliteration of the
catheter tip by the surrounding tissue (Brock et al., 1972b).
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Pressure-Depth Feasurements
Schettini and Walsh (197k) devised a method of simultaneously
measuring pressure and the depth of that measurement, using a
transducer with a small pressure-sensing element mounted at the end
of a cylindrical piston which was coupled to a finely-threaded
plunger. For continuous insertion or withdrawal at a constant rate
an adjustable drive system was used, and accurate measurement of the
depth of the plunger from the initial position could be made using a
rotational potentiometer. Using this system, inserting the trans¬
ducer at a constant rate to a depth corresponding to a preset
pressure (usually 30 mm Hg), with the point of dural contact taken as
the sero position, subarachnoid CSF pressure can be measured when the
dura is flattened against the transducer, a point can be identified
which represents contact with the brain surface, and insertion after
this gives pressure changes associated primarily with compaction of
the brain tissues of the subpial region. The pressure-depth test
reflects principally the behaviour of the subpial tissue, and
Schettini and Walsh (197'+) suggest that it is more meaningful to
record surface brain pressure than CSF pressure, because the latter
does not always correlate with the condition of the brain. Because
of the rich vascular supply to the brain, changes in cerebral
circulation will primarily affect the subpial compartment and only
secondarily be reflected in the CSF pressure which, in spite of an
expanded brain, may be abnormally low due to CSF absorption to
compensate for the increase in brain volume. In fact it is possible
that methods which were thought to be measuring epidural ICP may have
been recording subpial rather than subarachnoid CSF pressure if the
dura was pressed against the brain tissue. The slope of the
pressure increase as the transducer is advanced in the subpial
region gives a measure of the stiffness of the brain, and the subpial
region exhibits relaxation and creep behaviour similar to that
observed with viscoelastic materials (Schettini and Walsh,1973,1975) •
Using this method of measurement with the transducer placed at a depth
corresponding to the initial subpial contact in dogs, Schettini and
Moreshead (1973) showed that halothane in concentrations greater than
l/o caused a sustained increase in surface brain pressure, and that
thiopentone narcosis reduced this pressure. The increase in surface
brain pressure may have been due to an increase in brain water,
because the electrical impedance of the brain was also increased.
Measurement of Brain Retraction Pressure
An instrument has been devised which measures the pressure
required to retract the brain (Albin et al., 1980). This could
prove useful in determining which anaesthetic agents are best used
for maintenance anaesthesia during neurosurgical operations. Those
agents which were associated with the lowest brain retraction
pressure would be the best agents to use, provided that MAP and
thus CPP was not markedly reduced at the same time.
MEASUREMENT OF THE DIAMETER OF CEREBRAL VESSELS
Pial vessels may be observed directly and photographed
through the microscope before and after the administration of
the agent being studied. From the photographs the vessel
diameter can be measured. In addition, the change in diameter
of the cerebral vessels, before and after an agent is introduced,
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can be measured from X-ray films taken during carotid angiography
Certain
(Pischgold et al., 1968). / contrast media may affect CBF (Brown
and Donaldson, 1976), so this could be a source of error. This
method has been used in the author's department to assess the
effects of carbon dioxide and etomidate on cerebral vessel diameter.
In the investigations described in this thesis, arterial
pressure was measured continuously from a radial artery cannula
filled with saline and connected to an appropriately calibrated
electrical transducer and recorder system. Calibration was
checked before each investigation. The zero for the arterial
pressure was at the level of the heart. Before a cannula was
placed in a radial artery, Allen's test was performed to establish
that there was adequate ulnar collateral circulation. MAP was
measured from the chart recordings by adding one-third of the
pulse pressure to the diastolic pressure. CPP was calculated
by subtracting mean ICP from MAP.
In these investigations Student's t-test was used to test
for significant differences between the test groups in Chapters
K and 9, and a paired t-test was used to test for significant
changes from the control values of the different parameters
measured in the studies described in Chapters .5, 6, 7, 8 and 9.
MEASUREMENT OF ARTERIAL PRESSURE
STATISTICAL METHODS
MEASUREMENT OF CBF
Knowledge of the effects of anaesthetic agents on CBF is
necessary to explain the effects of these agents on ICP. I have
not measured CBF in any of the investigations described in this
thesis, so I will only refer "briefly to the methods used for the
measurement of CBF in man. These methods employ diffusible
indicators which are delivered to the brain tissue and subsequently
are removed by the blood stream. The first such method, described
by Kety and Schmidt (191.5)} uses nitrous oxide as the indicator.
The subject inhales a constant low concentration (10 to 15/^) of
nitrous oxide over a 10-minute period, and during this 10-minute
inhalation period a series of blood samples are taken from an
artery and the internal jugular vein. From these measurements CBF
can be calculated. This method was modified by the substitution
85
of Krypton for the nitrous oxide because the analysis of the
blood samples was easier. Further technical improvement was made
by McHenry (i960 who suggested looking at desaturation curves as
opposed to saturation curves. One advantage of the Kety Schmidt
and similar methods is that cerebral metabolism can be calculated
by multiplying the flow by the appropriate arteriovenous difference.
The methods used currently in man for measurement of CBF involve the
systemic administration of the radioactive inert gas ^""^Xenon, and
recording the washout of radioactivity from the brain using external
133
scintillation detectors. Administration of the Xe into the
internal carotid or vertebral artery gives the most accurate results
because extracerebral contamination of the clearance curve is
avoided. The intraarterial ^^Xe method gives a clearance curve
which is biexponential. However, this route of administration is
very invasive, and less invasive techniques have been developed
in which the^-^Xe is given by inhalation (Mallett and Veall, 1963),
or by intravenous injection (Agnoli et al., 1969). Using the
inhalation and intravenous methods there is contamination of the
extracerebral tissues, and when the cerebral curves are corrected
for arterial recirculation three exponentials can be extracted
(Obrist et al., 1967). The third component of the clearance curve
causes the calculated value of CBP to be about lt/o low on average.
The methods of calculating CBP from the clearance curves were
reviewed by James (1979)* Although the results obtained using the
intraarterial method are the most accurate, the inhalation and
intravenous methods give results which are of the same magnitude,
and because these methods are less invasive they are the ones most
commonly used in clinical practice at present. Lenzi and colleagues
(1978) have developed a new technique for assessing cerebral oxygen
utilisation and blood flow relationships, using two separate
15
inhalation periods of 6 minutes, one of 02 and the other of
15
O-labelled carbon dioxide with a 15-minute break between the
periods for washout. This technique is interesting because it gives
an index of the regional oxygen supply to demand relationships.
MEASUREMENT OP CBV
9^ jp
CBV can be measured using the intravenous injection of Tc -
labelled red blood cells and an emission tomographic brain scanner
(G-reenberg et al., 1978), or by following the clearance of intra-
99 rn
venously administered Tc using a gamma camera. The CT scan can
be used to estimate CBV by superimposing scans performed before and
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after the intravenous injection of sodium iothalamate (Ladurner
et al., 1976), and a photoelectric technique for .measurement of
CBV has been described (Kuyama et al., I98O).
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CHAPTER iL
THE EFFECTS OF TRACHEAL INTUBATION ON ICP
FOLLOWING INDUCTION OF ANAESTHESIA WITH
THIOPENTONE OR ALTHESIN IN PATIENTS UNDERGOING NEUROSURGERY
18
INTRODUCTION
Laryngoscopy and intubation are associated with increases
in ICP and MAP. The increases in ICP are likely to be more marked
in neurosurgical patients with raised ICP (Shapiro et al., 1972a,
1972c), and such increases in ICP may lead to transcompartmental
brain tissue herniation. The increase in MAP may accentuate brain
oedema in patients with intracranial pathology. Both thiopentone
and Althesin decrease ICP (see Chapter 5), and thus might reduce or
prevent the above changes. In this chapter I will describe a
randomised trial comparing the effects of thiopentone with those of
Althesin on ICP and MAP during the induction of anaesthesia.
METHOD
Twenty patients who were about to undergo craniotomy were
studied. All gave their informed consent for the study. Each
patient was premedicated with diazepam 10 mg. intramuscularly,
except for one patient who received papaveretum 10 mg. and hyoscine
0.2 mg. Anaesthesia was induced in 10 patients with thiopentone
and in 10 with Althesin, the choice of agent being randomised.
Before induction of anaesthesia arterial and venous cannulae were
inserted under local analgesia. A burr hole was made under local
analgesia, and a catheter was inserted into a lateral ventricle for
measurement of ICP.
Once MAP and ICP were 3table, d-tubocurarine A5 mg was given
U.0 mg. in one frail woman). This was followed immediately by an
induction dose of thiopentone (range 250 to A00 mg.) or Althesin
(range 5 to 5 ml.), the drug being given until there was loss of the
eyelash reflex. The patients were then hyperventilated moderately
with nitrous oxide and oxygen for 2 minutes, via a facemask, by hand
compression of the reservoir bag. Exactly 2 minutes after the
completion of the thiopentone or Althesin injection,laryngoscopy and
intubation were performed. After intubation the patient was
ventilated mechanically and a pharyngeal pack was inserted.
Ventilation was adjusted to produce moderate hypocapnia by reference
to an infra-red carbon dioxide analyser. In all patients arterial
blood gas tensions were estimated once the patient was established
on the ventilator. In addition, in the last 6 patients in the series
the arterial blood gas tensions were estimated immediately before the
induction of anaesthesia, and immediately before intubation. From
the chart records the following measurements of MAP and ICP were made:
l) for the 5 minutes immediately before induction of anaesthesia
(hereafter described as control MAP and ICP) and at 1, 2, 3, A and 5
minutes after induction; 2) immediately before laryngoscopy; 3) at
the point of maximum ICP in the first 60 seconds after intubation,
and ;+) at the point of maximum ICP during and in the first 60 seconds
after packing the pharynx.
RESULTS
Table 1 shows the pathology for which craniotomy was being
performed and the icp values for the individual patients. There
was no significant difference in control mean icp (10 - l cf. 11 - a)
between the two groups. However, two patients (one in each group)
so
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were noted to have control ICP values of greater than 20 mm Hg;
these results have been excluded from the statistical analysis
and are discussed separately later. The two groups were similar
with regard to age and sex distribution. The thiopentone group
had an average age of 51.1 years (range 33-66 years), the Althesin
group 55.1 years (range 71 years).
The values of MAP obtained in the individual patients are
given in Table 2. The difference in control MAP between the two
groups (106 (S.D. 15) of. 112 (S.D. 2l) mm Hg)was not statistically
significant. In 5 of the 20 patients, MAP decreased to less than
50 mm Hg following induction, in one patient to 13 mm Hg. At 5 mins
after induction MAP was greater than 50 mm Hg in all except three
patients.
Table 3 shows the changes in ICP with intubation related
to the control value and to the value obtained immediately before
laryngoscopy. In each group mean ICP decreased following the
induction of anaesthesia and increased slightly following laryngoscopy
and intubation. There was no significant difference between the two
groups except at 5 min. after induction, when mean ICP was
significantly less in the Althesin group (0.05 >P >0.02). There
was no significant difference between the groups in the response of
ICP to intubation. There was a significant correlation between the
pre-induction ICP and the increase in ICP associated with intubation
in the thiopentone group (0.05 > P > 0.02), but there was no such
correlation in the Adthesin group.
The control IMP values for the two groups were very similar
but the reduction in MAP after induction of anaesthesia with
tubocurarine and thiopentone was at each stage greater than that
S7
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V a 1k 0 112 +15
* B 8 +0.5 97 +23
C 2a .5 _T_ 100 0
D 9.5 0 57 0
?/ E 10.5 0 55 +5
F 13 0 A3 -5
G L 0 68 +20
H 17 +3 25 +5
V I 7.5 +1.5 63 +5





K 11.5 0 97 +16
L 12.5 -0.5 110 +8
M 10 0 30 -3
N 5 0 80 +10
0 5.5 +1.5 113 +12
* P 10 0 92 +11
Q 12.5 +2 175 +25
/ R 10 -0.5 95 +23
s 27.5 +2 118 +19
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obtained following tubocurarine and Althesin (Table l). This
difference reached significance (0.05> P > 0.02) at approximately
3 min. after the induction of anaesthesia which, incidentally, was
the time at which the maximum MAP was reached after intubation, and
remained significant (0.02 >P >0.0l) at A min., but not at 5 min.
The increase in arterial pressure which followed within 60 sec. of
intubation was significantly greater in the Althesin group
(0.02 > P> 0.01).
There were no significant differences between the two groups
in mean PaC02 at the time of intubation (thiopentone 1.0 - 1.2 KPa,
Althesin 1.5 - 1.1 KPa) or at 5 min. after induction (thiopentone
3.8 - 0.9 KPa, Althesin 1.2 - 0.8 KPa).
The changes in MAP and ICP caused by packing the pharynx
were minimal and there was no statistically significant difference
between the two groups (Table 5).
In the two patients with control ICP values greater than
20 mm Hg the changes in MAP were similar to those noted in patients
with control ICP values of less than 20 mm Hg. In these two patients
ICP decreased markedly following the administration of the induction
agent and tubocurarine (by lA mm Hg and 20 mm Hg; see Table 3) and
did not increase above the control value with intubation.
DISCUSSION
Increases in ICP at the time of laryngoscopy and intubation
were described first by Stephen and colleagues (l95l), and since
then many other workers have reported such ICP increases in normal
and neurosurgical patients (Lundberg, I960; Marx et al., 1962;
Adams et al., 1972; Hulme and Cooper, 1972; McLeskey et al;, 1971;
qi
Misfeldt et al., 197R; Burney and Winn, 1975; G-reenbaum et al.,1975)«
De Vault and colleagues (i960) found that tracheal intubation under
li^it general anaesthesia was consistently accompanied by a pressor
response, tachycardia, and in some instances cardiac arrhythmias.
These circulatory changes were not affected by the administration
of atropine but were reduced by phentolamine, indicating that they
could be mediated by the sympathicoadrenal system. This conclusion
is supported by the data of Reves and colleagues (l98l) who found a
transient increase in arterial noradrenaline levels during intubation
which suggested an adrenergic neuronal reflex pathway. The ICP
increase is not caused by changes in CVP because only small changes
in CVP occur during intubation (Shapiro et al., 1972c), The likely
mechanism of the increase in ICP is that a loss of autoregulatory
control (or a change in MAP which is too rapid for autoregulation to
cope with), allows the increase in MAP to cause an increase in CBF,
CBV and ICP, although it is possible that the increase in ICP is not
secondary to an increase in MAP (Greeribaum et al., 1975) • Distortion
of the jugular veins during laryngoscopy may be a contributing factor.
The ICP changes associated with this increase in MAP are likely
to be more marked in neurosurgical patients, especially those with
increased ICP caused by tumour or other intracranial space-occupying
lesion, and these increases could lead to transcompartmental
herniation of brain tissue (Shapiro et al., 1972a; Greenbaum et al.,
1975).
In this investigation the increases in ICP associated with
intubation were small. For the 18 patients included in the
statistical analysis (ICP less than 20 mm Hg) there was a mean
increase in ICP from the control level of 2.8 mm Hg (range -A..5 to
qz
27.5 mm Hg) and the mean increase from the prelaryngoscopy value
was l,_.6 mm Hg (range«*0.5 to 25 mm Hg). With the exception of 2
patients the increases in ICP from control level following intubation
were 7 mm Hg or less (7«5 mm Hg or less from the prelaryngoscopy
value). One patient showed an increase in ICP from control of
13 mm Hg but this was related to coughing and straining on the
endotracheal tube. Another patient showed an increase of 27.5 mm Hg.
This patient had a large meningioma and probably had a very low
intracranial compliance, and the PaC02 increased by 1.1 KPa between
induction of anaesthesia and laryngoscopy. The PaC02 was 5.2 KPa
at the time of intubation and this may have been the reason for the
marked increase in ICP, as this was the only patient who showed an
increase in PaC02 between induction of anaesthesia and intubation.
There are several reports on the changes in ICP occurring
with intubation. Shapiro and colleagues (1972c) found, in patients
intubated with suxamethonium, that the increases were greater in
patients who had symptoms or signs of increased ICP before operation
(increases from the pre-induction value of 19 to 30 mm Hg) than in
patients with "normal ICP" (increases from preinduction value of
-7 to +5 mm Hg). The changes did not, however, relate to the
measured ICP values immediately before induction of anaesthesia.
Burney and Winn (1975), who also used suxamethonium, showed increases
in ICP similar to those of Shapiro and colleagues, and their data
appeared to show no correlation between the initial values of ICP and
the increase associated with intubation. The variable response of
ICP to intubation in patients -with similar ICP values before intubation
may be explained by the pressure/volume relationship of the cranial
contents. Thus, when intracranial compliance is reduced a stimulus
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which affects ICP will produce a greater resp6nse than it would
if the compliance had been normal.
Other studies, in which suxamethonium was used as the
relaxant, have shown increases in ICP of up to 80 mm Hg, with peaks
of 100 mm Hg (Misfeldt et al., 1974; Greenbaum et al., 1975).
Workers who compared the increases of ICP following intubation under
relaxation with suxamethonium and pancuronium, found much smaller
increases in ICP when pancuronium 7fas used, provided that adequate
time was allowed for it to act (McLeskey et al., 1974; Lewelt et al.,
1976). Despite using very large doses of thiopentone, McLeskey and
colleagues found marked increases in MAP in their suxamethonium
group. Lewelt and colleagues (1976) did not record arterial blood
pressure during induction. The ICP changes recorded in the last two
studies are closest to those described by the author, probably "hecause
a non-depolarising relaxant was used in all three studies.
Suxamethonium may be associated with greater increases in ICP during
intubation because it causes muscle fasciculations, or because of a
direct action of the drug on the cerebral vessels (preliminary work
direct
by the author suggests that suxamethonium has very little/effect on
ICP (see Chapter 6) ), or because the duration of hyperventilation
before intubation will be shorter than when a non-depolarising muscle
relaxant is used. The longer period of hyperventilation before
intubation in patients receiving a long-acting muscle relaxant
produces hypocapnia, which may partially restore defective auto-
regulation (Paulson et al., 1972 ), and thus protect the cerebral
circulation against any sudden increase in MAP, which would otherwise
increase CBV and could promote the formation of cerebral oedema.
Large increases in ICP associated with intubation should be
avoided in neurosurgery because they may cause transcompartmental
pressure gradients and so induce brain shifts, may precipitate
cerebral oedema if secondary to an acute episode of arterial hyper¬
tension, or may result in an inadequate CPP. Misfeldt and
colleagues (197k) stated that increases in IGP associated with
intubation were harmless, but they concentrated only on CPP, (which
was always adequate in their investigations), and did not consider
the other factors discussed above, which are probably more important
in this context.
Several methods of reducing the increases in MAP and ICP
with endotracheal intubation have been suggested. King and
colleagues (l95l) showed that deepening anaesthesia to the second
or third plane of surgical anaesthesia obtunded or abolished the
increase in arterial pressure. Thiopentone can be used to deepen
anaesthesia before intubation (Shapiro et al., 1972c), and the intra¬
venous administration of a ^S-adrenergic blocking agent before
intubation has been suggested (Creenbaum et al., 1975), although this
has caused cardiovascular collapse in a patient with subarachnoid
haemorrhage (Farnon and Curran, 198l). Shapiro and colleagues (1972c)
suggested the use of fentanyl before intubation to attenuate the
associated ICP increase, and Dahlgren and Messeter (l98l) have shown
significant attenuation of the MAP response to laryngoscopy and
intubation by the administration of fentanyl 5 Jig/Kg intravenously
3 min. before intubation in patients about to undergo elective intra¬
cranial surgery. Davies and colleagues (1981) have shown that pre-
treatment with hydrallazine O.;^ mg/Kg caused a significant reduction
in the maximum MAP changes at intubation in patients undergoing intra¬
cranial surgery, but the average MAP change over the intubation period
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was no different from that in the control patients, and the
administration of hydrallazine 12.5 mg intravenously has been shown
to increase CBP and ICP in patients with intracranial pathology
(Overgaard and Skinh/j, 1975). Local anaesthesia of the larynx and
trachea would prevent coughing on intubation, but transtracheal
injection of lignocaine caused a greater increase in MAP than
intubation alone (Ward et al., 1965), and laryngoscopy for spraying
the vocal cords will itself increase ICP. Hyperventilation before
spraying the cords may prevent any associated increase in ICP
(Sondergard, 1961).
Intravenous injection of ligno.caine 1.5 mg/Kg during
thiopentone, nitrous oxide, oxygen anaesthesia has been shown to
prevent the ICP increase after intubation under suxamethonium
(Bedford et al., 1980). Prom the author's results and those of
other similar investigations, it appears that the increases in ICP
associated with intubation are smaller when a non-depolarising
relaxant is used.
Tubocurarine was used in this study, since it is commonly
used in neurosurgery, partly because the hypotension produced
(Thomas, 1957) may reduce bleeding from skin and muscle and aids in
the avoidance of hypertensive episodes during surgery. In this
respect it may have an advantage over pancuronium which can produce
increases in arterial pressure (Kelman and Kennedy, 1971; Gordon,
1975).
In this study tubocurarine and an intravenous induction
agent produced significant decreases in MAP, an effect which lasted
for only a few minutes. MAP decreased to a similar degree with
thiopentone and Althesin, but recovery was more rapid and complete
in the Althesin group. CPP was reduced to less than
60 mm Hg in ~]5% of the patients and to less than AO mm Hg in 20fu.
A 8PP of 50 mm Hg is at the lower end of the autoregulation
range (Olesen, 1973), thus tubocurarine can cause potentially
dangerous reductions in CPP which, even though short-lived, might
be considered to be a disadvantage of the drug. However, there was
no clinical evidence in the period after operation that this decrease
in CPP affected the recovery of the patient in any way, and it may
have been a factor in preventing large increases in ICP with intubation.
The wide inter-patient variation in MAP response to tubocurarine is in
agreement with the results of Thomas (1957)*
Four of the patients were receiving dexamethasone before
operation, but their ICP response to intubation did not appear to
differ from the other patients.
There had been no previous reported comparison between
thiopentone and Althesin for the induction of anaesthesia for
craniotomy. The author's results show that there was no significant
difference between these two agents in their effects on ICP when
combined with tubocurarine, and that there was no difference between
the t?/o groups with regard to the change in ICP following intubation
or packing the pharynx.
The positive correlation between control ICP and the increase
in ICP associated with intubation in the thiopentone group only just
reached statistical significance, and the increases in ICP with
intubation in this series were small. Thus the changes in ICP at
intubation are similar when thiopentone and Althesin are used for
indue tion of anaesthesia, even in patients with elevated ICP.
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SUMMARY
In this chapter an investigation is described in which
intracranial pressure and mean arterial pressure were studied in
20 patients during the induction of anaesthesia for craniotomy,
using tubocurarine as the muscle relaxant and either thiopentone
or Althesin for induction of anaesthesia. No significant
differences were found between the thiopentone and the Althesin
groups in the ICP changes with induction, intubation or pharyngeal
packing. Except for two cases (one in each group) the increases
in ICP associated with intubation were small. In these two
patients moderate increases from normal levels to 28 and 37 mm Hg
were recorded, but in one of these cases coughing and straining
followed intubation. Marked decreases in MAP were noted in both
groups, but the recovery of MAP was significantly more rapid in
the Althesin group. Only two patients had ICP values greater
than 20 mm Hg before operation and in neither did ICP increase
above control values during induction and intubation. Packing
the pharynx produced minimal changes in ICP in all patients.




THE EFFECT- OF ETOMIDATE ON TCP AND CPP
INTRODUCTION
At the time this study was started it was known that, of
the drugs used to induce anaesthesia, thiopentone, methohexitone
and Althesin caused a reduction in ICP and CBF, propanidid could
have variable effects on these parameters, and ketamine increased
them (see below). Etomidate is an intravenous agent for induction
and maintenance of anaesthesia which causes a reduction in CBF in
normal man (Herrshaft et al., 1975) and thus it would be expected
to reduce ICP also. This study was undertaken to determine the
effect of etomidate on ICP in patients with intracranial pathology
who were about to undergo craniotomy, and thus to determine its
suitability for use in patients with intracranial space-occupying
lesions.
METHODS
Ten patients with intracranial lesions requiring craniotomy
were investigated. All gave their informed consent for the study.
If considered necessary, the patients were premedicated with
diazepam 10 mg. intramuscularly. Anaesthesia was induced with
thiopentone given until the eyelash reflex was lost, and was
maintained with nitrous oxide (70^) in oxygen. Ventilation was
controlled and tubocurarine 1^5 mg. was administered to produce
neuromuscular blockade. The volume of ventilation was adjusted
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to produce normocapnia, and was maintained constant throughout
the period of the study. Arterial pressure was recorded from a
radial artery cannula and ICP from a catheter inserted into a
lateral ventricle. The patients were supine and tilted 10° head-up
during the investigations. The arterial and intracranial pressure
traces were observed for 5 minutes before the intravenous injection
of etomidate 0.2 mg/Kg (given over a period of 10 seconds), and for
10 minutes after the administration of etomidate. Surgery was then
continued. From the chart recordings, the following measurements
were made: l) MAP, mean ICP and CPP in the 5 minutes before the
injection of etomidate (control values for MAP, mean ICP and CPP);
2) MAP, mean ICP and CPP at one-minute intervals for 10 minutes
after the administration of the etomidate . (Only the results
obtained at 2-minute intervals are tabulated, as there was no
further information to be obtained from the more frequent measurements.)
Samples were taken for measurement of arterial blood-gas
tensions just before the administration of the etomidate (initial
PaC02) and at 10 minutes after etomidate administration (final PaC02).
The end-tidal carbon dioxide concentration was monitored continuously
with an infra-red gas analyser during the period of measurement.
RESULTS
Table 6 gives the ages and diagnoses of the patients and the
mean ICP during the control period and at 2-minute intervals after
the administration of etomidate. ICP decreased initially in all
the patients and then started to increase, but in only 2 patients
it returned to control levels within 10 minutes. This decrease
(01
TABLE 6
The mean intracranial pressure (mm Hg), diagnoses and ages (yr.) of the
10 patients. Control indicates the mean pressure in the 5 minutes
before administration of etomidate. The probability values represent






Time after etomidate (min.)
2 A 6 8 10
A (51) Aneurysm lA 9 9 6 8 8
B (;l6) Pituitary
tumour
28 22 22 23 23 23
C (35) Glioblastoma 16 10 11 12 1A 16
D (22) Glioblastoma 16 11 11 11 12 13
E (66) Pituitary
tumour
9 A L A 5 6
F (71) Pituitary
tumour
9 6 5 6 6 6
G (70) Pituitary
tumour
13 6 6 6 6 6
H (33) Pituitary
tumour
26 11 11 12 11 13
I (61) Glioblastoma 21 8 7 8 8 9
J (51) Meningioma 12 9 10 10 11 11
X 16.A 9.6 9.6 9.8 10.;+ 11.1
S.D. 6.62 A. 93 5.08 5.A3 5.32 5.A.
S.E.M. 2.09 1.56 1.61 1.72 1.68 1.7;
P <0.001 <0.001 <0.001 0.01>P 0.015
>0.001 >0.001
IOX
from control was statistically significant (0.01 >P >0.00l) at
the first minute after injection, and remained significant at the
1% level or greater for the 10 minutes of measurement.
There was a small decrease in MAP in 8 patients (Table 7)«
This decrease was statistically significant at 3 and k minutes after
the administration of etomidate (0.05J> P >0.02). The heart rate
decreased slightly in 8 patients hut did not differ significantly
from the control level at any time.
On average the CPP decreased slightly but this decrease was
not statistically significant (Table 8). The CPP decreased to
less than 60 mm Hg in one patient (patient B, minimum CPP = 5k mm Hg).
In k patients PaC02 was in the normal range and in 5 patients
was just below the lower limit of normal. One patient was markedly
hypocapnic (Table 9)« In most patients there was a slight decrease
in PaC02 over the 10-minute period of measurement so that the mean
PaC02 decreased by 0.23 KPa (stastical significance 0.01 P >"0.00l).
The decrease in end-tidal carbon dioxide concentration usually occurred
at between 2 and 7 minutes after the administration of etomidate.
Fig. 1 shows the scatter diagram and regression line for the
decrease in ICP after the administration of etomidate plotted against
the initial ICP value. The correlation (r = 0.62k) between the
decrease in ICP and initial ICP was not statistically significant.
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TABLE 7
The mean arterial pressure (mm Hg) of the 10 patients. 'Control'
indicates the mean pressure in the 5 minutes before the administration
of etomidate. The probability value represents the significance of
the change in MAP from the control value •
Patient iControl
Time after etomidate (min.)
MAP 2 4 6 8 10
A 183 185 175 180 130 180
B 102 87 78 77 83 90
C 123 123 122 128 133 135
D 108 108 108 108 108 103
E 37 83 ?8 83 85 85
F 115 107 107 122 125 120
& 102 93 95 95 90 90
H 133 128 130 I4O 133 137
I 107 107 105 105 100 100
J 1*4-3 112 105 93 103 103
X 120.3 113 .3 110.3 113.6 ll^.O 114 .3
S.D. 27.39 29 .03 28.10 30.hi 29.68 29 .42





The cerebral perfusion pressure (ram Hg) of the 10 patients. 'Control'
indicates the mean cerebral perfusion pressure in the 5 minutes before
the administration of etomidate
Patient Control
CPP
Time after etomidate (min.)
2 k 6 8 10
A 169 176 166 17L 172 172
B 7k 65 56 5k 60 67
C 107 113 111 116 119 119
D 92 97 97 97 96 90
E 78 79 7k 79 80 79
F 106 101 102 116 119 11A
Gr 89 87 89 89 8k 8k
. H 107 117 119 128 122 12k
I 86 99 98 97 92 91
J 131 103 95 88 92 92
X 103.9 103.7 100.7 103.8 103.6 103.2
S.D. 28.37 29.72 29.07 32 .A3 31.02 30.27
S.E.M. 8.98 9.M 9.20 10.26 9.82 9.58
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TABLE 9
The Paco2 values (KPa) of the 10 patients immediately
before the administration of etomidate (inicial Paco2)
and at 10 minutes after administration of etomidate
(final Paco2). The probability value refers to the
significance of the change in Paco2 during the period
of measurement.
















Figure 1. Scatter diagram and regression line for the
maximum decrease in ICP (mm Hg) following
the administration of etomidate 0.2 mg/Kg
plotted against the initial ICP.
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DISCUSSION
There have been many investigations on the effect of
intravenous anaesthetic agents on ICP, CBF and CPP. Doses of
barbiturates which do not cause unconsciousness do not alter CBF,
CMR02 (Kety et al., 19^8), or lumber CSF pressure (Horsley, 1937),
but, provided that respiratory depression does not occur,
barbiturates in doses sufficient to produce light anaesthesia cause
a highly significant decrease in CMR02 and a significant reduction
in CBF (McCall and Taylor, 1952b). ICP is reduced by thiopentone
(Horsley, 1937; Sondergard, 1961; Zattoni and Siani, 19^9, 1972;
Shapiro et al., 1973; Cunitz et al., 1978; Schulte am Esch et al.,
1978a, 1978b; Nayak et al., I98O), methohexitone (Hunter, 1972b;
Takasaki et al., 1973; Cunitz et al., 1978; Cunitz and G-aab, I98O),
and Althesin (Turner et al., 1973; Takahashi et al., 1973; Takasaki
et al., 1973; Rasmussen et al., 1978; Zattoni, 1980). (Nayak and
colleagues (198O) found no significant change in lumber CSF pressure
in normal patients following Althesin 0.05 ml/Kg but there was
coughing, muscle rigidity and tremors during the measurements.)
In normal patients propanidid had no effect on CSF pressure
(Takasaki et al., 1973), but in patients with intracranial pathology
its effect was variable (Zattoni and Siani, 1972). Schulte am Esch
and colleagues (1978b) found that propanidid 7 mg/Kg reduced ICP, but
that there were fluctuations of ICP up to the third minute after its
administration. Ketamine causes an increase in ICP (Bock et al.,
1972; Gardner et al., 1972; Gibbs, 1972; Shapiro et al., 1972b), CBF
is reduced by thiopentone (Pierce et al., 1962; Herrschaft et al.,1975;
Van Aken, 1976b; Cote et al., 1979), methohexitone (Herrschaft et al.,
and
197A, 1975)JAlthesin (Sari et al., 1976; Rasmussen et al., 1978).
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Propanidid caused a reduction in CBP in man (Herrschaft et al.,
1975), tut in dogs CBP increased insignificantly for the first 1 to
2 minutes and then decreased until the MAP returned to normal
(Takeshita et al., 19731 Miyauchi et al., 1973)• Ketamine causes an
increase in CBF in man (Takeshita et al., 1972h),which Hougaard and
colleagues (197k) found to be localised particularly to the fronto-
temporal and parieto-occipital regions, and in dogs (Dawson et al.,
1971;Bazaugour et al., 1975). Thus the effects of these anaesthetic
agents on CBP parallels their effect on ICP, which supports the
concept that anaesthetic drugs alter ICP by altering CBF and CBV
(see Chapter 2).
Thiopentone, by reducing MAP, can cause a significant
reduction in CPP (Schulte am Esch, 1978a, 1978b, 1980) although
smaller doses (3 nig/Kg) produced only minimal changes (Shapiro et al.,
1973; Cunitz et al., 1978). CPP is only minimally reduced by metho-
hexitone (Cunitz et al., 1978) or Althesin (Turner et al., 1973).
Propanidid causes a reduction in CPP (Schulte am Esch et al., 1978b)
as does ketamine (Bock et al., 1972; Schulte am Esch et al., 1978b).
The cerebral metabolic rate for oxygen (CMR02) is also
affected by the intravenous agents used for induction of anaesthesia.
CMR02 is reduced by thiopentone (Pierce et al., 1962; Cote et al.,1979)
and similar dose-dependent decreases have also been reported with
phenobarbitone in rats. It appears that little further reduction in
CMF02 can be expected once it has been reduced to about 5C^ of normal
(Wilsson and SiesjO, 1975). Acute tolerance to the depressant effect
of thiopentone on CMR02 can be demonstrated in dogs (Altenburg et al;,
1969). CMR02 is also reduced by Althesin (Sari et al., 1976;
Rasmussen et al., 1978), by propanidid in dogs (Takeshita et al., 1973;
to^
Miyauchi et al., 1973) and etoraidate (Van Aken and Roily, 1976;
Renou et al., 1978b, 1978c). Ketamine caused no significant change
in CMR02 in healthy patients (Takeshita et al., 1972b), hut increased
CMR02 in anaesthetised dogs (Dawson et al., 1971; Bazaugour et al.,
1975). The changes in CBP associated with the administration of
these intravenous anaesthetic agents closely parallel the changes in
CMR02,which suggests that the change in CBP is caused by the change
in CMR02.
In this study there was a decrease in ICP in all 10 patients
following the administration of etomidate intravenously. The change
in ICP for the group was statistically significant (P < O.OOl).
This reduction can be explained by the rapid decrease in CBF, and
thus CBV, which is known to occur after the administration of
etomidate (Herrschaft et al., 1975; Van Aken and Roily, 1976; Renou
et al., 1978b, 1978c). The studies of Herrschaft and colleagues
were in normal patients anaesthetised with propanidid, suxamethonium,
nitrous oxide, oxygen and halothane 0.1 to 0j+ vol,%. The use of
halothane may explain the more short-lived reduction in CBP that they
observed (less than 5 minutes) a3 compared with the duration of the
decrease in ICP that was observed in this study (more than 10 minutes).
The duration of the decrease in ICP seen in the author's studjr is more
in keeping with the duration of action of etomidate reported in the
literature by both Doenicke (1970, w^° reported that the time to
complete recovery after the administration of etomidate 0.3 mg/Kg was
approximately 12 minutes, and by Lewi and Heykants (1978) who found
that the plasma concentration fell by approximately 30% in 16 minutes
after a dose of 0.21 mg/Kg.
There was no significant correlation between initial ICP and
no
change in ICP following etoraidate. These results differ from
those of Turner and colleagues (1973) with Althesin. There was,
however, a tendency for a greater fall in ICP if the initial ICP
was higher, and in a larger series the correlation might have proved
significant.
The small decrease in PaC02 (average 0.23 KPa), which occurred
in most of the patients during the period of measurement, occurred
during constant ventilation which had heen established for at least
30 minutes before the administration of etomidate. It may have been
due to a reduction in metabolic rate, and thus a reduction in carbon
dioxide production. With one exception this decrease in PaC02
occurred between 2 and 7 minutes after the administration of etomidate,
whereas the maximum change in ICP occurred within 90 seconds and by
7 minutes ICP was beginning to increase again. Thus the influence on
ICP of this small change in PaC02 was probably minimal.
The MAP decreased in all except 2 patients, but the lowest
MAP recorded was 77 aim Hg which was above the value at which auto-
regulation of CBF ceases and CBF becomes pressure-dependent. The CPP
increased in 5C(£ of the patients and decreased in 50&, remaining
adequate in all patients. The heart rate decreased slightly in most
of the patients, but the change was not statistically significant.
These findings confirm the cardiovascular stability found with
etomidate (Doenicke, 197k; Morgan et al., 1975; Holdcroft et al., 1976;
Rifat et al., 1976; Famewo and Odugbesan, 1977; G-honeim and Yamada,
1977; Lees and Hendry, 1977; Patschke et al., 1977)• „
Etomidate has other possible advantages which were not
assessed in this study. Plasma histamine concentration does not
increase after its administration (Doenicke et al., 1973), (whereas
Kl
it does after Althesin and propanidid), and there is no reported
case of allergic reaction to the drug. In the dose required for
anaesthesia, respiratory depression is not a problem (Doenicke, 197k>
Morgan et al., 1975, 1977; Famewo and Odugbesan, 1977, 1973; G-honeim
and Yamada, 1977), although this property is not so important in
neuroanaesthesia as ventilation is usually controlled. Etomidate is
metabolised quickly and has been shown to be suitable for maintenance
of anaesthesia by a total intravenous technique, when given in a dose
of 100 jig/Kg for 10 minutes followed by 10 y.g/Kg for the remainder of
the operation, and supplemented with fentanyl as required (Boyes et al.,
1931). It has no toxic effects when given in large doses, and
patients are usually rouseable within 5 minutes of terminating the
infusion. Some patients do, however, take some time to wake and most
are drowsy for several hours afterwards. Thus its use by continuous
intravenous infusion may have a place as an alternative to thiopentone ,
methohexitone (Hunter, 1972a, 1972b) or Althesin, in maintaining
anaesthesia in patients with intracranial space-occupying lesions.
It has no analgesic properties so analgesic supplementation is
essential. The rapid metabolism of the drug and its ability to
reduce ICP suggest that it would be suitable for rapid reduction of
ICP in head injured patients, or for prophylactic use before chest
physiotherapy or other procedures known to increase ICP in this
group of patients.
Patel (1980) reported that the involuntary movements caused
by etomidate could cause ICP to increase. This would appear to
mitigate against its use in neuroanaesthesia, but involuntary
movements are rare when anaesthesia is induced over a period of 90
to 120 seconds by infusion of etomidate (Boyes et al., 198l), and
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will not be a problem when the patient is under the influence
of a muscle relaxant.
Prom the results of this study it can be concluded that
etomidate is a useful addition to the drugs available to the
neuroanaesthetist for induction of anaesthesia. This conclusion
is supported by the results of other authors (Cunitz et al., 1978;
Schulte am Esch et al., 1978a, 1978b, 1980; Cunitz and Gaab, 1980),
which were published after this investigation was completed.
In addition, etomidate could be used as an agent for the rapid




Ten patients with intracranial lesions, anaesthetised
with thiopentone, d-tubocurarine, and nitrous oxide (7&?°) in
oxygen (30%) received etomidate 0.2 mg/Kg intravenously.
Ventilation was controlled in each patient. ICP and MAP
were recorded. ICP decreased significantly in all patients
(0.01>P >0.001). Although PaC02 decreased during the
period of measurement, the extent and time-course of thi3
change suggested that it was not mainly responsible for
changes in ICP. MAP decreased in most patients, but the
decrease was statistically significant only at 3 and L. minutes
after the administration of etomidate (0.05 > P > 0.02).
The changes in CPP and heart rate were not clinically or
statistically significant. Thus etomidate can be used for
the induction of anaesthesia in patients with intracranial




THE EFFECTS OF TUBOCURARIN ON ICP AND CPP
11S"
INTRODUCTION
Although d-tuhocurarine is commonly used in neuroanaestnesia
the literature on its effect on ICP and CBP is contradictory.
Alexander and colleagues (l96;+) stated that it had no direct effect
on the cerebral circulation, a finding which has been supported by
the results of other workers (see below). There are, however,
very few reports of the effect of tubocurarine on ICP. Tarkkanen
and colleagues (197k) reported that tubocurarine could cause
significant increases in ICP during normocapnia in neurosurgical
patients. This finding is contradictory to all previous reports
and does not agree with the author's experience. In this chapter
I will describe the results of studies of the effect on ICP of
d-tubocurarine A-5 mg. given with thiopentone or Althesin, and of
smaller incremental doses of d-tubocurarine in patients wrho were
receiving nitrous oxide relaxant anaesthesia.
METHODS
In these investigations ICP was measured from a ventricular
catheter, which had been inserted for other ICP studies, and
arterial pressure was measured from a radial artery cannula.
The patients were placed supine with a 10° head-up tilt. The
patients gave their informed consent.
The first investigation involves the 20 patients described
in Chapter Each patient was premedicated with diazepam 10 mg.
intramuscularly, except for one patient who received papaveretum
10 mg and hyascine 0.2 mg. intramuscularly. Ten patients received
116
thiopentone (range 250 to ;.L00 mg), preceded by d-tubocurarine ;+5 mg
and 10 received Althesin (range 3 to 5 ml) preceded by d-tubocurarine
A5 mg O,_0 mg in one frail patient). The patients were then hyper¬
ventilated moderately with itfo nitrous oxide in oxygen for 2 mins-via
a facemask by hand compression of the reservoir bag until intubation.
End-tidal carbon dioxide concentration was observed on an infra-red
analyser throughout this period, and an arterial blood sample was
taken for determination of blood gas tensions 2 mins.after the
administration of d-tubocurarine in 6 of the patients. ICP and MAP
were measured for 5 mins. before induction of anaesthesia and for the
2 mins. between induction and laryngoscopy and intubation.
In the second investigation, 10 patients who were about to
undergo intracranial operations for cerebral tumour or aneurysm were
studied. If premedication was required this was with diazepam 10 mg.
intramuscularly or orally. The patients were anaesthetised with
thiopentone or Althesin followed by d-tubocurarine, intubated, and
maintained with nitrous oxide in oxygen supplemented with fentanyl.
The ventilator was adjusted to give a constant end-tidal carbon dioxide
concentration by reference to an infrared carbon dioxide analyser.
Once ICP and MAP had been stable for 5 min, d-tubocurarine 15 to 20 mg
was given intravenously, and ICP and MAP were recorded for 5 min before
any further drugs were given and before surgery was continued.




When d-tubocurarine 0 mg was given immediately before
thiopentone or Althesin at induction of anaesthesia there were
significant reductions in ICP, MAP and CPP (Tables 10, 11 and 12).
ICP was reduced in U+ out of the 20 patients and the maximum
increase in ICP was 6 mm Hg. CPP was reduced to less than 50 mm Hg
in 11 patients. The PaC02 at 2 minutes after the administration of
tuhocurarine was 3-76 (S.D. 0.80) KPa (range 2.1 to 5.3 KPa).
The administration of tubocurarine 15 to 20 mg intra¬
venously resulted in a statistically significant reduction in ICP
at A a**d 5 minutes after its administration compared with the
control value (0.05 >P >0.02) (Table 13) • In this dosage it
also caused small reductions in MAP and CPP which were not
statistically significant (Tables U,. and 15). The mean PaC0# at
the time of the administration of the tubocurarine was L.76
(S.D. O.96) KPa (range 3.7 to 6.7 KPa).
DISCUSSION
With the exception of suxamethonium which has been shown
to increase lumber CSP pressure by up to 23.5 mm Hg (Halldin and
Wahlin, 1959; Sondergard, 1961; Marx et al., 1962), the muscle
relaxants appear to have no primary effect on ICP. Creenbaum
and colleagues (1975) found that alcuronium appeared to have no
direct effect on ICP and, during induction of anaesthesia,
McLeskey and colleagues (197k) found that pancuronium had no
effect on ICP. It is the author's experience that ICP does not
change when pancuronium 2 to ^ mg is given to mechanically-
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TABLE 10
Mean ICP "before (control) and 1 and 2 min. after thiopentone
or Althesin and d-tubocurarine R5 rag. intravenously.
(Significance values are for comparison with the control values.)
Patient Control
(before induction)
1 minute 2 minutes
A 22.5 8.5 9
B 13 11 11
C 3 2.5 U
D 15 13 15
E 9 11 8
F 10 9.5 9
G 9 15 15
H 5 K 3
I 15.5 8.5 9.5
J 12.5 9 8.5
K 30 10 9
L 18 12 12
M 1L 11 12
N 9 9 8
0 6.5 5 5
P 6 5.5 2
Q 16 17 lb
R 11.5 8.5 6
S 12.5 1L 9.5
T 9.5 9 12.5
n 20 20 20
X 12.38 9.65 9.1
S.D. 6.26 3.63 3.76
2R7.5 193 182
c 2







MAP before (control) and 1 and 2 min. after thiopentone
or Althesin and d-tubocurarine h.5 nig. intravenously.
(Significance values are for comparison with the control values.)
Patient Control
(before induction)
1 minute 2 minutes
A 95 65 55
B 123 110 107
C 120 67 63
D 10? 38 48
E 90 58 53
P 103 53 52
& 97 43 48
H 107 73 53
I 83 25 13
J 127 103 ^ 65
K 103 88 70
L 112 55 70
M 135 73 88
N 98 35 30
0 100 70 40
P 113 107 93
Q 77 77 63
R 148 113 107
S 110 96 57
T 117 92 63
n 20 20 20
X 108.3 72.2 61.9
S.D. 17.17 26.35 23.47
2165 1443 1238




CPP before (control) and 1 and 2 min. after thiopentone
or Althesin and d-tubocurarine 2,5 mg. intravenously.
(Significance values are for comparison with the control values.)
Patient Control
(before induction)
1 minute 2 minutes
A 72.5 56.5 A6
B 110 99 96
C 117 6A.5 59
D 92 25 33
E 81 2,7 2,5
P 93 2,3-5 2,3
G 88 28 33
H 102 69 50
I 67.5 16.5 3.5
J 112,.5 96 56.5
K 73 78 61
L 92, 2,3 58
M 121 62 76
N 89 26 22
0 93.5 65 35
P 107 101.5 91
Q 61 60 2,9
R 136.5 102,-5 101
S 97.5 82 2,7.5
T 107.5 83 50.5
n 20 20 20
X 95.9 62.5 52.8






ICP values (mm Hg) before (control)and after d-tubocurarine
15 to 20 mg intravenously. (Significance values are for
comparison with the control values.)
Patient Control After d-tubocurarine
1 min 2 min 3 min A min 5 min
A 6.5 6.5 6.5 6.5 5.5 5.5
B 13.5 13.5 13.5 13 13 13.5
C 23 23 23.5 23 21 22.5
D A .5 A A A A A
E 21.5 21.5 20.5 20.5 20 19
F 50 A7.5 AA AA A5 A7.5
G 7.5 7 6 6 6 6
H 11.5 11.5 9 10 11 11
I 7.5 8 7.5 7.5 7.5 8
J -1.5 -1.5 -1.5 -1.5 -1.5 -1.5
n 10 10 10 10 10 10
X lA-A 1A.1 13.3 13.3 13.2 13.6




MAP values (mn Hg) "before (control) and after d-tubocurarine
15 to 20 mg intravenously.
Patient Control After d-tubocurarine
1 min 2 min 3 min 4 min 5 min
A 90 90 90 90 90 90
B 137 137 132 132 125 132
C 107 102 102 100 100 107
D 117 122 122 122 112 112
E 100 105 105 100 102 100
P 85 84 80 80 80 84
& 62 62 62 62 67 68
H 140 132 130 123 118 117
I 100 100 100 98 93 93
J 88 82 68 63 68 73
n 10 10 10 10 10 10
x 102.6 101.6 99.1 97 95.5 97-6
S.E.M. 7.57 7.46 7.75 7.65 6.29 6.34
ias
TABLE 15
CPP values (mn Hg) before (control) and after d-tubocurarine
15 to 20 mg intravenously-
Patient Control After d-tubocurarine
1 min 2 min 3 min A min 5 min
A 83.5 83.5 83.5 83.5 8a.5 8a.5
B 123.5 123.5 118.5 119 112 118.5
C 8L 79 78.5 77 79 8a.5
D 112.5 118 118 118 108 108
E 78.5 83.5 8a-5 79.5 82 81
E 35 36.5 36 36 35 36.5
G 5a.5 55 56 56 61 62
H 128.5 120.5 121 113 107 106
I 92.5 92 92.5 9.0.5 85.5 85
J 89.5 83.5 69.5 6a .5 69.5 7A.5
n 10 10 10 10 10 10
x 88.2 87.5 85.8 83.7 82.A 8;+..C5
S.E.M. 9.18 8.90 8.88 8.70 7.A8 7.53
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ventilated patients with head injuries, unless the patient has
been straining against the ventilator, in which case ICP decreases
after the administration of pancuronium. The latter is an example
of a secondary effect of muscle relaxants on ICP caused by a
reduction in muscle tone, mainly in the abdominal muscles, and CVP.
Studies in man showed that tubocurarine had no effect on ICP
provided that PaC02 was not allowed to increase (Sondergard, 1961).
However, in 20 patients with normal ICP, Tarkkanen and co-workers
(197k) showed increases in ICP of 8.1 (S.D. 6.8) mm Hg with doses
of 0.6 (S.D. O.l) mg/Kg of tubocurarine, which they attributed
partly to histamine release causing cerebral vasodilatation.
Tubocurarine is known to cause histamine release and, in patients
with intracranial tumours, histamine has been shown to cause a rapid
increase in internal carotid blood flow of about 60/S, lasting for
approximately 1 minute (Tindall and Greenfield, 1973)* Histamine
also increases lumbar CSP pressure in patients suffering from
headaches (Engel, 1970). Tarkkanen and colleagues allowed the
patients to breathe spontaneously for 1 to 2 minutes after the
administration of tubocurarine and the PaC02 increased by 0.6
(S.D. 0.5) KPa, which was sufficient to account for an increase in
ICP of about 20^S. The patients were either sedated or only very
lightly anaesthetised, and some of the increase in ICP could have
been due to an arousal effect as PaC02 increased and respiration
became more difficult. An incremental dose of tubocurarine of
0.2 - 0.1 mg/Kg administered during respirator-assisted respiration
caused smaller increases in ICP.
None of the muscle relaxants have been shown to affect C3P
(Alexander et al., 196^; Wollman et al.,196/+, 1965; Gauch et al.,
1973), but the former group provided no results to support
their statement.
In the author's investigations there were significant
reductions in ICP when d-tubocurarine 5 mg was given before
an induction dose of thiopentone or Althesin. However, several
different events were occurring at the same time. More than one
drug was given, there was a change from spontaneous respiration
to controlled ventilation and PaC02 may have been changing.
So any change in ICP cannot be solely attributed to tubocurarine,
but if it did cause a marked increase in ICP one would have
have expected to see evidence of it in these results. The maximum
increase in ICP seen in this investigation was small (6 mm Hg).
CPP was considerably reduced and was less than 50 mm Hg in 11
patients at some time during the first 2 minutes after the
administration of tubocurarine. This pressure is at the lower
limit of the autoregulation range (Olesen, 1973), so there is a
danger of producing cerebral ischaemia.
In the second investigation these variables were eliminated
"by administering the tubocurarine to patients who were already
anaesthetised, paralysed with tubocurarine and mechanically
ventilated. Tubocurarine 15 to 20 mg caused a small reduction
in ICP which was statistically significant at k and 5 minutes.
This smaller dose did not affect MAP or CPP, thus it might be
safer to give this agent in smaller incremental doses as suggested
by Savarese (1975). The small decrease in ICP is probably due to
increased muscle relaxation and a reduction in CVP, and not to a
direct effect on the cerebral vasculature.
The fact that suxamethonium does not influence CBP supports
\1<o
the view that the increase in CSF pressure associated with its
administration is due to the muscle fasciculations causing an
increase in intra-abdominal, intrathoracic and central venous
pressures. This view is also supported by the author's investig¬
ations in 5 patients. These patients were receiving a standard
relaxant anaesthetic with tubocurarine and nitrous oxide in oxygen
supplemented with fentanyl. When ICP had returned to normal after
a previous study, suxamethonium 1.5 mg/Kg was administered intra¬
venously. The maximum changes in ICP in the first 5 mins. after
the administration of suxamethonium were minimal (mean = l.L mm Hg,
range = 1 to 2.5 mm Hg). Thus even if there is a direct effect of
suxamethonium on the cerebral vessels, which might be expected
because of its structural resemblance to acetyl choline, it is very
small, and if muscle fasciculations are abolished, any effect of
sxixamethonium on ICP should be clinically insignificant.
In conclusion, the results reported here indicate that
tubocurarin^ has no direct effect on the cerebral circulation and
ICP. The marked reduction in CPP, which it causes when given in
large doses with intravenous anaesthetic agents at the induction
of anaesthesia is a major disadvantage in some patients, but it
may help to avoid excessive arterial pressure increases during
laryngoscopy and intubation, which in turn may reduce increases
in ICP and the formation and propagation of cerebral oedema.
In smaller doses it can be used safely during anaesthesia for
intracranial operations, where it has the advantages of a long
duration of action, and of causing some reduction in blood pressure,
which helps in arterial pressure control. It can, however, cause
bronchoconstriction (Weiss et al., 1971.), and is best avoided in
patients who are prone to bronchospasm.
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SUMMARY
Thirty patients who were about to undergo craniotomy
were studied. All were anaesthetised with thiopentone or Althesin
preceded by d-tubocurarine M5 mg and hyperventilated moderately with
70$ nitrous oxide in oxygen. In 20 patients ICP and MAP were
measured during induction of anaesthesia. In these patients there
were significant reductions from the control values in average ICP
(0.05 > P >0.02), MAP (P< 0.001) and CPP (P< 0.001) in the 2 mins
between induction of anaesthesia and intubation. In the other 10
patients, once intubation had been performed and anaesthesia was
established with 70ifo nitrous oxide supplemented with fentanyl, an
incremental dose of d-tubocurarine 15 to 20 mg was administered.
Ventilation was controlled to maintain a constant mean PaC02 of
A«7'6KPa (range 3*7 to 6.7 KPa). Tubocurarine 15 to 20 mg caused a
reduction in ICP from the control value which was statistically
significant (0.05 >P >0.02) at M and 5 minutes after its
administration, and small reductions in MAP and CPP which were not
statistically significant. These results indicate that d-tubocurarine
has no direct effect on ICP. The literature about the effects of
muscle relaxants on ICP and CBP is reviewed.
as
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The narcotic analgesics do not have any significant
effect on CBF or ICP provided that the PaC02 does not increase
following their administration (see telow). Fentanyl and droperidol
to
in combination have been shown to not alter or/decrease slightly the
ICP during controlled ventilation (Fitch et al., 1969a), and to have
no effect on CBF (Sari et al., 1972b). Because fentanyl is short-
acting, it has been widely used, sometimes with droperidol, to
supplement nitrous oxide, relaxant anaesthesia for neurosurgery.
However, Misfeldt and colleagues (1976) observed a marked increase
in ICP when they used droperidol and fentanyl for induction of
anaesthesia and, from the results of systematic investigations
during controlled ventilation, concluded that these drugs were contra-
indicated in neurosurgery unless hypocapnia was established and the
arterial pressure was normal or increased. Because this latter
report appears to contradict earlier work, this study was conducted
on the effect of fentanyl on ICP in neurosurgical patients during
controlled ventilation.
METHODS
Ten patients with intracranial lesions presenting for
craniotomy were studied. Diazepam 10 mg intramuscularly was
administered for premedication, if this was considered necessary.
Following the induction of anaesthesia with thiopentone (5 patients)
or Althesin (5 patients), which was given until the eyelash reflex
was lost, tubocurarine (h5 mg) was administered. Anaesthesia was
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maintained with 70^ nitrous oxide in oxygen. The ventilation
was adjusted to maintain the PaC02 at between 2.7 and A.0 KPa.
ICP was measured from a catheter in a lateral ventricle and
arterial pressure was measured from a radial artery cannula.
The studies were performed with the patient supine and tilted
10° head-up. When ICP and arterial pressure had remained stable
for 5 minutes, fentanyl 0.2 mg was given intravenously. The ICP
and arterial pressure recordings were followed for 10 minutes
before surgery was continued. End-tidal carbon dioxide concen¬
tration was maintained constant by reference to an infra-red carbon
dioxide analyser, and arterial blood gas tensions were measured at
the beginning and end of the 10-minute period.
The following measurements were obtained from the chart
recordings;
1) MAP and mean ICP in the 5 minutes before administration
of fentanyl (termed control MAP and control ICP);
2) MAP and mean ICP at 1 minute intervals for the first
10 minutes after the administration of the fentanyl;
3) CPP at 1-minute intervals for 10 minutes after the
administration of the fentanyl.
RESULTS
For brevity, the measurements in the tables are at 2-minute
intervals, as there was no additional information in the values
at 1 minute intervals.
The ages of the patients, their intracranial pathology,
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and the effects of fentanyl on mean ICP are presented in Table 16.
The average ICP for the group decreased initially from the control
value after the administration of fentanyl. ICP decreased in most
patients but increased in 3 patients, and in one patient ICP
decreased initially but increased after the head was turned. The
ICP changes after the administration of fentanyl ranged from -5 to
6 mm Hg. The maximum increase in ICP recorded was 6 mm Hg, and in
3 of the j+ patients showing an increase in ICP after fentanyl, the
ICP did not reach the pre-induction level; the fourth patient had
no pre-induction measurement for comparison. The changes in ICP
from the control level were not statistically significant for the
group.
In all the patients MAP decreased after the administration
of fentanyl (Table 17), and was less than 60 mm Hg in 2 patients
(55 and 53 mm Hg). These decreases in MAP were statistically
significant from 2 minutes after the administration of fentanyl
until the end of the period of measurement (0.01 P >-O.OOl).
CPP was less than 60 mm Hg in patients (39, 55, h.3 and 51 mm Hg),
but less than 4O mm Hg in only 1 patient (Table 18), and this for less
than 1 minute. The changes in CPP from control were statistically
significant at 1 minute after the administration of fentanyl (0.02>P
">0.0l), but from 2 minutes onwards were of greater significance
(0.01> P > 0.001).
Table 19 shows the PaC02 measurements obtained at the time
of the injection of fentanyl and 10 minutes after the injection.
These values showed little change during the period of measurement.
Although most of the PaC02 values were between 2.7 and 2^.0 KPa (the
range aimed for), one was 5.5 KPa and another 2.5 KPa. In each
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TABLE 16
Diagnosis and mean ICP values (mm Hg) before (control) and after
the administration of fentaryl 0.2 mg.
Patient Diagnosis Control Time after fentanyl (min)
(age,yr) (value beforeinduction. 11 «-) < ^ p ~i f\
known) 2 6 8 10
A (;+2) Pituitary tumour 12 10 8 7 8 7
B (71) Meningioma 15 (10) 13 10 1A 10 10
c (59) Meningioma 10 (13) 8 9* 11 11 12
D (59) Glioblastoma 10 (23) 11 10 16 15 15
E (A7) Aneurysm 20 (17) - - 19 20 19
P (59) Meningioma 9 (17) 8 9 10 10 11
& (35) Aneurysm 11 (15) 10 9 9 8 8
H (62) Glioblastoma 16 16 19 19 19 19
I (50) Acoustic neuroma 9 9 9 9 8 8
J (6A) Spontaneous
intracerebral
haemorrhage 9 8 8 8 8 8
Mean 12 .1 10.3 10.1 12.2 11.7 11.7
S.E.M. 1 .2 0.9 1.1 1.1 1.5 1 •/-!-
* Head turned at this time.
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TABLE 17
Mean arterial pressure (mm Hg) before (control) and after the
administration of fentanyl 0.2 mg.
Patient Control
Time after fentanyl (min.)
2 A 6 8 10
A 113 93 83 70 70 75
B 105 98 98 - 83 85
C 127 102 88 82 80 82
D 73 55 65 55 58 65
E 113 115 105 105 98 98
F 100 80 70 65 72 75
& 63 53 60 57 63 63
H 83 72 70 70 70 70
I 115 95 85 80 90 95
J 107 97 92 90 90 88
Mean 99.9 86.0 81.6 7A-9 77.A 79.6
S.E.M. 6.5 6.5 A-7 5.A A.l 3.8
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TABLE 18
Cerebral perfusion pressure (mm Hg) before (control) and after
the administration of fentanyl 0.2 mg.
Patient Control ■
Time after fentanyl (min.)
2 a 6 8 10
A 101 83 75 63 62 68
b 90 85 88 - 73 75
C 120 9a 79 71 69 70
D 63 la 55 39 a3 50
E 93 - - 86 78 79
P 91 72 61 55 62 6a
G 52 l3 51 a8 55 55
H 67 56 51 51 51 51
I 106 86 76 71 82 87
j 98 89 8a 82 82 80
Mean 88.1 72 .a 68.9 62.9 65.7 67.9
S.E.m. 6.7 6.6 a.8 5.3 a.2 a.l
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TABLE 19
Paco2 values at the time of injection of fentanyl



















patient the end-tidal carbon dioxide concentration remained constant
during the period of the study.
DISCUSSION
The narcotic analgesics have little effect on CBF and ICP
provided that respiration is not depressed and the PaC02 does not
increase. Thus if PaC02 remains constant morphine has no effect
on CBF (McCall and Taylor, 1952a; Moyer et al., 1957; Jobes et al.,
1977) or ICP (Keats and Mithoefer, 1955; Stullken and Sokoll,1975a),
but if the PaC02 rises ICP increases (Gurdjian et al., 1959; Keats
and Mithoefer, 1955). At constant PaC02 pentazocine produces
small decreases in ICP in patients undergoing intracranial surgery,
but when given to spontaneously breathing patients with 'brain
damage' the ICP and PaC02 increase (Barker et al., 1972). When
phenoperidine is given in combination with droperidol at constant
PaC02, changes in CSF pressure are small and can be in either
direction (Barker et al., 1968; Fitch et al., 1969a), and there is
no effect on CBF (Barker et al., 1968; Wilkinson and Browne, 1970).
The narcotic antagonist nalorphine causes CSF pressure to increase
if given to patients who have not previously received a narcotic
analgesic (Keats and Mithoefer, 1955), and levallorphan reduces CSF
pressure when given to dogs which are under the influence of morphine
(Weitzner et al., 1963).
Droperidol is often administered in combination with a
narcotic analgesic to supplement nitrous oxide relaxant anaesthesia.
When given on its own droperidol reduces CBF in dogs (Michenfelder
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and Theye, 197l)» In man, Misfeldt and colleagues (1976)
demonstrated a small but not significant increase in ICP following
the administration of droperidol, R.Miller and coworkers (1975)
found that a similar dose of droperidol had no effect on lumbar CSF
pressure and Cunitz and G-aab (1980) showed a significant reduction
in ICP with a larger dose. On balance, it appears that droperidol
has very little effect on ICP.
Morphine 0.6 mg/Kg decreases CMR02 in dogs (Takeshita et al.,
1972a), but in man the reports are conflicting. Moyer ani colleagues
(1957) found that morphine 60 mg intravenously caused a significant
reduction in CMR02, but Jobes et al. (1977) found that a dose of 1 to
5 mg/Kg had no effect on cerebral metabolism when given during nitrous
oxide anaesthesia. Pethidine reduces CMR02 in dogs which are lightly
anaesthetised with halothane (Messick and Theye, 1969). When fentanyl
is given to dogs anaesthetised with nitrous oxide in oxygen it causes ~
a reduction in CMR02 (Michenfelder and Theye, 197l), but when it is
given in combination with droperidol CMR02 is either slightly reduced
(Michenfelder and Theye, 197l), or not affected (Miller ani Barker,
1969). Droperidol alone has no effect on CMR02 in dogs (Michenfelder
and Theye, 197l)» In man CMR02 is unaffected by fentanyl combined
S
with droperidol (Sari et al., 1972b).
In dogs anaesthetised with nitrous oxide in oxygen fentanyl
0.006 mg/Kg caused a reduction in CBF of K1% (Michenfelder and Theye,
197l), but in man Sari and colleagues (1972b) found that CBF was
unaffected by fentanyl and droperidol in combination. Fitch and
coworkers (1969a) reported that, in patients with space-occupying
lesions ventilated ?/ith nitrous oxide and oxygen at normocapnia, the
intravenous administration of droperidol 5 mg together with fentanyl
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0.1 mg led to small decreases in ICP in 8 out of 9 patients.
Adams and colleagues (1972), however, found that droperidol
and fentanyl had no effect on ICP. The effect of these drugs on
ICP was also assessed by Misfeldt and coworkers (1976), who reported
that fentanyl 0.2 to 0.3 mg given after droperidol 7*5 to 12.5 mg
intravenously resulted in increases in ICP in 5 patients and
decreases in 3» These latter authors concluded that they could not
explain the difference between their results and those of Fitch and
colleagues. However, the disagreements appear to be small because,
of the 5 patients with increases in ICP reported by Misfeldt and
coworkers, 3 had very small increases (l, 2 and 3 mm Hg). In the
other 2 patients the increases were greater (8 and 9 mm Hg), but the
methodology employed by these workers would bias the results towards
the finding of increases in ICP, because they measured the highest
ICP achieved at an undefined time more than 10 minutes after the
administration of the drugs. Patients with space-occupying pathology
show 'spontaneous' variations in ICP, so that in any group of such
patients a method which selects the highest ICP value reached will
include increases in ICP which are not a result of the previous drug
administration, and the effect will increase the longer the period of
observation after the administration of the drug. In the study of
Misfeldt and colleagues, the 2 patients with the greatest increases
in ICP following the injection of fentanyl had plateau waves recorded
before the induction of anaesthesia, which indicates that ICP in these
patients was unstable before the administration of fentanyl.
The changes in ICP caused by supplementation of nitrous
oxtde/o;xygen anaesthesia with neuroleptanalgesia drugs are very small
in comparison with the large and consistent increases in ICP associated
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with the administration of some volatile anaesthetics to normocapnic
patients (Jennett et al., 1969; Adams et al., 1972). However, the
changes in ICP associated with the administration of enflurane,
during both normocapnia and hypocapnia, are very similar to those
seen with fentanyl (see Chapter 8).
Most neurosurgical operations are conducted during hypocapnia,
and the present study extends the information available in the
literature about neuroleptanalgesia drugs by reporting measurements
made at hypocapnia. Furthermore, since fentanyl is a short-acting
drug with a plasma half-life of 2 minutes (Schleimer et al., 1978),
the measurements ?;ere made during the first 10 minutes after drug
administration, at a time when the maximum effect of the drug is
seen clinically. This increased the likelihood that the changes
observed were causally related to the drug administered. During
hypocapnia fentanyl 0.2 mg caused small changes in ICP which could
be in either direction. The mean ICP decreased for h_ minutes after
the administration of fentanyl, but this fall was not statistically
significant.
The present results on the effect of fentanyl on MAP and CPP
are in complete agreement with those of other authors (Misfeldt et al.,
1976; Cunitz and G-aab, I98O), and emphasize the point made by the
former authors, that fentanyl should not be given to patients who
are hypotensive already, otherwise low CPP may result. In the
author's study values of CPP of less than 50 mm Hg were observed in
2 patients, both of whom were moderately hypotensive when the drug
was given (MAP = 73 and 63 mm Hg).
The author's finding of a variable response of ICP following
the administration of fentanyl is supported by the work of Vernhiet
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and colleagues (1977). This showed that fentanyl caused no
significant change in CBF, but that the individual response was
very variable. The variations in CBF correlated perfectly with
individual variations in CMR02. Fentanyl produces no obvious
regional modification of CBF (De Rood et al., 197k» Vernhiet et al.,
1977). Fentathienyl, a new agent with a structure similar to
fentanyl, causes no significant changes in CBF and CMR02 and, when
compared with fentanyl, shows less variability of response between
patients (Vernhiet et al., 1977), and may prove to have a more
predictable effect on ICP.
It must be emphasised that this discussion of the effect of
neuroleptanalgesia drugs on ICP and CBF refers to the administration
of the drugs to patients whose ventilation is controlled. In
spontaneously breathing patients fentanyl 0.1 mg and droperidol 5 mg
may cause an increase in lumbar CSF pressure because of an increase
in PaC02 (Miller, R., et al., 1975).
The results of the investigation described here allow the
following conclusions to be made. In hypocapnic patients with
.intra-cranial space-occupying lesions, changes in ICP following the
administration of fentanyl are small and may be in either direction.
Fentanyl causes decreases in MAP and CPP, but unless the patient is
already hypotensive the changes are small. The establishment of
hypocapnia before the administration of fentanyl does not provide
complete protection against a fall in CPP to less than 50 mm Hg if
the patient is already hypotensive (see patients D and G-). In the
author's view fentanyl is a valuable adjunct to nitrous oxide/oxygen
relaxant anaesthesia in patients with intracranial space-occupying
lesions, provided that it is not used in patients who are hypotensive.
Its effect on ICP in hypocapnic patients is small and, both clinically
and statistically insignificant.
SUMMARY
Ten patients who were about to undergo craniotomy were
studied. Each was anaesthetised with thiopentone or Althesin
followed by tubocurarine, and the lungs were hyperventilated
with nitrous oxide in oxygen. Fentanyl 0.2 mg was administered
intravenously and ICP and MAP were recorded continuously for 10
minutes. At the time of administration of fentanyl 9 out of the
10 patients were hypocapnic (PaC02 less than A KPa). The changes
in ICP were small and could be in either direction. Cerebral
perfusion pressures of less than 50 mm Hg were observed in 2
patients, who had moderate hypotension before the drug was given.
Thus fentanyl is a valuable supplement to nitrous oxide/oxygen
relaxant anaesthesia with hyperventilation in patients with intra¬
cranial space-occupying lesions, provided that hypotension is
absent. The literature concerning the effects of narcotic
analgesics and neuroleptanalgesia agents on ICP and CBF is reviewed.
CHAPTER 8
THE EFFECTS OF 2% ENFLURANE ON ICP AND CPP
1^3
INTRODUCTION
Enflurane is a volatile anaesthetic agent which has been
introduced into anaesthetic practice in Britain fairly recently.
The literature regarding its effect on ICP and CBP is conflicting.
In dogs the administration of enflurane produces cerebral metabolic
depression, cerebral vasodilatation and an increase in ICP which is
less than that caused by the administration of halothane (see below).
In man, however, most workers have found that the administration of
enflurane has very little effect on ICP and CBP provided that the
PaC02 remains constant, but some investigations have shown
substantial increases in ICP in some patients (see below).
Enflurane causes a substantial reduction in arterial pressure and
thus reduces CPP. This investigation was performed in order to
determine the effect of enflurane on ICP and CPP in patients with
cerebral tumours.
METHODS
Ten patients with cerebral tumours were studied. All
were about to undergo intracranial surgery. Informed consent was
obtained for all the investigations. If considered necessary, the
patients were premedicated with diazepam 10 mg orally. Anaesthesia
was induced with thiopentone and maintained with nitrous oxide
70fo in oxygen supplemented with fentanyl to a maximum dose of 0.2 mg.
Muscle relaxation was achieved with d-tubocurarine hfj mg and
ventilation was controlled so as to maintain a PaC02 as near as
possible to the normal range. ICP was measured from a ventricular
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catheter in 9 patients and a subarachnoid bolt in 1 patient
(patient J) because the lateral ventricles were compressed.
Arterial pressure was measured from a radial artery cannula.
During the investigation the patients were supine with a 10°
head-up tilt except for 1 patient who was studied in the prone
position (patient B). Once stable, ICP and arterial pressure
were recorded for 5 minutes (control readings), 2/b enflurane was
then administered (from an enflurotec vaporizer) in 7C$ nitrous
oxide in oxygen for 15 minutes (if CPP was reduced to a level which
was considered unacceptable the enflurane was stopped after less
than 15 minutes).
After 15 minutes the enflurane was stopped, and ICP and
arterial pressure were recorded for a further 10 minutes. At the
end of the study, pressure/volume testing was performed by
measuring the ICP response to 1 ml injections of saline into the
lateral ventricle to a maximum of 5 injections, or until ICP
exceeded 20 mm Hg, whichever was the first. Arterial blood
samples were taken for measurement of blood gas tensions just
before the enflurane was started, and at the time when the admin¬
istration of enflurane was stopped. During the period of
measurement the end-tidal carbon dioxide concentration was
continuously displayed on an infra-red carbon dioxide analyser.
Arterial blood samples were taken for measurement of enflurane
concentration (using a gas chromatograph) at 5, 10 and 15 minutes
after the start of the administration of enflurane.
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RESULTS
There was no significant change in TCP during the
administration of 2^ enflurane (Tahle 20). The ICP changes
ranged from -18.5 to 5.5 mm Hg. MAP and GPP were reduced by the
administration of 2% enflurane (Tables 21 and 22). These changes
were stastically significant (PCO.OOl). Neither MAP nor CPP
were significantly different from control 10 minutes after the
administration of enflurane was stopped. CPP was reduced to less
than LO mm Hg in 3 patients and in another 3 patients the admin¬
istration of enflurane was prematurely stopped because CPP was
approaching this value.
PaC02 values were the same before and at the end of the
enflurane administration, but although the mean PaC02 was in the
hypocapnic range there was a considerable scatter of PaC02 values
from 3.7 to 6.7 KPa (Table 23). Of the 7 patients with normal
initial ICP values, 2 had an increased pressure/volume response
(2 mm Hg or more (Miller and Leech, 1975) ), and the test was not
performed on 2 (Table 23). One of the latter patients had an
excessive increase in ICP when the PaC02 was increased into the
normocapnic range, and was therefore studied during hypocapnia.
The blood, enflurane concentrations are shown in Table 2a;
they were not measured in patient A.
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TABLE 20
ICP values (mm Hg) before (control), during and after the
administration of 2/o enflurane
Patient Control During enfluraneadministration
After enflurane
stopped
5 min 10 min 15 min 5 min 10 min
A 2 2 2 2 2 2
B 18 19 20 19.5 21 21.5
C 58.5 43.5 AO AO 48 50
D 10 10.5 9.5 9.5 9.5 9.5
E 7.5 7.5 8 9.5 8.5 6.5
F 4.5 5 5 - 5.5 5
G- 7.5 8 8.5 - 6.5 5.5
H 8.5 11.5 12.5 - 1A 10
I -1 0 0 0 0.5 0.5
J 22.5 20.5 19 - 18 18.5
n 10 10 10 6 10 10
X 13.8 12.8 12.5 13-4 13-A 12.9
S.E.M. 5-44 A.00 3.69 6.01 4.38 4.64
I if7
TABLE 21
MAP values (mm Hg) "before (control), during and after the
administration of 2% enflurane. (Significance values are for
comparison with the control values.)
Patient Control During enfluraneadministration
After enflurane
stopped
5 min 10 min 15 min 5 min 10 min
A 115 97 87 53 67 102
B 102 92 87 90 97 100
C 100 80 70 75 85 85
D 98 70 63 57 55 63
E 91 62 43 48 55 67
F 78 62 50 - 55 55
G 77 67 60 - 82 100
H 93 73 63 - 95 108
I 85 63 53 50 52 62
J 83 60 50 62 73
n 10 10 10 6 10 10
x 92.2 72.6 62.6 62.2 70.5 81.5
S.E.M 3.78 a .14 4.77 6-83 5.57 6.26




CPP values (mm Hg) before (control), during and after the
administration of 2% enflurane. (Significance values are for
comparison with the control values.)




5 min 10 min 15 min 5 min 10 min
A 113 95 85 51 65 100
B 8A 73 67 70.5 76 78.5
C Al.5 36.5 30 35 37 35
D 88 59.5 53.5 A7.5 A5.5 53.5
E 83.5 5A*5 35 38.5 A6.5 60.5
P 73.5 57 A5 - A9.5 50
G 69.5 59 51.5 - 75.5 9A .5
H 8A .5 61.5 50.5 - 81
■
98
I 86 63 53 50 51.5 61.5
J 60.5 39.5 31 — AA 5A.5
n 10 10 10 6 10 10
X 78.A 59.9 50.2 A8.8 57.15 68.6
S.E.M. 5.99 5.19 5.33 5.08 A.99 7.18




Paco2 values (kPa) immediately before and at the end of the
administration of enflurane, and the response of ICP (mm Hg)









A 3.7 3.7 1
B 5.8 5.7 2.5
C 6.3 6.7 5
D 5.3 5.4 1
E A-3 4.2 2
P 5.2 5.4 2
G- 3.9 3.6 -
H 4.5 4.9 -
I 4-5 4-7 0






Blood enflurane concentrations (mg %) at 5, 10
and 15 minutes after the commencement of the
administration of 2% enflurane.
Patient 5 min. 10 min. 15 min.
A
B 4-5 7.4 6.6
C 3.5 7.4 8.5
D 10.6 10.1 8.9
E 8.3 6.0 7.9
F 11.8 9.6 -
a 5.9 7.5 -
H 12.6 8.2 -
I 8.A 8.0 8.8
J 6.9 7.6 -
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DISCUSSION
All the volatile anaesthetic agents which have been investi¬
gated have been shown to increase CBF and ICP and decrease CMR02.
In man CBF is increased by diethyl ether in certain concentrations
(Smith and Wollman, 1972), and halothane (Wollman et al., 196;,.;
Christensen et al., 1967; De Rood et al., 1.971 )• In dogs CBF is
increased by chloroform (McDowall and Harper, 1965), trichloro-
ethylene (McDowall, 1966b), and isoflurane (Cucchiara et al., 1971)•
Methoxyflurane increases CBF according to Michenfelder and Theye
(1973) but other authors found a decrease in CBF with methoxyflurane
(McDowall and Harper, 1965; Gray et al., 1971b). McDowall and Harper
(1965), who measured CBF at 30 minutes after the commencement of
methoxyflurane administration, may have missed an early increase, and
the results of Graj"- and colleagues (1971b) may be explained by the
fall in CBF which occurs with time in the anaesthetised dog (Raichle
et al., 1970). Thus it is most likely that methoxyflurane causes an
increase in CBF because otherwise it would be difficult to explain
its effect on ICP. In man CMR02 is decreased by diethyl ether
(Smith and V/oilman, 1972) and halothane (Wollman et al., 196/+;
McHenry et al.,1965; Christensen et al,,1967). In dogs CKR02 is
reduced by trichlorcethylene (McDowall et al.,196l), methoxyflurane
(Michenfelder and Theye,1973)» anl isoflurane (Cucchiara et al.,197R)«
In man ICP is increased by diethyl ether (Lundberg, 1959;
Sondergard, 196l), trichloroethylene (Jennett et al., 1969), methoxy¬
flurane (Fitch et al., 1969b; Jennett et al., 1969), halothane
(Sondergard, 1961; Marx et al., 1962; Jennett et al., 1969; Gordon,
1970; Adams et al.,1972; Zattoni and Siani,1972; Stullken and Sokoll,
1975a), isoflurane (Adams et al., 1981) and fluroxene (Jorgensen and.
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Henriksen, 1973). Chloroform increases ICP in cats (Finesinger
and Cobb, 1935). The changes in ICP during the administration
of volatile agents are generally greater in patients with initially
increased ICP than in patients with normal ICP (Fitch et al.,1969b;
Jennett et al.,1969;
/Gordon, 1970; Richardson et al., 1970; Shapiro et al., 1972c;
Zattoni and Siani, 1972). Most volatile anaesthetic agents also
reduce CPP because they both increase ICP and reduce MAP.
The anaesthetic gas cyclopropane has a biphasic effect on
CBF; 5 and 13% cyclopropane decrease CBF, 20 and 37% increase it
(Alexander et al., 1968a). This is probably due to changes in
plasma catecholamine levels during cyclopropane administration
(Michenfelder and Theye, 1972). Cyclopropane increases ICP
(Sondergard, 1961), and in certain concentrations (5, 13 and 37%)
it reduces CMR02 (Alexander et al., 1968a,1970).
Previous investigations into the effect on ICP of enflurane
have given conflicting results. In dogs 3% enflurane caused
increases in ICP which were greater when ICP was increased experi¬
mentally (Boop and Knight, 1978). These increases were less than
those caused by equipotent concentrations of halothane (Hans et al.,
1980). However, in two-thirds of a group of dogs with cerebral
oedema, enflurane caused a reduction of ICP because of its hypo¬
tensive effect in the presence of defective autoregulation, which
caused a reduction in hydrostatic pressure in the dilated cerebral
vascular bed (Hans et al., 1980; Stevenaert et al., 1980). In rats
Mann et al. (1980) showed an increase in CSF formation rate and an
increased resistance to CSF reabsorption during enflurane anaesthesia,
when compared with pentobarbitone anaesthesia. In man, Zattoni et al.
(197'l) reported that 1 to 2% enflurane caused increases in ICP of up
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to 9 to 15 mm Hg in patients with intracranial lesions
presenting with high ICP. These increases were not always
abolished by hypocapnia, and were frequently negligible if ICP was
near normal. Ewalenko-de-Toeuf (1980) showed similar increases
in ICP with 2% enflurane in some neurosurgical patients, but in
most patients there was no change in ICP. Cunitz et al. (1976)
found that ICP was increased to a lesser extent by enflurane than
by halothane at normocapnia in neurosurgical patients, but Stullken
and Sokoll (1975) found that these two agents caused similar
increases in ICP. In hypocapnic head-injured patients 1.5%
enflurane caused a mean increase in ICP of 9.6 mm Hg (Schulte am
Esche et al., 1979). Induction of anaesthesia with 3% enflurane
in patients with intracranial lesions, not surprisingly, caused an
increase in ICP (Tambuniello et al., 1978). With 1%> enflurane,
McLeskey and colleagues (197k) found a negligible change in ICP,
as the author did with 2% enflurane.
Enflurane caused an increase in CBF in two investigations
in dogs (Michenfelder and Cucchiara, 197k > Takasaki, 197k)>
but in another there was no significant change (Sakabe, 1975),
possibly because of the reduction in arterial pressure associated
with the administration of enflurane. Also in dogs, it caused a
decrease in CMR02 which was proportional to the enflurane concen¬
tration (Michenfelder and Cucchiara, 197k; Takasaki et al., 197k;
Sakabe, 1975). In patients with subacute or chronic ischaemic
brain lesions 1% enflurane caused a reduction in CBF (Reinhold et al.,
197k,
/1976), and in patients with head injury, in whom the MAP was maintain¬
ed with phenylephrine, 1% enflurane had no effect on CBF or the
distribution of rCBF (De Rood et al., 1980a, 1980b). In normal
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patients 2% enflurane has no effect on CBP (Van Aken et al., 1977;
Roily and Van Aken,1979)* CMR02 is reduced "by about 28,% during
the administration of 1% enflurane in man (De Rood et al., 1980a).
Thus in man enflurane appears to have little effect on CBP but
reduces CMR02.
In this investigation 2% enflurane caused no significant
change in ICP in patients with cerebral tumours, 60fo of whom had
significant intracranial compression. MAP was significantly
reduced causing CPP to be reduced to less than 50 mm Hg, which is
at the lower end of the range of aut©regulation (Olesen, 1973),
in 5 patients, and to values approaching this in another A patients
before the enflurane was stopped. This confirms the results of
other workers who found that enflurane reduced CPP (Zattoni et al.,
197AJ Cunitz et al., 1976; Schulte am Esch et al., 1979). The
change in ICP during the administration of enflurane ranged from
-18.5 to 5*5mm Hg, and the patient who showed the greatest increase
in ICP had an increase in PaC02 of O.A KPa during the period of
administration of enflurane. Although it was intended to study
the patients at normocapnia, in 3 patients the PaC02 differed widely
from the normocapnic range. From the results obtained in these
patients, there was no evidence that alteration in PaC02 influenced
the response of ICP to enflurane. The blood enflurane concen¬
trations tended to plateau by the 10 minute epoch, thus the maximum
effect on ICP of enflurane should be seen within 10 minutes of its
administration, and the maximum ICP response should have been
evident even when the administration of enflurane was stopped
prematurely.
Prom the literature there is a consensus that
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halothane causes the greatest increase in ICP of all the volatile
agents. The majority of investigations show that enflurane has
less effect on CBF and ICP than does halothane. Although enflurane
causes significant increases in CBF and ICP in dogs, the majority of
studies in man indicate that it has little effect on CBF and ICP.
Increases in ICP of up to 15 mm Hg have been reported, but usually
the increases are small or non-existent. The largest reported
increases in ICP with enflurane are less than those reported with
halothane. This study in patients with cerebral tumours, many of
whom had reduced compliance of the intracranial contents, confirmed
that changes in ICP were small and could be in either direction.
The magnitude of these changes was similar to that observed with
fentanyl 0.2 mg (see Chapter 7). There was a considerable reduction
in CPP, but the concentration of enflurane was greater than that
which would normally be used to supplement nitrous oxide-relaxant
anaesthesia in the clinical situation. Enflurane may cause a small
degree of cerebral vasodilatation (McKay et al., 197&) and the
reduction in MAP may help to prevent the consequent increase in CBF
and ICP with enflurane, although the work of De Rood and colleagues
(1980b), in which CBF was unchanged when the arterial pressure was
kept constant during enflurane administration, would appear to
contradict this hypothesis.
With enflurane concentrations of greater than 2.5% high
amplitude spikes and/or spike and wave complexes may appear on the
EEG, and their occurrence is increased by increasing the inspired
concentration of enflurane, by a reduction in PaC02, and by noise
(de Jong and Heavner, 1971; Neigh et al., 1971; Michenfelder and
Cucchiara, 197A). However, enflurane does not appear to exacerbate
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a pre-existing susceptibility to seizure activity (Opitz and
Oberwetter, 1979), so this property of the drug does not contra-
indicate its use in neuroanaesthesia.
Thus, low concentrations of enflurane can safely be used
during anaesthesia for intracranial operations provided that the
arterial pressure is carefully monitored. Its effects on MAP
could be useful in the control of arterial pressure and the
induction of hypotension during neurosurgery.
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SUMMARY
Ten patients with cerebral tumours were anaesthetised
with thiopentone, nitrous oxide fOfo in oxygen, d-tubocurarine
and fentanyl. Ventilation was controlled to give a mean PaC02
of (range 3.6 to 6.7) KPa). 2}0 enflurane was administered
and ICP and MAP were recorded continuously for 10 to 15 minutes.
The changes in ICP were not significant and ranged from -18.5 to
5£mm Hg. There were significant reductions in MAP (P-<£ O.OOl)
and CPP (P<C O.OOl) during the administration of enflurane.
In A patients the administration of enflurane had to be
prematurely terminated because of a low CPP. Thus enflurane has
very little effect on ICP in patients with cerebral tumours and
low concentrations of enflurane can safely be used during
anaesthesia for intracranial operations provided that the arterial
pressure is carefully monitored. The literature concerning the
effect of volatile anaesthetic agents on ICP and CBP is reviewed.
CHAPTER 9
INVESTIGATIONS ON THE USE OP ANAESTHETIC AGENTS
IN THE INTENSIVE CARE OP HEAD INJURIES:
THE EFFECTS OP NITROUS OXIDE, ALTHESIN AND
THIOPENTONE ON ICP DURING CHEST PHYSIOTHERAPY IN
PATIENTS WITH SEVERE HEAD INJURY
IS^
INTRODUCTION
In the preceding chapters investigations on the effects of
anaesthetic agents on ICP and CPP in patients about to undergo
intracranial surgery are described. The investigations described
in this chapter were designed to determine whether anaesthetic
agents modify the increases in ICP which occur during chest physio¬
therapy in patients with severe head injury (Cibson et al., 1975).
These increases are thought to be partially due to noxious stimulation
and partially due to an increase in intrathoracic pressure as a result
of chest compression. When the investigations were begun it was
thought that the analgesic property of nitrous oxide might help to
reduce these increases in ICP. Thiopentone and Althesin both reduce
ICP (see Chapter 5), and would be expected to reduce ICP increases
during chest physiotherapy. This chapter describes investigations
of the effects of nitrous oxide, Althesin and thiopentone on ICP
during chest physiotherapy in patients with head injury, and also the
effect of nitrous oxide on ICP in such patients when no noxious
stimulus was being applied.
METHODS
The patients had severe head injuries and were being
mechanically hyperventilated (PaC02 3*3 to l^.O KPa) under the
influence of non-depolarizing muscle relaxants, a supplementary dose
of which was given before each investigation. The only sedative
drugs which the patients were receiving were papaveretum and/or
diazepam, and no patient received these drugs within one hour of an
episode of chest physiotherapy. During chest physiotherapy the
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lungs were hyperinflated by anaesthetists using a Mapleson C
circuit (Mapleson, 1950 (with a fresh gas flow of greater than
twice the minute volume of the patient). ICP was recorded from a
subdural catheter or device, or an extradural device (Coroneos et al.,
1973), using a transducer, amplifier and chart recorder. The maximum
increase in mean ICP occurring during the period of chest physiotherapy
was read from the chart recordings. Random number tables were used to
choose the treatment for each episode of chest physiotherapy.
The initial study was to compare the effects of chest physio¬
therapy on ICP in the presence of lOOyo oxygen or 50V° nitrous oxide in
50% oxygen (Entonox). This study was stopped when Entonox had been
given 12 times to 3 patients, because it was found that Entonox was
accentuating the ICP changes produced by chest physiotherapy.
In a second study, the effect of Entonox on ICP in a further
9 patients with severe head injury was investigated when they were
not receiving chest physiotherapy. Mechanical ventilation had beer-
established for at least 6 hours, with PaC02 values between 3«3 and
i±.0 KPa, and the inspired oxygen concentration was less than 5C$.
ICP was recorded at a fast chart speed for 10 minutes before the
administration of Entonox, for either 5 minutes (2 administrations)
or 10 minutes (lA_ administrations) during the administration of
Entonox (through the oxygen inlet of the Cape ventilator), and for
10 minutes after the discontinuation of the Entonox. During the
last 6 Entonox administrations, end-tidal carbon dioxide concentration
was measured by mass spectrometry (BOC). Arterial blood gas tensions
T/ere measured within R hours of the Entonox administration as part of
the routine intensive care management.
In the third study 10($ oxygen, thiopentone (3 mg/Kg) and
lOOfo oxygen, or Althesin (0.03 ml/Kg) and 100^ oxygen were given
|4>l
in random order to 10 patients for chest physiotherapy. The
thiopentone or Althesin was given to the patient over 30 seconds,
and 30 seconds later the systolic arterial pressure was measured
using a sphygmomanometer. Chest physiotherapy was then performed
for 5 minutes. This study was repeated using higher doses of
thiopentone (a«5 mg/Kg) and Althesin (0.0L.5 ml/Kg) by the author's
colleagues.
RESULTS
Mean ICP before chest physiotherapy was the same in the
100$ oxygen group as in the Entonox group. Mean ICP increased
by 22.7 mm Hg (S.D. 10.62) when physiotherapy was performed with
Entonox compared with 10.5 mm Hg (S.D. lO.Ll) during physiotherapy
using 10C$ oxygen (Table 25). This difference between the two
groups was statistically significant (0.02 > P C> O.Ol). In
two patients A-waves (Lundberg, i960) were precipitated by
Entonox and physiotherapy, but this also occurred in one patient
when physiotherapy was being carried out with oxygen alone.
When Entonox was administered to patients not undergoing
chest physiotherapy there was a mean increase in ICP of 3.8 mm Hg
(S.D. 2.l) (range 0 to 8.5 mm Hg) (P< 0.001). There was a mean
decrease in ICP of mm Hg (S.D. 2.8) after the withdrawal of
nitrous oxide (P< O.OOl) (Table 26).
There was a mean fall in end-tidal carbon dioxide
concentration of less than 0.1$ (range 0 to 0.1$) during the
period of nitrous oxide administration.
Mean ICP before chest physiotherapy was the same in the
I&2.
TABLE 25
Comparison of increases in ICP produced by chest physiotherapy
during lO0/o oxygen and during Entonox administration. Control
values are those of mean ICP before physiotherapy
OXYGEN ENTONOX
Control Change from Control Change from
control control
mm Hg mm Hg mm Hg mm Hg
7 -HO 19 +16
15 +40 15 +40
26 +15 16 +40
18 +3 7 +6
9 +4 10 +11
15 +4 8 +23
14 +10 10 +23
7 +5 12 +19
13 +9 10 ^+22
9 +7 13 +33
10 +8 12 +15
14 +24
n = 11 12
x 12.8 +10.5 * 12.2 +22.7 *




ICP (mm Hg) before, during and after Entonox. The peak values
reached during Entonox administration were used in calculating
the changes









{ 6.5 +2+.5 -5
B 13.5 +2 -3.5
C 6 +1 -1






































x = 10.6 d = +3.8 d = -2l.6
S.D. 8.53 2.2,0 2.83
<0.001 <0.001
161*-
Peak change from control of mean intracranial pressure (mm Hg) during
chest physiotherapy. (Significance values are for the comparison of







































































































































n 20 20 19 19 19 19
X 11.6 7.6 11.a 3.9 11.9 A.3







Peak change from control of mean intracranial pressure (mm Hg)
during chest physiotherapy
OXYGEN ALONE THIOPENTONE/OXYGEN ALTHESIN/OXYGEN
(Control) (A.5 mg/Kg) (0.02,3 ml/Kg)
Before Peak Before Peak Before Peak
physio- change physio- change physio- change
therapy therapy therapy
n 21 21 19 19 18 18
x 6.38 7.1A 7.37 5.97 5.A7 A.92
S.E.M. 1.06 0.93 1.10 0.71 1.27 0.55
oxygen alone, the thiopentone and oxygen, and the Althesin and
oxygen groups. Mean ICP increased by 3«9 mm Hg (S.D. 2.86),
when physiotherapy was performed with thiopentone, by 4.3 mm Hg
(S.D. 4..47) with Althesin, and by 7.6 mm Hg (S.D. 4.70) with oxygen
alone (Table 27). The change in ICP during chest physiotherapy was
significantly less with thiopentone and oxygen (0.01> P>-0.00l)
and with Althesin and oxygen (0.05 !> P > 0.02) than with oxygen alone.
The scatter diagram (Fig.2) shows that there is considerable
variability in the ICP response to physiotherapy in all three groups.
The systolic arterial pressure 30 seconds after the administration of
thiopentone or Althesin was 110 mm Hg or more in all except one
patient, in whom the pressure was 100 mm Hg on 2 occasions following
the administration of Althesin.
A subsequent study, in which higher doses of thiopentone
(4..5 mg/Kg) and Althesin (O.O45 ml/Kg) were used but which followed
the same protocol in all other respects, showed no significant
differences between the test groups and the control group (Table 28).
The full results of the latter study are not included because the
author was not directly involved in this investigation.
DISCUSSION
Reports on the effect of nitrous oxide on ICP are contra¬
dictory. Increases in ICP have been reported during the induction
of anaesthesia in patients with intracranial tumours and aneurysms
(Sondergard, 1961; Laitinen et al., 19^7; Hulme and Cooper, 1972;
Hen riksen and Jorgensen, 1973; Cold, 1975; Greenbaum et al.,1975;
Phirman and Shapiro, 1977) > anii smaller increases have been
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described during established anaesthesia with hypocapnia in
patients with cerebral tumours (Misfeldt et al., 197k). However,
G-ordon and G-reitz (1970) found no increase in lumbar CSF pressure
when nitrous oxide was administered with the anaesthetic gases to
patients with normal ICP. Nitrous oxide may also increase ICP
after air encephalography by diffusion into the intracranial air
space at a faster rate than nitrogen diffuses out (Saidman and Eger,
1965; G-ordon and Greitz, 1970J Campkin and Turner, 1972). CPP is
significantly reduced during induction of anaesthesia with nitrous
oxide (Hulme and Cooper, 1972; Henriksen and Jorgensen, 1973).
Increases in CBP occur when nitrous oxide is administered
to dogs (McDowall and Harper, 1965; Theye and Michenfelder, 1968;
Sakabe et al., 1978; Oshita et al., 1979), but the reports on the
effect of nitrous oxide on CBF in man are conflicting. Wollman
and colleagues (1965) reported no change in CBF when ftffo nitrous
oxide was given to healthy male volunteers, whereas Sakabe and
colleagues (1976) found an increase in CBF equivalent (which is
the ratio of CBF to CMR02) during the administration of 60% nitrous
oxide to human volunteers. There has been no report of the effect
of nitrous oxide on ICP or CBF in patients with severe head injuries,
although it has been suggested that increases in ICP may occur
(Henriksen and Jorgensen, 1973) • C?,ffi02 is increased by nitrous
oxide in dogs (Theye and Michenfelder, 1968), but is decreased by
it in man (Wollman et al., 1965). On balance it appears that
nitrous oxide increases CBF and ICP in man, and that the greatest
increases in ICP occur when nitrous oxide is used for induction of
anaesthesia in patients with initially raised ICP.










































Figure_2. Scatter diagram of the maximum change in mean
ICP during chest physiotherapy (mm Hg) following
the administration of thiopentone, Althesin or
no drug (control).
during chest physiotherapy in patients with severe head injuries
which were thought to he partly a result of an increase in intra¬
thoracic pressure due to chest compression, and partly a result of
cerebral activation produced by noxious stimulation. Although it
has never been demonstrated that short-lived increases in ICP
associated with chest physiotherapy are harmful, it is reasonable
to assume that in certain circumstances they could be detrimental
to the patient with a head injury. The large increases, which
sometimes occur, could cause or accentuate brain shift and may cause
cerebral ischaeaiia by reducing CPP, Even small increases in ICP
may lead to cerebral ischaemia in focal areas of damaged brain
because small increases in local tissue pressure, which reduce local
perfusion pressure, may seriously impair an already compromised
local circulation. As Entonox is an analgesic it might be expected
to decrease such increases in ICP. However, after Entonox had been
given on 12 occasions during chest physiotherapy it was clear that
the increases in ICP were exacerbated. The inspired oxygen concen¬
tration was different in the two study groups and this could have
had a small influence on the ICP values obtained, but this study was
designed to determine what happened when the use of Entonox was
compared with the method normally used in clinical practice.
The increase in ICP during the administration of Entonox in
the absence of chest physiotherapy is almost certainly due to a
cerebral vasodilatory action of the drug. An increase in end-tidal
carbon dioxide concentration, which was expected because of the
initial rapid uptake of nitrous oxide, was not seen and therefore an
increase in PaC02 cannot account for the increase in ICP. In the
absence of chest physiotherapy the increases in ICP were small, but
no
they might be greater in patients with severe head injury breathing
spontaneously, especially when the volume of the intracranial contents
is on the steep part of the pressure/volume curve.
The results of these investigations indicate that Entonox
should be avoided in spontaneously breathing head-injured patients
during transport and admission to hospital. However, the use of
nitrous oxide during general anaesthesia in patients with head
injuries is not contra-indicated by these results, but it should not
be used for the induction of anaesthesia and should not be introduced
until after intubation has been performed and hyperventilation with
lO0o oxygen has been established (Henriksen and Jorgensen, 1973;
Phirman and Shapiro, 1977)* Misfeldt and colleagues (197k) showed
that prior hyperventilation for 10 minutes or more with 1O0a> oxygen
prevented any marked increase in ICP during the administration of
nitrous oxide, and Jorgensen and Henriksen (1973) demonstrated that
any increase in ICP associated with the administration of nitrous
oxide could be effectively counteracted by hyperventilation.
However, when controlled hyperventilation has been in use for several
hours, as in the management of severe head injury, any protective
effect of hypocapnia against the increases in ICP induced by nitrous
oxide may be lost because of the adaptation of CBF and ICP to the
lower PaC02 values. The increase in ICP induced by nitrous oxide
can be prevented or reduced by the administration of thiopentone
(Phirman and Shapiro, 1977; Schulte am Esch et al., 1980).
Thiopentone and Althesin cause reductions of ICP and CBF
(see Chapter 5)« Intravenous bolus doses of thiopentone have been
used to reduce elevated ICP rapidly, but the effect is short-lived
and continuous infusion is required to maintain the reduction of ICP
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(Shapiro et al., 1973; Levin et al., 1979)* Shapiro and
colleagues (197k) have demonstrated reductions in ICP and increases
in CPP with the administration of thiopentone and pentobarbitone in
patients with persistent intracranial hypertension, and good results
have been reported from the use of thiopentone and pentobarbitone
infusions in patients with head injury in whom raised ICP could not
be reduced by conventional treatment (Levin et al., 1979; Marshall
et al., 1979). Althesin (l to 2 ml) has also been given in bolus
doses to reduce ICP in patients with severe head injury (Versari et
al., 1980; Moss et al., 1980), and Bedford and co-workers (1980)
reported that lignocaine 1.5 to 2 mg/Kg often controlled increased
r
ICP in patients with head trauma.
Before this investigation there were no reports on how
thiopentone or Althesin affected the response of ICP to chest
physiotherapy. The results of this study show that pre-treatment
with thiopentone 3 mg/Kg or Althesin 0.03ml/Kg intravenously
significantly reduce the increase in ICP caused by chest physiotherapy
in patients with head injury without causing large reductions in
arterial pressure. However, there was still considerable variability
in the ICP response to physiotherapy when thiopentone or Althesin were
administered (Pig. 2). Surprisingly, higher doses of these drugs did
not significantly reduce this increase in ICP, although the result
with Althesin was almost significant. The mean ICP before physio¬
therapy was much lower in the patients receiving the higher doses,
and this may explain the difference in results. Therefore the drugs
may be ineffective when the ICP is low.
It must be pointed out that this was a clinical study and
thus it was impossible to standardise the inflation pressures and
HZ
PaC02 values during chest physiotherapy. However, any changes
in these parameters which occurred during the investigations would
be similar to those which normally occur during chest physiotherapy,
so that the results are applicable to the clinical situation.
These results suggest that the main mechanism of the
increases in ICP associated with chest physiotherapy is likely to
be the increase in intrathoracic pressure, leading to increases in
CVP and spinal CSF pressure, which in turn causes an increase in ICP.
If these increases had been largely due to noxious stimulation one
would have expected thiopentone or Althesin, by counteracting such
stimulation, to reduce them to a much greater extent, although
combination of thiopentone or Althesin with a potent analgesic may
have had more effect in reducing the increases, because thiopentone
and Althesin have no analgesic properties. The thiopentone and
Althesin probably reduced the magnitude of the increases in ICP by
reducing ICP before physiotherapy was begun, so that ICP effectively
started at a lov/er level in the thiopentone and Althesin groups.
At lower values of ICP the decrease caused by the thiopentone and
Althesin would be expected to be less because the intracranial
compliance would be greater, and thus these drugs would be expected
to have less effect on the changes in ICP occurring during chest
physiotherapy.
Although thiopentone and Althesin will cause some reduction
in ICP changes during chest physiotherapy, they do not abolish these
changes and the ICP display should therefore be observed carefully
during chest physiotherapy. Thus the duration and aggressiveness
of the physiotherapy can be adjusted to avoid increases in ICP of
more than 5 mm Hg. In patients with increased ICP before physio-
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therapy the administration of thiopentone or Althesin will probably
help to reduce these increases in ICP.
In the investigations reported in this chapter ICP was
measured from the subdural or extradural spaces. In Chapter 3 I
have pointed out that values of ICP measured from these sites do not
correspond exactly with those obtained from a ventricular catheter.
However, in the investigations reported here it is the changes in ICP
which are important and these can be measured reliably from the
subdural or extradural sites.
Prom the results described in this chapter the following
conclusions can be drawn. Chest physiotherapy can cause marked
increases in ICP in patients with severe head injury. 5Q?o Nitrous
oxide in oxygen worsens these increases in ICP and thus should not be
used in head injured patients. Thiopentone and Althesin can reduce
the ICP increases but neither drug prevents them. During chest
physiotherapy ICP should be carefully monitored and the intensity of
the physiotherapy adjusted according to the ICP response. 50^ Nitrous
oxide in oxygen causes ICP to increase in patients with head injury and
thus should be used in such patients only when controlled hyper¬
ventilation has been commenced.
ilk-
SUMMARY
Three separate investigations were performed on patients
with severe head injuries who were being mechanically hyperventilated
(PaC02 3.3 to J+.O KPa). During chest physiotherapy the lungs were
manually hyperinflated with 100% oxygen or 5C% nitrous oxide in
oxygen (Entonox) using a Mapleson C circuit. In a randomised trial
Entonox accentuated the ICP changes produced by chest physiotherapy,
the average maximum increase in ICP during chest physiotherapy with
Entonox was 22.7 nun Hg (S.D. 10.62) compared with 10.3 mm Hg
(S.D. 10.!,.l) when 100% oxygen was given. This difference was
statistically significant (0.02 ;>P> O.Ol). When Entonox was given
to 9 patients with severe head injury who were not receiving chest
physiotherapy there was a mean increase in ICP of 3*8 mm Hg (S.D. 2.;l),
and a mean decrease of ;+.6 mm Hg (S.D. 2.8) after the withdrawal of
nitrous oxide. Both these changes were statistically significant
(P <! O.OOl). When thiopentone (3 mg/Kg) or Althesin (D.03ml/Kg)
or no drug at all were given at random to 10 patients who were being
manually ventilated with 100% oxygen during chest physiotherapy, the
average maximum increases in ICP during physiotherapy were 3«9 mm Hg
(S.D. 2.86), )+.3 mm Hg (S.D. t_»K7) and 7.6 mm Hg (S.D. A.70)
respectively. These average changes in ICP were significantly less
in both the thiopentone group (0.01 PO.OOl) and the Althesin
group (0.05 ^>P >0.02) than in the oxygen only group. In a
subsequent study both thiopentone 2,..5 mg/Kg and Althesin 0.0/,_5 ml/Kg
caused a reduction in the average maximum ICP increases during chest
physiotherapy when compared with the oxygen only group, but this
reduction was not statistically significant. In this latter study
the average ICP immediately before physiotherapy was lower than in
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the previous study. Thus Entonox increases ICP in patients with
head injury and exacerbates the increases in ICP associated with
chest physiotherapy. Thiopentone and Althesin reduce the increases
in ICP associated with chest physiotherapy, but do not prevent them.
The literature concerning the effect of nitrous oxide on ICP, CBF





In order to decide which anaesthetic agents can safely be
used during intracranial operations, and how to produce the best
possible operating conditions without causing damage to the brain,
the neuroanaesthetist needs a detailed knowledge of the physiology
and pathophysiology of the cranial contents, and of how anaesthetic
drugs and manoeuvres alter ICP, CBF and CMR02. Similar consider¬
ations apply to the intensive care of patients with head injury.
In Chapter 2 I have already discussed the possible mechanisms
by which anaesthetic agents could influence ICP and concluded that,
in the absence of PaC02 changes which themselves influence ICP, the
most likely mechanism is a change in C3F caused either by a direct
effect of the agent on the cerebral vessels or by its influence on
cerebral metabolic rate, which in turn causes a reduction in CBF.
A change in metabolic rate could only be the mechanism of the
change in CBF with agents, such as the intravenous induction agents,
which reduce both CBF and CMR02 in parallel. This mechanism would
not be valid for the volatile agents in which the relationship
between CMR02 and CBF is uncoupled. The change in CBF leads to a
change in CBV which in turn alters ICP. Thus ICP measurements during
drug administration could be regarded as a continuous assessment of
CBV. ICP measurements have the advantage that the;/ are continuous
whereas CBF measurements are intermittent, and any variations which
occurred in between measurements would be missed.
Cerebral pathology can alter the normal physiological responses
of the brain, and cause changes in ICP and the distribution of CBF.
It can also influence the way in which anaesthetic agents affect CBF
and ICP. When there is significant intracranial space occupation,
any agent which causes cerebral vasodilatation will cause a much
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greater increase in ICP than it would if there was no space
occupation. This effect has been demonstrated with volatile
anaesthetic agents (Jennett et al., 1969). Such vasodilator stimuli
might be expected to precipitate plateau waves but these have not been
demonstrated during anaesthesia with volatile agents. However, in
the author's investigations in patients with severe head injuries,
they did occur during chest physiotherapy whilst nitrous oxide in
oxygen was being administered (Chapter 9). Conversely, any agent
which causes cerebral vasoconstriction would be expected to cause a
greater reduction in ICP in patients with initially raised ICP than
in patients with normal ICP. This effect has been demonstrated with
Althesin (Turner et al., 1973), but not with etomidate although there
was a trend in that direction (Chapter 5)»
Cerebral autoregulation and carbon dioxide reactivity are
important mechanisms for control of CBF, which may be disturbed in
various disease processes (see Chapter l). Autoregulation is
usually lost first. Autoregulation may also be disturbed by deep
general anaesthesia with cyclopropane or halothane and following
induced hypotension (Chapter 2). In contrast,cerebrovascular
reactivity to carbon dioxide is usually maintained during general
anaesthesia (Chapter 2), so that hyperventilation will still influence
ICP during general anaesthesia. However, according to Adams and
colleagues (1972) hypocapnia must be established 10 minutes before the
halothane is introduced if it is to influence the ICP changes with
this agent. YThen cerebral autoregulation and cerebrovascular
reactivity to carbon dioxide are disturbed and the luxury perfusion
syndrome exists, intracerebral steal and inverse intracerebral
steal can occur. If intracerebral steal is due to the diversion of
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blood flow because of a change in the diameter and thus the
resistance of vessels which are still reactive, then anaesthetic
agents may cause steal effects through their effect on CBP.
However, if steal effects are due to 'intracerebral squeeze', through
changes in local tissue pressure influencing the resistance to flow
within non-reactive vessels, then anaesthetic drugs which increase
ICP would be expected to cause intracerebral steal by increasing
local tissue pressure, and those which red.uce ICP would cause inverse
intracerebral steal by reducing local tissue pressure. There is
some evidence that intracerebral steal and inverse intracerebral steal
occur with halothane and Althesin anaesthesia respectively (Chapter l).
When autoregulation is lost on a focal or global basis, marked
changes in CBP and ICP may occur due to hypertension or hypotension
caused by the administered drug, because the CBP is pressure passive.
Under these circumstances hypotension is more likely to cause cerebral
ischaemia, and hypertension may lead to the formation of cerebral
oedema, because the increase in arterial pressure is transmitted
through the dilated arterioles to the capillaries in which the hydro¬
static pressure is increased. Such an increase in hydrostatic
pressure favours the formation of oedema. Thus under these conditions
it is important to keep the arterial pressure stable. Anaesthetic
agents which have a marked effect on arterial pressure in either
direction should be used with care, and the choice of a suitable
combination of anaesthetic drugs may reduce the formation and spread
of cerebral oedema fluid.
Prom the above discussion, it is clear that the ideal
anaesthetic agents for use during intracranial surgery should
reduce CBF and ICP and should not cause excessive
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changes in arterial pressure. However, a reduction in CBF without
a parallel reduction in cerebral oxygen consumption could impair
cerebral oxygenation. Thus information on the effects of anaesthetic
agents on CMR02 is important also in choosing suitable drugs for use
in neuroanesthesia. With the exception of ketamine, the intravenous
induction agents and the Volatile anaesthetic agents reduce CMR02 and
thus do not interfere with the oxygen supply to demand ratio for the
brain.
The pathological influences on CBP and ICP must be taken into
account not only in deciding upon anaesthetic techniques, but also
in the design and interpretation of investigations of drug effects
on these parameters. In this context it is also important to
consider physiological influences on CBP and ICP. Because of the
influence of the arterial blood gases on CBP and ICP, it is obvious
that these should be kept within fairly narrow limits during such
investigations in order to avoid changes which are not due to the
drugs administered. It is more important that the PaC02 is kept
within narrow limits than the Pa02, because ICP is much more sensitive
to changes in PaC02. CBP is unaffected by a reduction of Pa02 until
this is less than 6.7 KPa, and an increase in Pt02 from 0.21 to 1 only
causes a 10% decrease in CBP (see Chapter l). Changes in body
temperature also alter ICP, and it is important to keep the temperature
constant during investigations on this parameter. In addition, when
testing the effects of anaesthetic agents on ICP, it is important to
avoid any factors which may cause an increase in cerebral metabolism,
such as arousal due to surgical stimulation. With the exception of
enflurane (Mann et al., 1980), which increases the rate of formation
of CSF, anaesthetic agents have not been shovm to influence the rate
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of CSF production, but the respiratory alkalosis which is
deliberately induced during anaesthesia for intracranial operations
can be expected to reduce CSF production by about /+05^ (Oppelt et al.,
1963). Both ketamine and enflurane cause an increased resistance
to CSF reabsorption (Marin et al., 1980). The other parameter which
may influence ICP is the central venous pressure. Increases in
central venous pressure may lead to an increase in cerebral venous
pressure which Yn.ll cause ICP to increase. Thus, during investig¬
ations on the effects of anaesthetic agents on ICP, the pulmonary
inflation pressure should be constant and stra.ining against the
ventilator should be avoided by the use of adequate doses of muscle
relaxa.nts. Any increase in CVP caused by the myocardial depressant
effect of the anaesthetic agents must be taken into account in the
interpretation of the results.
In the original work described in this thesis, PaC02, Pa02
and ventilator inflation pressures were kept constant and surgical or
other stimulation was avoided during measurements of ICP (except in
some of the studies described in Chapter 9)• The investigations
were short so that temperature cha.nges would have little effect on
the ICP values recorded. These investigations were performed on
patients with intracranial disorders because it is in such patients
that ICP changes are most important. The effect of drugs on ICP is
clinically insignificant in patients without brain pathology.
Therefore, the information obtained from these investigations is
directly relevant to clinical neuroanaesthesia in which the
anaesthetist is managing patients with intracranial pathology.
In the original work described in Chapters L to 8, ICP was
measured from a ventricular catheter and arterial pressure from an
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intra-arterial cannula. These are the most direct methods of
measurement of ICP and arterial pressure. In one patient in the
enflurane study a subarachnoid bolt was used for ICP measurement
because the ventricles were seen to be collapsed on the CAT scan,
and in the investigations in patients with head injuries a subdural
catheter or a Leeds device placed in the subdural or extradural space
was used. In Chapter 3 I have discussed the discrepancies between
ICP values obtained from the extradural or subdural spaces and those
obtained using a ventricular catheter. The correlation of the
measurements is not perfect for either site when compared with those
from the ventricular site, but in those investigations in which the
subdural and extradural sites were used the changes in ICP rather
than its absolute value were important. Changes in ventricular fluid
pressure are generally reflected well in the pressure changes recorded
from the subdural and extradural spaces, and in the different study
groups in Chapter 9 the method of measurement was comparable,
therefore when the groups were compared any error in the recorded
values caused by the site of measurement should have been eliminated.
During the investigations on patients who were about to undergo
intracranial surgery the anaesthetic technique was the standard
method which was normally employed in the author's hospital for such
operations. The same technique is routinely used in many other
neurosurgical centres. Three points should be made about the
anaesthetic management. Firstly, if premedication was required
diazepam was administered either intramuscularly or orally. This
agent reduces CBF and CMROa in man and in dogs (Cotev and Shalit,
1975,* Sari et al., 1975), but has no effect on ICP in dogs (Campan
and Lazorthes, 1976), and in the dose used for premedication, does
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not depress respiration significantly. Therefore, it will not
interfere with the ICP response to the agent under investigation.
Secondly, nitrous oxide, the maintenance anaesthetic agent used in
all the investigations, may show a drug interaction with some sedative
drugs regarding their effect on CBF and CMR02, and this has been
demonstrated with diazepam in rats (Carlsson et al., 1976). However,
even if such drug interactions occur with the agents studied by the
author, they would also occur when the drugs were used in clinical
practice, because nitrous oxide is very commonly employed as a
maintenance agent in neuroanesthesia. Thirdly, fentanyl is used
frequently during anaesthetic maintenance for intracranial operations.
No drug interactionsbetween this drug and other anaesthetic agents
regarding their effect on CBF, ICP or CMR02 have been reported, but
if an interaction occurs between this agent and enflurane (see
Chapter 8) this would also occur when the drugs were used in clinical
neuroanaesthetic practice. Thus the information obtained from these
investigations is directly relevant to practical neuroanaesthesia.
The study, described in Chapter 2*., on induction of anaesthesia
in patients about to undergo intracranial operations, confirms that
ICP is decreased following induction of anaesthesia with both thio¬
pentone and Althesin (provided that PaC02 is not allowed to increase)
and shows that the two agents have similar effects on ICP during the
induction of anaesthesia. It also demonstrates that the ICP response
during laryngoscopy and intuba.tion is similar when either of these two
agents is given with d-tubocurarine to allow intubation. Large
increases in ICP could still occur in some patients using this
combination of drugs for intubation, but it appears that these
increases are smaller if non-depolarising relaxants are used for
intubation than if suxamethonium is used (see Chapter a)» When
suxamethonium is the relaxant used, pretreatment with small doses of
a non-depolarising muscle relaxant may reduce the increases in ICP
during intubation by abolishing the muscle fasciculations, because
the limited data obtained by the author and described in Chapter 6
indicates that the effect of suxamethonium on ICP is very small when
muscle fasciculations are abolished. The study on induction of
anaesthesia also confirms the dramatic reduction of MAP and CPP which
occurs when thiopentone or Althesin is given in combination with
d-tubocurarine in the dose required for intubation. This arterial
pressure reduction may help in reducing the response of ICP to
intubation which is probably partially caused by an increase in
arterial pressure due to catecholamine release (De Vault et al.,1960;
Reves et al., 1981), but in many patients the CPP was reduced below
the lower limit of the autoregulatory range which could lead to
cerebral ischaemia. Fortunately the reduction of MAP and CPP was
short-lived and did not appear to affect the patients adversely.
Several methods have been suggested for reducing the ICP response to
intubation, and these are discussed in Chapter 3. The most useful
seem to be the use of thiopentone (or other intravenous anaesthetic
agent) or fentanyl to deepen anaesthesia before intubation, and the
administration of lignocaine intravenously which probably works by
deepening anaesthesia as well as by suppressing the cough reflex.
The results on the effect, of etomidate on ICP indicate that
it would be a suitable alternative to thiopentone, Althesin or metho-
hexitone for induction of anaesthesia for intracranial surgery.
One problem with this agent is that the involuntary movements which
are often associated with its administration may cause ICP to increase
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(Patel, 1980). However, if it is given by infusion, as described
in the multicentre study on etomidate infusion (Boyes et al., 198l),
the incidence of involuntary movements is low. So, used in this way,
etomidate could be a useful agent for induction and maintenance of
anaesthesia for intracranial surgery. In addition to etomidate,
thiopentone, methohexitone and Althesin have been shown to decrease
ICP and CBF (see Chapter 5), and thus an infusion containing any one
of these agents would decrease CBV and ICP and consequently be useful
in patients in whom a decrease in brain bulk and ICP was considered
necessary. Hunter (1972a, 1972b) has described the use of both thio¬
pentone and methohexitone infusions for supplementing nitrous oxide/
relaxant anaesthesia, and the use of Althesin in similar circumstances
is common practise in parts of Great Britain. However, when these
agents are used analgesic supplementation is required because they do
not have analgesic properties of their own. Etomidate infusions may
prove useful also in reducing elevated ICP in patients with severe head
injury.
Until the report by Tarkkanen and colleagues (197a) it was
believed that non-depolarising muscle relaxants had no effect on the
cerebral circulation or ICP except by their indirect effects, which
reduced straining against the ventilator or coughing on an endotracheal
tube. The literature on the effect of the muscle relaxants on ICP and
CBE is reviewed in Chapter 6. The author's data on the effects of
d-tubocurarine on ICP indicate that even in large doses it has little
or no effect on ICP. In small doses (15 to 20 mg) it definitely does
not increase ICP; it causes a small reduction in ICP. If larger
doses do cause sufficient release of histamine to cause cerebral vaso¬
dilatation, the hypotension induced when given with thiopentone or
Althesin would appear to prevent any associated increase in CBF.
Thus d-tubocurarine is not contra-indicated in patients with intra¬
cranial lesions, but care should be taken to avoid excessive decreases
in MAP because of the danger of causing cerebral ischaemia. This may
be achieved by using another relaxant for intubation, for example
alcuronium or suxamethonium (the latter agent should be preceded by a
small dose of non-depolarising agent), and then giving the d-tubocurarine
in smaller incremental doses. Although the reduction of CPP is usually
short-lived, it can last for several minutes in old or dehydrated
patients, so care must be taken when administering d-tubocurarine to
such patients. Tubocurarine has useful properties for neuroanaesthesia
because its hypotensive effect helps in the control of arterial pressure
and it is long-acting. Alcuronium is fairly short-acting so that there
is a greater risk of the patient coughing or straining against the
ventilator, although careful monitoring of neuromuscular blockade using
a nerve stimulator will prevent this. Pancuronium, although long-
acting, has the disadvantage of causing arterial hypertension (Kelman
and Kennedy, 1971; G-ordon, 1975) which can cause problems during some
intracranial operations. Tubocurarine should be avoided in patients
who are subject to bronchospasm because it can cause severe
bronchoconstriction.
Nitrous oxide causes an increase in ICP in patients with
intracranial space-occupying lesions, especially during induction of
anaesthesia (see Chapter 9), but it is generally accepted that it is
safe to use it for maintenance of anaesthesia during intracranial,
operations. However, in patients with high ICP due to cerebral
tumours it is recommended that nitrous oxide is not introduced until
intubation has been performed and hyperventilation is established
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(Henriksen and Jorgensen, 1973; Phirman and Shapiro, 1977)*
The author's results show that nitrous oxide also increases ICP in
patients with head injury, and it would seem wise to avoid it in
patients with significant head injuries until hypocapnia is
established and intubation is completed.
Fentanyl is commonly used to supplement nitrous oxide for
maintenance of anaesthesia during intracranial operations. The
results given in Chapter 7 show that during hypocapnia fentanyl has
very little effect on ICP and that changes can occur in either
direction. These results are similar to those of other authors at
normocapnia (Misfeldt et al., 1976; Cunitz and Gaab, 1980), and are
supported by reports on the effect of fentanyl on CBF (De Rood et al.,
1974; Vernhiet et al., 1977). It appears that other narcotic agents
similarly do not affect CBF or ICP provided that the PaC02 is not
allowed to increase. This is true for morphine, pentazocine and
phenoperidine (when given in combination with droperidol), but if
PaC02 is allowed to increase ICP will increase. Thus fentanyl should
only be given if the patient's ventilation is, or will be, controlled
before this agent can significantly increase PaC02 by causing
respiratory depression. Fentanyl should also be avoided if the
patient is hypotensive (see Chapter 7).
Most volatile anaesthetic agents increase CBF and ICP whilst
decreasing CMR02; this is true for diethyl ether, trichloroethylene,
methoxyflurane, halothane and isoflurane (see Chapter 8). If such
agents are administered during spontaneous respiration, the
resultant respiratory depression will magnify the increase in CBF
and ICP caused by the volatile agent. The author's results indicate
that during normocapnia and hypocapnia enflurane appears to have very
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little effect on ICP. These results are in agreement with those
in most of the reported studies of the effect of enflurane on ICP
in humans, although in some of these studies some patients showed
fairly substantial increases in ICP (see Chapter 8). Thus
enflurane appears to have the least effect on ICP of the commonly used
volatile agents. Studies on CBF in man also support the view that
the effect of enflurane on the cerebral vessels and ICP is minimal
(see Chapter 8). However, enflurane does cause a marked decrease in
MAP and CPP so that the arterial pressure must be carefully observed
during its administration. The author's results in patients with
cerebral tumours confirm that enflurane is a suitable agent for use
in neuroanaesthesia. It could be used to control arterial pressure
whilst causing very little change in brain bulk. Despite its effect
on the electroencephalograph it seems unlikely that it will
precipitate convulsions in patients with cerebral lesions.
The changes in ICP associated with the administration of
enflurane are very similar to those caused by fentanyl, and thus
enflurane should be as useful a supplement to nitrous oxide/oxygen/
relaxant anaesthesia as fentanyl, particularly when its hypotensive
effect would be beneficial.
During intracranial surgery, ventilation is usually controlled
so that the PaC02 is in the hypocaprdc range. There are two
conflicting points of view with regard to the use of volatile
anaesthetic agents or neuroleptanalgesia agents for the
supplementation of nitrous oxide anaesthesia during hypocapnia.
The first point of view is that previous hypocapnia renders increases
in ICP with volatile anaesthetic agents, particularly halothane, so
small as to be clinically unimportant (Adams et al., 1972).
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In the investigation of Adams and. colleagues (1972) ICP increased
in 10 out of 1? cases with the administration of 0.5 to 1% halothane
at a mean PaC02 of 5«5 KPa, hut only one patient showed an increase
greater than mm Hg. The second point of view holds that although
hypocapnia reduces the changes in ICP produced hy volatile
anaesthetics, major changes in ICP still occur in patients whose
intracranial "compression is advanced (Jennett et al., 19^9; G-ordon,
1970). If the second view is correct, then neuroleptanalgesia
supplementation may be preferable. However, the author's work, and
that of others, shows that both at hypocapnia and normocapnia enflurane
has effects on ICP which are very similar to those of fentanyl, so that
this agent should be equally useful as a supplement to anaesthesia in
neurosurgery (see Chapter 8). The marked reduction in CPP seen with
enflurane does not occur with fentanyl unless it is given when the
arterial pressure is already reduced (see Chapter 7), so that fentanyl
will be the agent of choice if hypotension is not wanted. If the
mechanism for CSP absorption is disturbed the increased production of
CSP during enflurane anaesthesia demonstrated by Mann and coworkers
(1980) may contraindicate the use of this agent.
Chest physiotherapy performed during the intensive care of
patients with head injury causes increases in ICP (G-ibson et al.,1975)
which may on occasions be considerable in magnitude. There have been
no reports on the effect of anaesthetic drugs on these increases in
ICP. It is clear from the results presented in Chapter 9 that the
analgesic effect of 50fo nitrous oxide in oxygen is overridden by its
cerebral vasodilatory effect, and that this agent could be positively
harmful if used during chest physiotherapy in patients with head
injury. This argument can be taken a stage further by suggesting
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that Entonox should not be used as an analgesic in patients with
head injury during transport or admission to hospital, because of
its potential harmful effects on ICP. Thiopentone and Althesin
in small anaesthetic doses did significantly reduce the changes in
ICP which occurred during chest physiotherapy in patients with head
injury, but the scatter of ICP changes was considerable. Larger
doses of thiopentone and Althesin did not significantly reduce the
ICP changes. The initial ICP was lower in the second study
investigating the larger doses, and this may explain why the increases
in ICP were not significantly reduced. Thus thiopentone and Althesin
appear to be of use in reducing the ICP changes due to chest physio¬
therapy only when the initial ICP is raised, and they are not
effective in abolishing these changes.
Before concluding that knowledge of the effects of anaesthetic
agents on ICP should influence the neuroanaesthetist"s choice of
agents, one has to consider at what value of ICP harmful effects will
be produced when the cranium is intact, and how much the increase in
brain bulk caused by agents which increase ICP interferes with surgical
access when the cranium is open. The problem of deciding when to
treat increased ICP when the cranium is intact has been discussed in
Chapter 1. When the ICP and the compliance of the intracranial
contents are normal, increases in ICP are probably not significant,
but in the presence of raised ICP and reduced compliance of the intra¬
cranial contents, a small increase in CBV may cause substantial
increases in ICP, which could lead to cerebral damage either through
shift causing distortion of the brain, or reduction in CPP causing
ischaemia. Thus in some patients with considerable intracranial
compression, even a small increase in CBV may compromise brain function.
ni
In such patients, great care should he taken to minimise changes in
GBV and ICP, Once the cranium is open the ICP falls to zero, hut the
restraints on hrain bulk are removed, so that there is a danger of
herniation of the brain through the craniotomy site if ICP was high
before decompression. The same process, but in a lesser degree, can
cause difficulties with surgical retraction and access to the site of
operation. Thus the greater the brain bulk the greater the pressure
that will have to be applied with the brain retractor in-order to
obtain the same degree of surgical access. Therefore, even if a
small increase in ICP will not cause harm in most patients, during
intracranial, surgery it will 'be advantageous to keep CBV to a minimum,
in order to reduce retraction pressures which in turn will diminish
the amount of ischaemia caused by retraction both under the retractor
and on the surface of the contralateral hemisphere. As anaesthetic
agents increase ICP by increasing CBV, it is clearly advantageous to
use agents which either do not affect ICP or, preferably, reduce it,
so that brain retraction pressures are reduced to a minimum. It is
therefore the author's belief that knov/ledge of the effects of
anaesthetic agents on ICP is important in deciding which are the best
anaesthetic agents to use during intracranial operations, and that
optimum operating conditions are produced by anaesthetic agents which
reduce ICP. The other important factor in the choice of anaesthetic
agents is the maintenance of an adequate CBF. Anaesthetic agents can
reduce CBP by decreasing CPP through an increase in ICP or a decrease
in MAP or both.
Several conclusions can thus be made regarding the agents
investigated in the original work described in this thesis. Etomidate,
Althesin and thiopentone reduce TCP and will therefore produce safe
R2.
anaesthesia in patients with raised ICP, and if given by infusion
should produce good operating conditions. Tubocurarine has no
effect on ICP and does not alter CBV and operating conditions.
Fentanyl and enflurane cause no significant change in ICP although
in individual patients changes in either direction can occur. The
changes are so smell, however, that they will not have detrimental
effects on the brain tissue or significantly interfere with surgical
access. The increase in ICP caused by nitrous oxide administration
during controlled hyperventilation is small and probably clinically
insignificant except when ICP is already very high. All these agents
therefore are suitable for use during intracranial surgery. Of these
agents, fentanyl can cause a significant reduction in CPP when the
patient is hypotensive at the time of its administration, and enflurane
in a concentration of 2/o can cause reduction of CPP to levels which
are associated with cerebral ischaemia. So, in addition to their
effect on ICP and thus operating conditions, the effect of anaesthetic
agents on CPP must be taken into account and measures taken to avoid
dangerous reductions in this pressure. Short-lived large reductions
in CPP, as when tubocurarine is given with thiopentone or Althesin
during the induction of anaesthesia, do not appear to be detrimental
to the patient (see Chapter l) but are probably best avoided.
When considering the effects of anaesthetic agents on the
response of ICP to manoeuvres such as endotracheal intubation and
chest physiotherapy, one must decide again whether these responses,
which are generally short-lived, are in any way detrimental to the
patient. There is no evidence tha.t these increases in ICP do cause
harm, although it is reasonable to assume that even short-lived large
increases in ICP can accentuate brain shift and may compromise the
m
circulation to damaged regions of the train. The increase
in'ICP associated with endotracheal intubation is usually
secondary to an increase in MAP, and that associated with
chest physiotherapy is secondary to an increase in cerebral
venous pressure, both of which will increase the hydrostatic
pressure in the cerebral capillaries and promote cerebral oedema
formation. Even if these increases in ICP were not detrimental
it would be unwise to exaggerate them, so it can be concluded
from the results reported in Chapter 9 that 50fj nitrous oxide
in oxygen should not be used for analgesia during chest physio¬
therapy in patients with head injury. Thiopentone and Althesin
may help to avoid further brain damage during chest physiotherapy,
particularly in patients with high ICP, but there is no direct
evidence to confirm this. The mean increase in ICP
associated with endotracheal intubation was small when thio¬
pentone and Althesin were given together with tubocurarine for
intubation, and the MAP did not increase above the control value.
Therefore this combination of agents may help to prevent the
potentially harmful consequences of endotracheal intubation in
patients with raised ICP.
The pressures measured in these studies were global
pressures, and it would be interesting to know how anaesthetic
agents affected local tissue pressures, for example under the
blade of the brain retractor. Such measurements would give
additional help in determining which techniques of anaesthesia
were best employed for intracranial surgery.
However, the investigations described in this thesis
have provided information which, when added to that obtained
by other workers, allows rational decisions to be made on the
choice of anaesthetic agents for use during intracranial
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The use of anesthetic drugs
to reduce ICP changes in head-injured patients
by E. MOSS, M.B., Ch.B., F.F.A.R.C.S.*
J.S. GIBSON, M.A., M.B., B.Chir.**
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SUMMARY
Chest physiotherapy causes increases in intracranial pressure (ICP) in
patients with severe head injuries. In mechanically hyperventilated severe head
injuries (Paco2 3.3 - 4 kPa) 30 % nitrous oxide in 30 % oxygen exacerbated
ICP increases associated with chest physiotherapy, ivhile thiopentone and Althe-
sin reduced these changes in ICP. (Acta anaesth. belg., 1980, 31, suppl.,
43-48).
Key words : Nitrous oxide, thiopentone, Althesin, chest physiotherapy, intra¬
cranial pressure.
Changes in intracranial pressure (I.C.P.) are common in patients with
severe head injuries, and increases in I.C.P. may be detrimental to the
patient in that they may cause brain shifts and reduce cerebral perfusion
pressure. Intravenous anesthetic induction agents such as thiopentone,
methohexitone, propanidid, Althesin and etomidate have all been shown
to reduce cerebral blood flow (C.B.F.) (4, 11, 12, 15), and thus cerebral
blood volume and I.C.P. (2, 5, 6, 10, 16, 19). So in patients with
head injury these agents can be used to reduce I.C.P. rapidly whilst
one is waiting for a dehydrating agent such as mannitol to take effect.
They can also be used by continuous infusion to control I.C.P.,
although systemic hypotension often limits their use. This paper
describes the effects of 50 % nitrous oxide in 50 % oxygen, thiopentone
and Althesin on the I.C.P. rises known to occur during chest physio¬
therapy in head-injured patients (3). These increases in I.C.P. are thought
* Department of Anaesthetics, Leeds General Infirmary, Great George Street,
Leeds LSI 3EX, England.
** Department of Anaesthesia, The University of Leeds, 24 Hyde Terrace, Leeds
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to be due partially to noxious stimulation and partially to the increase
in central venous pressure caused by chest hyperinflation and compres¬
sion.
Method
Two separate studies were performed. In both studies the patients had
severe head injuries and were being mechanically hyperventilated to Pa^
values of 3.3 to 4.0 kPa. During chest physiotherapy the patients were
ventilated manually by anesthetists, and before any study was performed
the patient received a further dose of muscle relaxant. I.C.P. was re¬
corded from a subdural catheter or device or an extradural device (1),
using a transducer, amplifier and chart recorder. The maximum rise in
mean I.C.P. during the period of chest physiotherapy was read from the
chart recordings.
In the first study patients were given, in random order, either 100 %
oxygen or 50 % nitrous oxide in 50 % oxygen during chest physio¬
therapy. This study was stopped when nitrous oxide had been given
12 times to 3 patients.
In the second study, 100 % oxygen, thiopentone (3 mg/kg) and
100 % oxygen, or Althesin (0.03 ml/kg) and 100 % oxygen were given
at random to 10 patients for chest physiotherapy. Each patient received
each treatment twice. The thiopentone or Althesin was given to the
patient over a 30-second period, and 30 seconds later the systolic arterial
pressure was measured. Chest physiotherapy was then performed for 5 min¬
utes.
Result's
There was a greater increase in I.C.P. when nitrous oxide was used
during chest physiotherapy than when 100 % oxygen alone was used
(0.02 > P > 0.01) (fig. 1) (9).
In 2 patients A-waves (7) occurred during physiotherapy with nitrous
oxide, but an A-wave also occurred in one patient given physiotherapy
with 100 % oxygen.
There was a statistically-significant reduction in the I.C.P. increase asso¬
ciated with the chest physiotherapy when thiopentone and Althesin were
used, compared with 100 % oxygen alone. This reduction in I.C.P.
change was achieved without significant arterial hypotension.
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Discussion
Noscious stimulation causes an increase in I.C.P. in patients with head
injury by causing a reflex increase in CBF and cerebral blood volume. Chest
physiotherapy also causes I.C.P. increases in patients with head injury (3).
These could be due partially to noxious stimulation causing systemic
hypertension and cerebral activation, and partially to the increase in
FIG. 1. — Comparison of the increases in ICP with chest physiotherapy during
Entonox (50 '% nitrous oxide in 50 % oxygen) and 100 '% oxygen administration in
patients with severe head injuries. The bars represent the standard errors of the means.
(Reproduced from : Moss E., McDowall D.G. ICP increases with 50 % nitrous oxide
in oxygen in severe head injuries during controlled ventilation. Brit. J. Anaesth.j 51,
757-761, 1979, by kind permission of the Editor and publishers.)
central venous pressure caused by chest hyperinflation and compression.
Such increases in I.C.P. could be detrimental in that they may cause
or worsen brain shifts, or reduce cerebral perfusion pressure.
Anesthetic agents might be expected to reduce the increases in I.C.P.
associated with chest physiotherapy, either by an analgesic effect, as in
the case of nitrous oxide, or by reducing I.C.P. as do thiopentone (5)
and Althesin (19). We have shown that 50 % nitrous oxide in 50 %
oxygen exacerbates the increases in I.C.P. associated with chest physio-
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therapy (9). This can be explained by the I.C.P. increase which nitrous
oxide causes in patients with head injury (9, 17), which is prob¬
ably caused by cerebral vasodilation (8, 13, 14, 18). Schulte am
Esch and his colleagues (17) showed an average increase in I.C.P. ol
15 mm Hg with 66.6 % nitrous oxide and Moss and McDowall (9),
using 50 % nitrous oxide, showed an average increase of 4 mm Hg.
This I.C.P. increase more than offsets any benefit gained from the analgesic
action of nitrous oxide during chest physiotherapy.
Thiopentone and Althesin were effective in reducing the I.C.P. changes
with chest physiotherapy in these patients with severe head injuries,
but there were still some unacceptably large increases in I.C.P. during
chest physiotherapy using both agents, particularly Althesin. This is pos¬
sibly because the doses used were too small, and we are at present
conducting a further study using thiopentone (4.5 mg/kg) and
Althesin (0.045 ml/kg). With the smaller doses of these agents,
the changes in arterial pressure and cerebral perfusion pressure were not
clinically significant. With the larger doses significant hypotension may be
caused, and this possibility is the subject of further investigation.
Thus, the rapid reduction in I.C.P. caused by thiopentone and Althesin
is useful in reducing the I.C.P. changes during chest physiotherapy in
head-injured patients, and can also be used to reduce high I.C.P. rapidly.
Nitrous oxide exacerbates the I.C.P. increases which occur during
chest physiotherapy in head-injured patients, and this would suggest that
nitrous oxide should not be used for analgesia in head-injured patients.
*
* *
Acknowledgements. — The authors thank the staff of the Intensive Care
Units at Leeds General Infirmary, St. James's University Hospital (Leeds) and
Pinderfields General Hospital (Wakefield) for their cooperation in these stu¬
dies, and Mrs. M. Albers for secretarial assistance.
RESUME
E. MOSS, J.S. GIBSON et D.G. McDOWALL. — Emploi de drogues anesthe-
siques pour reduire les changements de pression intracranienne chez des
traumatises craniens.
La physiotherapie de la cage thoracique occasionne des augmentations de
la pression intracranienne chez des patients avec des traumatismes craniens
severes. Chez des traumatises craniens severes hyperventiles artificiellement
(Paco2 3,3 - 4 kPa), 50 % de protoxyde d'azote et 50 % d'oxygene potentialisent
les augmentations de la pression intracranienne associee avec la physiotherapie
de la cage thoracique, tandis que le thiopentone et l'Althesine reduisent ces
changements de pression intracranienne.
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SAMENVATTING
E. MOSS, J.S. GIBSON en D.G. McDOWALL. — Gebruik van anesthetische
stoffen om de intracraniele drukveranderingen te verminderen bij hersen-
getraumatiseerde patienten.
Borstkasfysiotherapie veroorzaakt stijgingen van de intracraniele druk bij
patienten met hersentraumata. Bij mechanisch gehyperventileerde (Paco2 3,3 -
4 kPa) zware hersentraumata patienten, deed 50 % lachgas met 50 % zuurstof
de intracraniele druk toename geassocieerd met borstkasfysiotherapie verergeren,
dan wanneer thiopentone en Althesine deze intracraniele druk veranderingen
verminderden.
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EFFECTS OF TRACHEAL INTUBATION ON INTRACRANIAL
PRESSURE FOLLOWING INDUCTION OF ANAESTHESIA WITH
THIOPENTONE OR ALTHESIN IN PATIENTS
UNDERGOING NEUROSURGERY
E. Moss, D. Powell, R. M. Gibson and D. G. McDowall
summary
Intracranial pressure (i.c.p.) and mean arterial pressure (m.a.p.) were studied in 20 patients during
the induction of anaesthesia for craniotomy. Tubocurarine was administered as the muscle relaxant
and either thiopentone or Althesin for the induction of anaesthesia. No significant differences were
found in the i.c.p. changes with induction, intubation or pharyngeal packing, between the thio¬
pentone and the Althesin groups. Except for two patients (one in each group) the increases in
i.c.p. associated with intubation were small. In these two patients moderate increases from normal
values to 28 and 37 mm Hg were recorded, but in one of these patients coughing and straining
followed intubation. Marked decreases in m.a.p. were noted in both groups, but the recovery of
m.a.p. was significantly more rapid in the Althesin group. Only two patients had i.c.p. values
greater than 20 mm Hg before operation and in neither did i.c.p. increase above control values
during induction and intubation. Packing the pharynx produced minimal changes in i.c.p. in all
patients.
Increases in intracranial pressure (i.c.p.) and mean
arterial pressure (m.a.p.) occurring at the time of
laryngoscopy and intubation were described first by
Stephen and colleagues (1954). Such changes in i.c.p.
are likely to be more marked in neurosurgical patients
especially those with increased i.c.p. caused by
tumour or other intracranial space-occupying lesion
(Shapiro et al., 1972b). In addition it has been
suggested that these increases in i.c.p. may lead to
transcompartmental herniation of brain tissue
(Shapiro et al., 1972a). An increase in m.a.p. is a
well-recognized response to intubation (King et al.,
1951; DeVault, Greifenstein and Harris, I960)
which may accentuate cerebral oedema in patients
with intracranial pathology. Thiopentone and
Althesin have been shown to decrease i.c.p. (Horsley,
1937; Turner et al., 1973), presumably by decreasing
cerebral blood flow (Pierce et al., 1962; Sari et al.,
1976). Thus both these agents might mitigate the
above i.c.p. changes. This paper describes a ran¬
domized trial comparing the effects of thiopentone
with those of Althesin on i.c.p. and m.a.p. during the
induction of anaesthesia.
E. Moss, m.b., ch.b., f.f.a.r.c.s.; D. powell, m.b., b.s.,
l.r.c.p., m.r.c.s., d.obst.r.c.o.g., f.f.a.r.c.s.; R. M.
Gibson, e.r.d., c.st.j., m.sc., m.d., f.r.c.s.e., f.r.c.s.;
D. G. McDowall, m.d., f.f.a.r.c.s.; Departments of
Anaesthesia and Neurosurgery, Leeds General Infirmary,
and University of Leeds.
method
Twenty patients undergoing craniotomy were studied.
All gave their informed consent for the study. Each
patient was premedicated with diazepam 10 mg i.m.,
except for one patient who received papaveretum 10
mg and hyoscine 0.2 mg. Anaesthesia was induced in
10 patients with thiopentone and in 10 with Althesin,
the choice of agent being randomized. After a pre¬
liminary Allen test, a cannula was placed in one
radial artery following infiltration of local analgesic.
I.v. lines were inserted subsequently. A burr hole
was made under local analgesia, and a catheter was
inserted into a lateral ventricle. The arterial cannula
and the ventricular catheter were connected to
pressure transducers and the pressures were dis¬
played on a chart recorder. The zero for the arterial
pressure was at heart level and the reference point for
i.c.p. was the external auditory meatus.
Once m.a.p. and i.c.p. were stable, tubocurarine
45 mg was given (40 mg in one frail woman). This was
followed immediately by an induction dose of thio¬
pentone (range 250-400 mg) or Althesin (range 3-5
ml), the drug being given until there was loss of the
eyelash reflex. The patients were then hyperventilated
moderately with nitrous oxide and oxygen for 2 min,
via a face mask, by hand compression of the reservoir
bag. Exactly 2 min after the completion of the thio¬
pentone or Althesin injection, laryngoscopy and
intubation were performed. After intubation the
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patient was ventilated mechanically and a pharyngeal
pack was inserted. Ventilation was adjusted to produce
moderate hypocapnia by reference to an infra-red
carbon dioxide analyser. In all patients arterial blood-
gas tensions were estimated once the patient was
established on the ventilator. However, in addition,
in the last six patients in the series the arterial blood-
gas tensions were estimated immediately before the
induction of anaesthesia and immediately before
intubation. From the chart records the following
measurements were made: (1) m.a.p. and i.c.p. in the
5 min immediately before induction of anaesthesia
(hereafter described as control m.a.p. and i.c.p.) and
at 1, 2, 3, 4 and 5 min after induction; (2) m.a.p. and
i.c.p. immediately before laryngoscopy and (3) at the
point ofmaximum i.c.p. in the first 60 s after intuba¬
tion. From these measurements cerebral perfusion
pressure (c.p.p.) was calculated by subtracting the
values of i.c.p. from the corresponding values of
m.a.p.
RESULTS
The indications for craniotomy and the i.c.p. values
in the individual patients are presented in table I.
There was no significant difference in control mean
i.c.p. between the two groups. However, two patients
(one in each group) were noted to have control i.c.p.
values of greater than 20 mm Hg; these results have
been excluded from the statistical analysis and are
discussed separately later. The two groups were
similar with regard to age and sex distribution. The
thiopentone group had an average age of 51.1 yr
(range 33-66 yr), the Althesin group 55.1 yr (range
43-71 yr).
The values of m.a.p. obtained in the individual
patients are displayed in table II. The difference
Table I. Intracranial pathology and mean intracranial pressure {mm Hg)
Max. i.c.p.
Control in 1st min
Patient (pre- after
(age, yr) Pathology induction) 1 min 2 min intubation 3 min 4 min 5 min
Thiopetitone
A (59)! Glioblastoma! 22.5 8.5 9 13 15 16 12
B (47) Metastatic carcinomaf* 13 11 11 14 14 14 13
C (46) Pituitary tumour* 3 2.5 4 9 8 8 7
D (41) Dural repair 15 13 15 28 28 19 16.5
E (61) Pituitary tumour 9 11 8 10 10 9 9.5
F (66) Metastatic carcinomaf ? 10 9.5 9 12 10 10 15
G (49) Meningioma 9 15 15 16 13 13 13.5
H (63) Metastatic carcinoma 5 4 3 4.5 4 4 3.5
1(33) Aneurysm 15.5 8.5 9.5 17 15.5 19 28





K (60)f Glioblastoma 30 10 9 15 12 14 13
L (59) Meningioma 18 12 12 15 12 10 11
M (47) Aneurysm 14 11 12 15 12 10 10
N (56) Pituitary tumour 9 9 8 10 9 8 9
O (57) Aneurysm 6.5 5 5 6 5 5 2
P (45) Pituitary tumour 6 5.5 2 4.5 3.5 2 4.5
Q (43) Meningioma* 16 17 14 15.5 15.5 15 15
R (54) Aneurysm 11.5 8.5 6 13 11 12.5 14.5
S (59) Meningioma! 12.5 14 9.5 11.5 10.5 10 9




* Papilledema before operation; f Dexamethasone before operation; J patients A and K were excluded from the
statistical analysis (see text); ?—fundus could not be visualized.
TRACHEAL INTUBATION AND I.C.P.






























































































* Papilledema before operation; t dexamethasone before operation; J patients A and K were excluded from the
statistical analysis (see text); ?—fundus could not be visualized.
between the two control m.a.p. (106 mm Hg (SD 15)
and 112mmHg (SD 21)) was not statistically
significant. In five of the 20 patients, m.a.p. decreased
to less than 50 mm Hg following induction of
anaesthesia, in one patient to less than 20 mm Hg. At
5 min after induction m.a.p. was greater than 50 mm
Hg in all except three patients.
Table III depicts the changes in i.c.p. with
intubation related to the control value and to the
value obtained immediately before laryngoscopy. In
each group mean i.c.p. decreased following the
induction of anaesthesia and increased slightly
following laryngoscopy and intubation. There was
no significant difference between the two groups
except at 5 min after induction, when mean i.c.p. was
significantly less in the Althesin group (0.05 >P>
0.02). There was no significant difference between
the groups in the response of i.c.p. to intubation.
There was a significant correlation between the pre-
induction i.c.p. and the increase in i.c.p. associated
with intubation in the thiopentone group (0.05 >P>
0.02), but there was no such correlation in the
Althesin group.
Table IV shows the changes ofm.a.p. from control
in the first 5 min following induction. In the last
column the changes in m.a.p. produced by laryn¬
goscopy and intubation are presented. As already
stated, the control m.a.p. was very similar but the
m.a.p. after induction ofanaesthesia with tubocurarine
and thiopentone was at each stage lower than those
obtained following tubocurarine and Althesin. This
difference reached significance (0.05 > P> 0.02) at
approximately 3 min after the induction of anaes¬
thesia which, incidentally, was the time at which the
maximum m.a.p. was reached after intubation, and
remained significant (0.02 >P> 0.01) at 4 min, but
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Table III. I.e.p.—changes from control and changes following intubation compared with prelaryngoscopy value
(mm Hg)






















































































































Kt -20 -21 -15 -18 -16 -17 + 6
L -6 -6 -3 -6 -8 -7 + 3
M -3 -2 + 1 -2 -4 -4 + 3
N 0 -1 + 1 0 -1 0 + 2
O -1.5 -1.5 -0.5 -1.5 -1.5 -4.5 + 1
P -0.5 -4 -1.5 -2.5 -4 -1.5 + 2.5
Q* + 1 -2 -0.5 -0.5 -1 -1 + 1.5
R -3 -5.5 + 1.5 -0.5 + 1 + 3 + 7
St + 1.5 -3 -1 -2 -2.5 -3.5 + 2
T -0.5 + 3 + 27.5 + 25 + 18 + 3.5 + 25
Mean -1.3 -2.4 + 2.7 + 1.1 -0.3 -1.7 + 5.2
SD 2.35 2.69 9.40 9.13 7.34 3.48 7.6
SEM 0.78 0.90 3.03 3.04 2.45 1.16 2.53
* Papilledema before operation; t dexamethasone before operation; % patients A and K were excluded from the
statistical analysis (see text); ?—fundus could not be visualized; § significance between thiopentone and Althesin groups:
0.05 >P> 0.02.
not at 5 min. The increase in arterial pressure which
followed within 60 s of intubation was significantly
greater in the Althesin group (0.02 >P> 0.01).
There were no significant differences between the
two groups in mean PaC(l„ at the time of intubation
(thiopentone 4.0 ± 1.2 kPa, Althesin 4.5 ± 1.1 kPa) or
at 5 min after induction (thiopentone 3.8 + 0.9 kPa,
Althesin 4.2 + 0.8 kPa).
The changes in m.a.p. and i.e.p. caused by packing
the pharynx were minimal and there was no statistic¬
ally significant difference between the two groups
(table V).
In the two patients with values of i.c.p. greater
than 20 mm Hg the changes in m.a.p. were similar to
those noted in patients with i.c.p. less than 20 mm Hg.
In these two patients i.c.p. decreased markedly
following the administration of the induction agent
and tubocurarine (by 14 mm Hg and 20 mm Hg; see
table III) and did not increase above the control
value with intubation.
DISCUSSION
In this study, in which anaesthesia was induced with
either thiopentone or Althesin, and muscular relaxa¬
tion was produced with tubocurarine, the increases in
i.c.p. which resulted from intubation were small.
Thus, of the 18 patients with a control mean i.c.p. of
less than 20 mm Hg, the mean change from control
with intubation was 2.8 mm Hg (range —4.5 to 27.5
mm Hg) and the mean change from the immediate
TRACHEAL INTUBATION AND I.C.P. 357
Table IV. Arterial pressure—changes from control and changes following intubation compared with prelaryngoscopy
value (mm Hg)
Changes
Max. change from pre-
from control laryngoscopy
in 1st min value
after following
Patient 1 min 2 min intubation 3 min 4 min 5 min intubation
Thiopentone
Aft -30 -40 -27 -25 -22 -25 + 15
Bf* -13 -16 -11 -11 -13 -20 + 20
C* -53 -57 -20 -33 -25 + 10 + 37
D -69 -59 -20 -20 -7 -17 + 32
E -32 -37 -33 -33 -33 -35 + 12
Ff? -50 -51 -72 -55 -50 -36 + 4
G -54 -49 -49 -54 -55 -57 0
H -34 -54 -55 -44 -12 + 1 + 10
I -58 -70 -58 -61 -55 -48 + 12
Jt* -22 -62 -54 -64 -54 -50 + 8
Mean -42.8 -50.6 -41.3 -40.2 -33.8 -28.0 15.0
SD 18.42 15.87 20.99 19.82 20.23 23.21 12.43
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* Papilledema before operation; t dexamethasone before operation; J patients A and K were excluded from the
statistical analysis (see text); ?—fundus could not be visualized; § significance between thiopentone and Althesin groups.
pre-laryngoscopy value was 4.6 mm Hg (range —0.5
to 25 mm Hg). Ofthe four patients with papilloedema,
none showed an increase of more than 6 mm Hg
from control i.e.p. at intubation. Except for two
patients, all the increases in i.e.p., as a result of
intubation, were 7 mm Hg or less. One patient
showed an increase of 13 mm Hg from the control
value. This was related to coughing and straining on
the endotracheal tube. In the other patient an
increase of 27.5 mm Hg was noted. This patient had
a large meningioma but no papilloedema or symptoms
of increased i.e.p. before operation. However, during
cannulation of the ventricle a substantial quantity of
cerebrospinal fluid was lost, so this patient may have
had a higher i.e.p. before operation than that recorded
after cannulation of the ventricle. Also, in this
particular patient, PaC02 increased by 1.1 kPa
between induction of anaesthesia and laryngoscopy,
Paco„ being 5.2 kPa at the time of intubation. This
may have been the reason for the marked increase in
i.e.p., as this was the only patient in the series who
showed an increase in PaCOo between induction of
anaesthesia and intubation.
There have been several previous studies of changes
in i.e.p. occurring with intubation. Shapiro and his
colleagues (1972b) found, in patients intubated under
suxamethonium, that the increases were greater in
those patients who had symptoms or signs of
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Table V. Changes in i.c.p. and m.a.p. related to packing the
pharynx (mm Hg)
I.c.p. M.a.p.
before Change in before Change in
Patient pack i.c.p. pack m.a.p.
Thiopentone
Aft 14 0 112 + 15
Bf* 8 + 0.5 97 + 23
C* 24.5 -1 100 0
D 9.5 0 57 0
E 10.5 0 55 + 5
Ff? 13 0 45 -5
G 4 0 68 + 20
H 17 + 3 25 + 5
I 7.5 + 1.5 63 + 5
Jt* 15 + 2 72 -5




Kt 11.5 0 97 + 16
L 12.5 -0.5 110 + 8
M 10 0 30 -3
N 5 0 80 + 10
O 5.5 + 1.5 113 + 12
P 10 0 92 + 11
Q* 12.5 + 2 175 + 25
R 10 -0.5 95 + 23
St 27.5 + 2 118 + 19
T 15 -2.5 110 0
Mean + 0.2 + 12.1
SD 1.36 9.10
SEM 0.61 4.07
* Papilloedema before operation; f dexamethasone before
operation; ?—fundus could not be visualized.
increased i.c.p. before operation. They found increases
in i.c.p. from the pre-induction value averaging
22 mm Hg (range 19-30 mm Hg) and from the pre-
laryngoscopy value averaging 27 mm Hg (range 20-
34 mm Hg) in their "increased i.c.p. group". The
increases in their "normal i.c.p. group" averaged
1.5 mm Hg (range —7 to +5 mm Hg) and 6 mm Hg
(range 4-7 mm Hg) respectively. The changes did
not, however, relate to the measured i.c.p. values
immediately before induction of anaesthesia. Burney
and Winn (1975), who also used suxamethonium,
showed increases in i.c.p. similar to those of Shapiro
and colleagues, and in our opinion their data, like
Shapiro's, showed no correlation between the initial
values of i.c.p. and the increase associated with
intubation. This discrepancy between clinical signs
of i.c.p. and the pre-induction value of measured
i.c.p. is probably explained by the pressure/volume
relationship of the intracranial space. Thus, con¬
siderable intracranial compression can be present
when i.c.p. is either normal or increased only slightly.
In these circumstances the varying degrees of intra¬
cranial compression result in different i.c.p. changes
with such stimulation as intubation.
The reports in the literature which showed the
greatest increases in i.c.p. with intubation were those
of Greenbaum and colleagues (1975) who described
increases of as much as 80 mm Hg with peaks of
100 mm Hg, and Misfeldt, Jorgensen and Rishoj
(1974) who described increases of up to 50 mm Hg
with peaks of more than 80 mm Hg. These workers
used suxamethonium for intubation.
McLeskey and colleagues (1974) and Lewelt,
Moszynski and Kozniewska (1976) used pancuronium
to produce muscular relaxation for intubation while
measuring i.c.p. McLeskey and colleagues found
much smaller increases in i.c.p. when pancuronium
was used, as compared with suxamethonium. None
the less, despite using very large doses of thiopentone
they had marked increases in m.a.p. in some patients
in their pancuronium group. Lewelt and his co¬
workers found no significant increase in mean i.c.p.
at intubation, provided that adequate time was
allowed for the relaxant to act. They did not induce
anaesthesia until pancuronium had produced a full
muscular relaxation, and they did not record arterial
pressure during induction. In terms of the magnitude
of i.c.p. changes observed, the results of Lewelt,
Moszynski and Kozniewska (1976) and McLeskey
and colleagues (1974) are closest to those described
here, probably because in all three studies a com¬
petitive muscle relaxant was used. Suxamethonium
may increase the i.c.p. change with intubation
because of the muscle fasciculations, or the direct
action of the drug, or because the duration of hyper¬
ventilation before intubation is likely to be shorter
than that which exists when a long-acting muscle
relaxant is used. The longer period of hyperventila¬
tion in patients receiving a long-acting muscle
relaxant produces hypocapnia which may partially
restore defective autoregulation (Paulson, Olesen and
Christensen, 1972) and thus protect the cerebral
circulation against any sudden increase in m.a.p.
We believe that large changes in i.c.p. associated
with intubation are important in neurosurgery
because they may cause transcompartmental pressure
gradients and so induce brain shifts, may precipitate
cerebral oedema if secondary to an acute episode of
systemic hypertension or may result in an inadequate
c.p.p. In stating that increases in i.c.p. associated
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with intubation are harmless, Misfeldt, Jorgensen
and Rishoj (1974) have concentrated only on c.p.p.
and did not consider the other factors discussed
above, which are probably of greater importance in
this context.
Tubocurarine was chosen for this study, since it is
commonly used in neurosurgery, partly because the
hypotension produced (Thomas, 1957) may reduce
bleeding during reflection of skin and muscle. In this
respect it may have an advantage over pancuronium
which does not produce hypotension and may, indeed,
produce increases in arterial pressure (Kelman and
Kennedy, 1971; Gordon, 1975). In this study tubo¬
curarine and an i.v. induction agent produced
significant decreases in m.a.p., an effect which lasted
for a few minutes only. M.a.p. decreased to a similar
degree with Althesin and thiopentone, but recovery
was more rapid and complete in the Althesin group.
Mean c.p.p. was reduced to less than 60 mm Hg in
75% of the patients and to less than 40 mm Hg in
20% of the patients. A mean c.p.p. of 50 mm Hg is
at the lower end of the autoregulation range (Olesen,
1973; Lassen, 1974). However, there was no clinical
evidence in the period after operation that this
decrease in c.p.p. affected the recovery of the patient
in any way, and indeed it may have been a factor in
avoiding large increases in i.c.p. on intubation. The
wide inter-patient variation in m.a.p. response to
tubocurarine is in keeping with the observations of
Thomas (1957). Unlike Tarkkanen, Laitinen and
Johansson (1974), we saw no increases in i.c.p. which
could be attributed to tubocurarine. The fact that we
ventilated our patients immediately after the adminis¬
tration of the tubocurarine may explain this difference
in results.
Four of the patients were receiving dexamethasone
before operation, but their i.c.p. response to intuba¬
tion did not appear to differ from the other patients.
There has been no previous reported comparison
between thiopentone and Althesin for the induction
of anaesthesia for craniotomy. Our results show that
there was no significant difference between these two
agents in their effects on i.c.p. when combined with
tubocurarine, and that there was no difference
between the two groups with regard to change in
i.c.p. following intubation or packing the pharynx.
The positive correlation between pre-induction
i.c.p. and the increase in i.c.p. associated with intu¬
bation in the thiopentone group only just reaches
statistical significance, and the i.c.p. increases with
intubation in this series were small. We conclude,
therefore, that the changes in i.c.p. at intubation are
similar with thiopentone and Althesin even in patients
with increased i.c.p.
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EFFETS DE L'lNTUBATION TRACHEALE SUR
LA PRESSION INTRACRANIENNE APRES
INDUCTION DE L'ANESTHESIE A L'AIDE DE
THIOPENTONE OU D'ALTHESINE SUR DES
MALADES SUBISSANT UNE INTERVENTION
NEUROCHIRURGICALE
RESUME
On a etudie sur 20 malades la pression intracranienne (ICP)
et la tension arterielle moyenne (m.a.p.) pendant l'induction
de l'anesthesie pour une craniotomie. On a administre de la
tubocurarine en tant que decontracturant musculaire, et
soit du thiopentone, soit de l'althesine pour l'induction de
l'anesthesie. On n'a trouve aucune difference importante
dans les variations de 1'ICP, lors de l'induction, de l'intuba-
tion ou du bourrage pharyngien entre le groupe soumis au
thiopentone et celui soumis a 1'althesine. A l'exception de
deux malades (un dans chaque groupe), les augmentations
de 1'ICP associees a l'intubation ont ete faibles. On a
enregistre sur ces deux malades, des augmentations
moderees allant des valeurs normales a 28 et 37 mm Hg,
mais sur l'un de ces deux malades 1'intubation a ete suivie
de toux et de fatigue. On a note sur les deux groupes une
diminution marquee de la m.a.p., mais la recuperation de la
m.a.p. a ete beaucoup plus rapide dans le groupe anesthesie
a I'althesine. Seuls deux malades ont eu des valeurs ICP
superieures a 20 mm Hg avant l'operation et sur aucun
d'eux 1'ICP n'a augmentee au-dela des valeurs temoins
pendant 1'induction et l'intubation. Le bourrage du pharynx
n'a produit que des variations minimales dans 1'ICP de tous
les malades.
WIRKUNGEN TRACHEALER INTUBATION AUF
DEN INTERKRANIELLEN DRUCK NACH
NARKOSEEINLEITUNG MIT THIOPENTON
ODER ALTHESIN VOR NEUROCHIRURGISCHEN
EINGRIFFEN
ZUSAMMENFASSUNG
Der interkranielle Druck (i.c.p.) und der mittlere arterielle
Druck (m.a.p.) wurden an 20 Patienten wahrend Narko-
seeinleitung fur eine Kraniotomie gemessen. Zur Muskel-
entspannung wurde Tubocurarin, fur die Narkose entweder
Thiopenton oder Althesin verabreicht. Zwischen diesen
beiden Gruppen ergaben sich keine wesentlichen Unter-
schiede, was Veranderungen des i.c.p. bei Einleitung,
Intubation oder pharingealer Packung betrifft. Abgesehen
von zwei Patienten (einer pro Gruppe) waren die mit Intu¬
bation verbundenen Anstiege von i.c.p. gering. Bei diesen
beiden Patienten wurden massige Anstiege von den Normal-
werten auf 28, bezw. auf 37 mm Hg berichtet, doch bei
einem dieser Patienten kam es nach der Intubation zu
Husten und Anspannung. Deutlich Verringerungen von
m.a.p. wurden in beiden Gruppen festgestellt, aber die
Wiederherstellung dieser Werte ging in der Althesin-
Gruppe wesentlich schneller vor sich. Nur zwei Patienten
hatten vor der Operation hohere i.c.p.-Werte als 20 mm Hg,
und bei keinem der beiden stieg dieser Wert wahrend Ein¬
leitung und Intubation iiber den Kontrollwert. Die pharin-
geale Packung fiihrte bei alien Patienten nur zu minimalen
Anderungen des i.c.p.
EFECTOS QUE EJERCE LA INTUBACION
TRAQUEAL SOBRE LA PRESION
INTRACRANEAL SIGUIENDO LA INDUCCION
DE ANESTESIA CON TIOPENTONA O
ALTESINA EN PACIENTES SOMETIDOS
A NEUROCIRUGIA
SUMARIO
Se estudiaron la presion intracraneal (i.c.p.) y la presion
arterial media (m.a.p.) en 20 pacientes durante la induccion
de anestesia para craneotomia. Se administro tubocurarina
como relajante muscular y tiopentona o Altesina para la
induccion de anestesia. No se descubrieron diferencias
significativas en los cambios de la i.c.p. mediante induccion,
intubacion y taponamiento faringeal entre los grupos de
tiopentona y Altesina. Exceptuando dos pacientes (uno en
cada grupo), los aumentos en la i.c.p. asociada con intuba¬
cion fueron de escasa magnitud. En estos dos pacientes se
registraron aumentos moderados de los valores normales a
28 y 37 mm Hg, pero uno de estos pacientes sufrio tos y
esfuerzo despues de la intubacion. Se notaron marcadas
disminuciones en la m.a.p. en ambos grupos, pero la
recuperation de la m.a.p. fue significativamente mas rapida
en el grupo de Altesina. En solo dos pacientes se presentaron
valores de i.c.p. superiores a 20 mm Hg antes de la operation
y en ninguno de ellos aumento el i.c.p. en mas de los valores
de control durante la induccion e intubacion. El tapon¬
amiento de la faringe produjo cambios minimos en la i.c.p.
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EFFECT OF ETOMIDATE ON INTRACRANIAL PRESSURE AND
CEREBRAL PERFUSION PRESSURE
E. Moss, D. Powell, R. M. Gibson and D. G. McDowall
summary
Ten patients with intracranial lesions, anaesthetized with thiopentone and nitrous oxide (70%) in
oxygen (30%) received etomidate 0.2 mg kg-1 i.v. Ventilation was controlled in each patient.
Intracranial pressure (i.c.p.) and mean arterial pressure (m.a.p.) were recorded. I.c.p. decreased
significantly in all patients (0.01 >P> 0.001). Although Paco, decreased during the period of
measurement, the extent and time-course of this change suggested that it was notmainly responsible
for changes in i.c.p. M.a.p. decreased in most patients, but the decrease was statistically significant
only at 3 and 4 min after the administration of etomidate (0.05 > P > 0.02). The changes in cerebral
perfusion pressure (c.p.p.) and heart rate were not clinically or statistically significant. We conclude
that etomidate can be used for the induction of anaesthesia in patients with intracranial space-
occupying lesions without increasing i.c.p. or seriously reducing c.p.p.
All the agents used commonly i.v. to induce anaes¬
thesia have been shown to decrease intracranial
pressure (i.c.p.) (Horsley, 1937; Hunter, 1972;
Turner et al., 1973) and cerebral blood flow (c.b.f.)
(Pierce et al., 1962; Herrschaft et al., 1975; Sari et al.,
1976), with the sole exception of ketamine, which
increases both i.c.p. (Evans et al., 1971; Gardner,
Olson and Lichtiger, 1971; Takeshita, Okuda and
Sari, 1972) and c.b.f. (Dawson, Michenfelder and
Theye, 1971; Takeshita, Okuda and Sari, 1972).
Etomidate, an i.v. agent, has been introduced recently
for induction of anaesthesia and has the advantages
of cardiovascular stability (Doenicke, 1974; Morgan,
Lumley and Whitwam, 1975; Holdcroft et al., 1976;
Rifat, Gamulin and Gemperle, 1976; Famewo and
Odugbesan, 1977; Ghoneim and Yamada, 1977; Lees
and Hendry, 1977; Patschke et al., 1977), freedom
from marked respiratory depression (Doenicke, 1974;
Morgan, Lumley and Whitwam, 1975, 1977; Famewo
and Odugbesan, 1977, 1978; Ghoneim and Yamada,
1977), and rapid inactivation (Kay, 1976; Lees and
Hendry, 1977). It has been shown by Herrschaft and
his co-workers (1975) that etomidate decreases c.b.f. in
normal man, and thus it would be expected to reduce
i.c.p. also. This study was undertaken to determine
the effect of etomidate on i.c.p. in patients with
E. Moss, m.b., ch.b., f.f.a.r.c.s., D. powell, m.b., b.s.,
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and University of Leeds.
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intracranial pathology who were about to undergo
craniotomy, and thus to determine its suitability for
use in patients with intracranial space-occupying
lesions.
methods
Ten patients with intracranial lesions requiring
craniotomy were investigated. All gave their informed
consent for the study. If considered necessary, the
patients were premedicated with diazepam 10 mg i.m.
Anaesthesia was induced with thiopentone, which was
given until the eyelash reflex was obtunded, and was
maintained with nitrous oxide 70% in oxygen.
Ventilation was controlled using a Manley Pulmovent
ventilator and tubocurarine 45 mg was administered to
produce neuromuscular blockade. The volume of
ventilation was adjusted to produce normocapnia and
this was maintained constant throughout the period of
the study. Allen's test was performed on all the
patients and, if there was adequate ulnar collateral
circulation, a radial artery cannula was inserted.
After infiltration of the scalp with local analgesic a
burr hole was made, through which a catheter was
inserted into a lateral ventricle. The radial artery and
ventricular cannulae were connected to suitably
calibrated transducers, the signals from which were
amplified and recorded on chart recorders. The zero
reference for the arterial transducer was the mid-
axillary line (with the patient supine, tilted 10°
head-up), and for the ventricular transducer was the
external auditory meatus. The arterial pressure and
intracranial pressure traces were observed for 5 min
before the injection of etomidate 0.2 mg kg-1 body
0007-0912/79/040347-06 $01.00 © Macmillan Journals Ltd 1979
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weight given i.v. over a period of 10 s. The arterial
pressure and i.c.p. were recorded for 10 min after the
administration of the etomidate and before surgery
was continued. Cerebral perfusion pressure (c.p.p.)
was calculated by subtracting mean i.c.p. from the
mean arterial pressure (m.a.p.). From the recordings,
the following measurements were made: (i) m.a.p.,
mean i.c.p. and c.p.p. in the 5 min before the injection
of etomidate (control values for m.a.p., mean i.c.p.
and c.p.p.); (ii) m.a.p., mean i.c.p. and c.p.p. at
1-min intervals for 10 min after the administration of
the etomidate. (Only the results obtained at 2-min
intervals are tabulated.)
Samples were taken for measurement of arterial
blood-gas tensions just before the administration of
the etomidate (initial PaCC)2) and at 10 min after the
administration of etomidate (final PaC02). During the
period of measurement the end-tidal carbon dioxide
concentration was monitored continuously with an
infra-red gas analyser.
RESULTS
The ages and diagnoses of all the patients and their
mean i.c.p. during the control period, and at 2-min
intervals after the administration of etomidate are in
table I. It was found that i.c.p. decreased initially in
all the patients and then started to increase, but in
only two patients, it returned to control values
within the 10 min (fig. 1). This decrease from control
was statistically significant (0.01 >P> 0.001) at the
1st min after injection, and remained significant at the
Table I. The mean intracranial pressure (mm Hg), diagnoses and ages (yr) of the 10 patients. Control
indicates the mean pressure in the 5 min before administration of etomidate. The probability values represent





i.c.p. 2 min 4min 6 min 8 min 10 min
A (51) Aneurysm 14 9 9 6 8 8
B (46) Pituitary tumour 28 22 22 23 23 23
C (35) Glioblastoma 16 10 11 12 14 16
D (22) Glioblastoma 16 11 11 11 12 13
E (66) Pituitary tumour 9 4 4 4 5 6
F(71) Pituitary tumour 9 6 5 6 6 6
G (70) Pituitary tumour 13 6 6 6 6 6
H (33) Pituitary tumour 26 11 11 12 11 13
I (61) Glioblastoma 21 8 7 8 8 9
J (51) Meningioma 12 9 10 10 11 11
X 16.4 9.6 9.6 9.8 10.4 11.1
SD 6.62 4.93 5.08 5.43 5.32 5.43
SEM 2.09 1.56 1.61 1.72 1.68 1.72
P 0.001 <0.001 < 0.001 0.01 >P 0.01 >P
>0.001 >0.001
Fig. 1. The average i.c.p. ( + SEM) (mmHg) for the
10 patients before (control) and after the administration of
etomidate 0.2 mg kg-1.
1% level or greater for the 10 min of measurement.
There was a small decrease in m.a.p. in eight
patients which was significant statistically at 3 and 4
min after the administration of etomidate (0.05 >
P> 0.02) (table II). The heart rate decreased slightly
in eight patients but did not differ significantly from
the control value at any time.
On average c.p.p. decreased slightly, but this
decrease never reached statistical significance (table
III, fig. 2). In only one patient did the c.p.p. decrease
to less than 60 mm Hg (patient B, minimum c.p.p. =
54 mm Hg).
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Table II. The mean arterial pressure {mm Hg) of the 10
patients. "Control" indicates the mean pressure in the 5 min
before the administration of etomidate. The probability value
represents the significance of the change in m.a.p. from the
control value
Patient Control 2 min 4 min 6 min 8 min 10 min
A 183 185 175 180 180 180
B 102 87 78 77 83 90
C 123 123 122 128 133 135
D 108 108 108 108 108 103
E 87 83 78 83 85 85
F 115 107 107 122 125 120
G 102 93 95 95 90 90
H 133 128 130 140 133 137
I 107 107 105 105 100 100
I 143 112 105 98 103 103
X 120.3 113.3 110.3 113.6 114.0 114.3
SD 27.39 29.03 28.10 30.47 29.68 29.42
SEM 8.66 9.18 8.89 9.64 9.39 9.30
P 0.05 >P
>0.02
Table III. The cerebral perfusion pressure {mm Hg) of the
10 patients. "Control" indicates the mean cerebral perfusion
pressure in the 5 min before the administration of etomidate
Patient Control 2 min 4 min 6 min 8 min 10 min
A 169 176 166 174 172 172
B 74 65 56 54 60 67
C 107 113 111 116 119 119
D 92 97 97 97 96 90
E 78 79 74 79 80 79
F 106 101 102 116 119 114
G 89 87 89 89 84 84
H 107 117 119 128 122 124
I 86 99 98 97 92 91
I 131 103 95 88 92 92
X 103.9 103.7 100.7 103.8 103.6 103.2
SD 28.37 29.72 29.07 32.43 31.02 30.27
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Fig. 2. The average m.a.p., average c.p.p. (+ SEM)
(mm Hg) for the 10 patients before (control) and after the
administration of etomidate 0.2 mg kg-1.
Table IV. Paco, values (kPa) of the 10 patients
immediately before the administration of
etomidate {initial Paco,) and at 19 after
administration of etomidate {final Pago,)- The
probability value refers to the significance of the
change in Paco, during the period of measure¬
ment
It can be seen (table IV) that in five patients
PaCo2 was in the lower part of the normal range, and
in four patients just below the lower limit of normal.
One patient was markedly hypocapnic. In most
patients there was a slight decrease in PaCf)2 over the
10-min period of measurement, so that mean Paco_,
decreased by 0.23 kPa (statistically significant:
0.01 >P>0.001). The decrease in the end-tidal
carbon dioxide concentration occurred usually at
between 2 and 7 min after the administration of
etomidate.
Figure 3 shows the scatter diagram and regression
line for the decrease in i.c.p. after the administration
















of etomidate plotted against the initial i.c.p. value.
The correlation (r = 0.624) between decrease in i.c.p.
and initial i.c.p. was not significant statistically.
DISCUSSION
It is known that thiopentone, methohexitone and
Althcsin reduce i.c.p. (Horsley, 1937; Hunter, 1972;
Turner et al., 1973) and c.b.f. (Pierce et al., 1962;
Herrschaft et al., 1975; Sari et al., 1976), but that
ketamine increases i.c.p. (Evans et al., 1971; Gardner,
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Fig. 3. Comparison of the maximum decrease in i.c.p.
produced by etomidate with the initial i.c.p. value.
Olson and Lichtiger, 1971; Wyte et al., 1972) and
c.b.f. (Dawson, Michenfelder and Theye, 1971;
Takeshita, Okuda and Sari, 1972). In the presence of
intracranial space-occupying lesions, it is preferable
to use agents which either do not affect i.c.p. or
which decrease it. Thus, it is important to determine
the effect on i.c.p. of any new anaesthetic agent,
such as etomidate, to ascertain its suitability for use
in patients with increased i.c.p.
In this study there was a decrease in i.c.p. in all 10
patients following the administration ofetomidate i.v.
This reduction can be explained almost certainly by
the rapid decrease in c.b.f., and thus cerebral blood
volume, which is known to occur after the adminis¬
tration of etomidate (Herrschaft et al., 1975). Herr-
schaft's studies were in normal patients anaesthetized
with propanidid, suxamethonium, nitrous oxide,
oxygen and halothane 0.1-0.4 vol%. The use of
halothane may explain the more short-lived reduction
in c.b.f. that they observed (less than 5 min) as
compared with the duration of the decrease in i.c.p.
that we observed (more than 10 min). The duration
of the decrease in i.c.p. seen in our study is more in
keeping with the duration of action of etomidate
reported in the literature both by Doenicke (1974),
who reported that the time to complete recovery
after the administration of etomidate 0.3 mg kg-1
was approximately 12 min, and by Lewi and Heykants
(1978) who found that the plasma concentration
decreased by approximately 90% in 16 min after a
dose of 0.21 mgkg-1. The numbers in this present
series were inadequate to show whether there was a
greater decrease in i.c.p. if the i.c.p. was high initially.
The small decrease in PaCOz (average 0.23 kPa),
noted in most of the patients during the period of
measurement, occurred during constant ventilation
which had been established for at least 30 min before
the administration of etomidate. It may have been
a result of a reduction in metabolic rate, and thus a
reduction in carbon dioxide production. With one
exception this decrease in PaC02 occurred between
2 and 7 min after the administration of etomidate,
whereas the maximum change in i.c.p. occurred
within 90 s, and by 7 min i.c.p. was beginning to
increase again. Thus, the influence on i.c.p. of this
small change in PaCOa was probably minimal.
Although the m.a.p. decreased in all but two
patients, the lowest m.a.p. recorded was 77 mm Hg
which was above the value at which the autoregulation
of c.b.f. ceases and c.b.f. becomes pressure-depen¬
dent. The c.p.p. increased in 50%of the patients and
decreased in 50%, remaining adequate in all. The
heart rate decreased slightly in most of the patients,
but the change was not significant statistically. These
findings confirm the cardiovascular stability found
with etomidate (Doenicke, 1974; Morgan, Lumley
and Whitwam, 1975; Holdcroft et al., 1976; Rifat,
Gamulin and Gemperle, 1976; Famewo and Odug-
besan, 1977; Ghoneim and Yamada, 1977; Lees and
Hendry, 1977; Patschke et al., 1977).
There are other possible advantages of etomidate
which were not assessed in this study. Plasma
histamine concentration does not increase after its
administration (Doenicke et al., 1973) (whereas it
does after Althesin and propanidid), and as yet there
is no reported case of allergic reaction to the drug.
In the dose required for anaesthesia, respiratory
depression is not a problem (Doenicke, 1974;
Morgan, Lumley and Whitwam, 1975, 1977;
Famewo and Odugbesan, 1977, 1978; Ghoneim and
Yamada, 1977), although this is not so important in
neuroanaesthesia as ventilation is usually controlled.
Etomidate is metabolized quickly and, judged on
clinical grounds in man, is not cumulative (Kay,
1976; Lees and Hendry, 1977). Thus, its use by
continuous i.v. infusion may have a place, as an
alternative to methohexitone (Hunter, 1972) or
Althesin, in maintaining anaesthesia in patients with
intracranial space-occupying lesions. The rapid
metabolism of the drug and its ability to reduce i.c.p.
suggest that it would be suitable for the rapid reduc¬
tion of i.c.p. in patients with head injuries, or for
prophylactic use before chest physiotherapy or other
procedures known to increase i.c.p. in this group of
patients.
On the basis of this study, we conclude that
etomidate would be a useful addition to the drugs
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available to the neuroanaesthetist for the induction of
anaesthesia, a conclusion which is supported by
recent reports by Cunitz, Danhauser and Wickbold
(1978) and Schulte am Esch, Pfeifer and Thiemig
(1978). In addition, it could be used as an agent for
the rapid reduction of i.c.p. and possibly for main¬
tenance of anaesthesia by continuous infusion.
Note added in proof: Since this manuscript was
prepared, Renou and colleagues (1978) have published
work showing a reduction in c.b.f. following
etomidate in patients with intracranial pathology.
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EFFET DE L'ETOMIDATE SUR LA PRESSION
INTERCRANIENNE ET SUR LA PRESSION DE
PERFUSION CEREBRALE
RESUME
Dix malades ayant des lesions intracraniennes, anesthesias
au thiopentone et au protoxyde d'azote (70%) dans Poxy-
gene (30%), ont regu de 1'etomidate par voie intraveineuse
a raison de 0,2 mg kg-1. La ventilation a ete controlee sur
30
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chaque patient. La pression intracranienne (ICP) et la
pression arterielle moyenne (MAP) ont ete enregistrees.
L'ICP a diminue d'une maniere significative chez tous les
malades (0,01 >P> 0,001). Bien que la P&cot ait diminue
pendant la periode ou l'on a pris les mesures, l'importance
et le temps de ce changement laissent penser que celle-ci
n'a pas ete essentiellement responsable des variations de
l'ICP. La MAP a diminue chez la plupart des patients,
mais cette diminution n'a eu d'importance statistique que
3 et 4 min apres l'administration d'etomidate (0,05 >P>
0.02). Les variations de la pression de la perfusion cere-
brale (CPP) et de la frequence cardiaque n'ont eu aucune
importance clinique ou statistique. Nous en concluons
que l'etomidate peut etre utilise pour l'induction de l'anes-
thesie sur les malades ayant des lesions intracraniennes
envahissantes et qu'il ne fait pas augmenter l'ICP ou
diminuer serieusement la CPP.




Zehn Patienten mit intrakraniellen Verletzungen erhielten
intravenos 0,2 mg kg-1 Etomidat, wahrend sie mit
Thiopenton und Stickoxyd (70%) in Sauerstoff (30%)
narkotisiert waren. Die Beatmung wurde bei alien Patienten
kontrolliert. Der intrakranielle Druck (I.C.P.) und der
mittlere arterielle Druck (M.A.P.) wurden aufgezeichnet.
1.C.P. sank wesentlich bei alien Patienten (0,01 > P > 0,001).
Obwohl PaCo2 wahrend der Messungsperiode sank,
deuteten Ausmass und Zeitablauf dieser Veranderung
darauf hin, dass sie nicht in erster Linie fur die Anderungen
von I.C.P. verantwortlich war. M.A.P. sank bei den
meisten Patienten, doch war diese Verringerung nur bei 3
und 4 Minuten nach der Verabreichung von Etomidat
(0,05 > P > 0,02) statistisch von Bedeutung. Die Verander-
ungen des zerebralen Perfusionsdruckes (C.P.P.) und die
Herztatigkeit waren klinisch oder statistisch unbedeutend.
Wir schliessen daraus, dass Etomidat fur die Einleitung von
Narkose bei Patienten mit intrakraniellen grosseren
Verletzungen verwendet werden kann, ohne I.C.P. zu
erhohen oder C.P.P. ernsthaft zu verringern.
EFECTO EJERCIDO POR ETOMIDATA SOBRE
LA PRESION INTRACRANEAL Y PRESION
DE PERFUSION CEREBRAL
SUMARIO
Diez pacientes con lesiones intracraneales, anestesiados con
tiopentona y oxido nitroso (70%) en oxigeno (30%),
recibieron etomidata 0,2 mg kg^1 intravenosamente. La
ventilacion fue controlada en todos los pacientes. Se
registro la presion intracraneal (I.C.P.) y presion arterial
media (M.A.P.). La I.C.P. disminuyo significativamente en
todos los pacientes (0,01 >P> 0,001). Aunque el PaCOj
disminuyo durante el periodo de medicion, la magnitud y
el transcurso de tiempo de este cambio sugirieron que no
era principalmente responsable de los cambios en la I.C.P.
La M.A.P. disminuyo en la mayoria de los pacientes,
pero la disminucion fue estadisticamente significativa
solamente despues de 3 y 4 min de administrarse etomidata
(0,05 >P>0,02). Los cambios en la presion de perfusion
cerebral (C.P.P.) y en los latidos del corazon no fueron
clinica ni estadisticamente significativos. Concluimos que
la etomidata puede emplearse para la induccion de anestesia
en pacientes con lesiones intracraneales que ocupan espacio,
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EFFECTS OF FENTANYL ON INTRACRANIAL PRESSURE
AND CEREBRAL PERFUSION PRESSURE DURING HYPOCAPNIA
E. Moss, D. Powell, R. M. Gibson and D. G. McDowall
summary
Ten patients presenting for craniotomy were studied. Each was anaesthetized with thiopentone or
Althesin followed by tubocurarine and the lungs were hyperventilated with nitrous oxide in oxygen.
Fentanyl 0.2 mg was administered i.v. and the intracranial pressure (i.c.p.) and mean arterial pressure
were recorded continuously for 10 min. At the time of administration of fentanyl nine of the 10
patients were hypocapnic (.Paco, less than 4 kPa). The changes in i.c.p. were small. Cerebral perfusion
pressures less than 50 mm Hg were observed in two patients who had moderate hypotension before
the drug was given. We conclude that fentanyl is a valuable agent in the hyperventilation technique
in patients with intracranial space-occupying lesions, provided that hypotension is absent.
Fitch and colleagues (1969a) reported first that the
administration of fentanyl and droperidol either did
not alter, or decreased slightly, the intracranial
pressure (i.c.p.) in patients with intracranial space-
occupying lesions during controlled ventilation, and
Sari, Okuda and Takeshita (1972) found that Thala-
monal had no effect on cerebral blood flow (c.b.f.)
or the cerebral metabolic rate for oxygen. Because
fentanyl is short-acting, and as a result of these
studies, it has been used widely, sometimes with
droperidol, to supplement nitrous oxide/oxygen/
relaxant anaesthesia for neurosurgery. However,
when Misfeldt and colleagues (1976) used droperidol
and fentanyl for the induction of anaesthesia, they
observed a marked increase in i.c.p. Following these
observations they studied systematically the effects of
droperidol and fentanyl on i.c.p. during controlled
ventilation at normocapnia, and concluded that these
drugs were contraindicated in neurosurgery, unless
hypocapnia was established and the arterial pressure
was normal or increased. Because this latter com¬
munication appears superficially to contradict earlier
work, this study was conducted on the effect of
fentanyl on i.c.p. in neurosurgical patients during
controlled ventilation.
methods
Ten patients with intracranial lesions presenting for
craniotomy were studied. If indicated, diazepam
10 mg i.m. was administered, otherwise no pre-
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medication was given. Following the induction of
anaesthesia with thiopentone (five patients) or
Althesin (five patients), which were given until the
eyelash reflex was lost, tubocurarine 45 mg was
administered. Anaesthesia was maintained subse¬
quently with nitrous oxide in oxygen. The ventilation
was adjusted to maintain the PaCOa at between 2.7
and 4.0 kPa. As all the craniotomies were being
performed for major intracranial procedures during
which induced hypotension could be required, after
Allen's test had been performed, a cannula was
inserted into a radial artery and connected to a
pressure transducer. If there was no ventricular
catheter in situ already, one was inserted through a
burr hole into a lateral ventricle. In this way cerebro¬
spinal fluid could be withdrawn and the surgical
access improved. The ventricular catheter was
connected also to a pressure transducer and i.c.p.
and arterial pressure were recorded continuously on
a chart recorder. The zero level for the arterial
pressure was heart level and the zero for the i.c.p.
was the external auditory meatus, the operating
table being tilted 10° head-up. Once the i.c.p. and
arterial pressure had remained stable for 5 min
fentanyl 0.2 mg was given i.v. The i.c.p. and arterial
pressure recordings were followed for 10 min.
Pco2 was maintained constant during the measure¬
ments by observing the end-tidal carbon dioxide
concentration on an infra-red carbon dioxide
analyser and TaC02 was measured at the beginning
and end of the 10-min period.
The following measurements were obtained from
the chart recordings:
(1) The mean arterial pressure (m.a.p.) and mean
i.c.p. in the 5 min before the injection of fentanyl
(termed control m.a.p. and control i.c.p.);
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Table I. Diagnosis and mean i.c.p. (mm Hg) before (control) and after the administration of fentanyl
0.2 mg
Control
(value before Time after fentanyl (min)
Patient induction,
(age, yr) Diagnosis if known) 2 4 6 8 10
A (42) Pituitary tumour 12 10 8 7 8 7
B (71) Meningioma 15 (10) 13 10 14 10 10
C (59) Meningioma 10 (13) 8 9* 11 11 12
D (59) Glioblastoma 10 (23) 11 10 16 15 15
E (47) Aneurysm 20 (17) — — 19 20 19
F (59) Meningioma 9 (17) 8 9 10 10 11
G (33) Aneurysm 11 (15) 10 9 9 8 8
H (62) Glioblastoma 16 16 19 19 19 19
I (50) Acoustic neuroma 9 9 9 9 8 8
J (64) Spontaneous intracerebral
haemorrhage 9 8 8 8 8 8
Mean 12.1 10.3 10.1 12.2 11.7 11.7
SEM 1.2 0.9 1.1 1.4 1.5 1.4
* Head turned at this time.
Fig. 1. The average i.c.p. (mean) and SEM before (control) and after the administration of fentanyl
0.2 mg i.v. The changes from control i.c.p. were not significant statistically.
(2) M.a.p. and mean i.c.p. at 1-min intervals for the
first 10 min after the administration of the fentanyl;
(3) The cerebral perfusion pressure (c.p.p.) (m.a.p. —
mean i.c.p.) at 1-min intervals for 10 min after the
administration of the fentanyl.
RESULTS
The ages of the patients, their intracranial pathology
and the effects of fentanyl on mean i.c.p. are presented
in table I. The average i.c.p. for the group decreased
initially from the control value after the administra¬
tion of fentanyl (fig. 1). I.c.p. decreased in six
patients (—5, —5, —1, —3, —1 and — 1 mm Hg),
increased in three patients (+ 2, +6 and +3) and
remained constant in one patient until the patient's
head was turned, whereupon it increased (+2 mm
Hg).
The maximum increase recorded in i.c.p. was
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Table II. Mean arterial pressure {mm Hg) before {control)
and after the administration offentanyl 0.2 mg
Time after fentanyl (min)
Patient Control 2 4 6 8 10
A 113 93 83 70 70 75
B 105 98 98 — 83 85
C 127 102 88 82 80 82
D 73 55 65 55 58 65
E 113 115 105 105 98 98
F 100 80 70 65 72 75
G 63 53 60 57 63 63
H 83 72 70 70 70 70
I 115 95 85 80 90 95
J 107 97 92 90 90 88
Mean 99.9 86.0 81.6 74.9 77.4 79.6
SEM 6.5 6.5 4.7 5.4 4.1 3.8
6 mm Hg, and in three of the four patients showing
an increase in i.c.p. after fentanyl, the i.c.p. did not
reach the pre-induction value; the fourth patient
had no pre-induction measurement for comparison.
The changes in i.c.p. from control were not sig¬
nificant statistically for the group. In all 10 patients
m.a.p. decreased after the administration of fentanyl
(table II, fig. 2) and was less than 60 mm Hg in two
patients (55 and 53 mm Hg). These decreases in
m.a.p. were significant statistically from 2 min after
the administration of fentanyl until the end of the
period of measurement (0.01 > P> 0.001). C.p.p.
was less than 60 mm Hg in four patients (55, 51,
43 and 39 mm Hg), and less than 40 mm Hg in only
one patient (table III), and this for less than 1 min.
The changes in c.p.p. from control were significant
statistically at 1 min after the administration of
fentanyl (0.02 >P> 0.01) but from 2 min onwards
were of greater significance (0.01 > P> 0.001). For
brevity the measurements in the tables are presented
at 2-min intervals, because there was no additional
information in the readings at 1-min intervals.
Table III. Cerebral perfusion pressure {mm Hg) before
{control) and after the administration of fentanyl 0.2 mg
Time after fentanyl (min)
Patient Control 2 4 6 8 10
A 101 83 75 63 62 68
B 90 85 88 — 73 75
C 120 94 79 71 69 70
D 63 44 55 39 43 50
E 93 — — 86 78 79
F 91 72 61 55 62 64
G 52 43 51 48 55 55
H 67 56 51 51 51 51
I 106 86 76 71 82 87
J 98 89 84 82 82 80
Mean 88.1 72.4 68.9 62.9 65.7 67.9








































Fig. 2. The average m.a.p., average c.p.p. and SEM before (control) and after the administration of
fentanyl 0.2 mg i.v. The changes from control m.a.p. and c.p.p. were significant statistically
(see text).
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However, the small differences between the figures
quoted above and those in the tables are caused by
this point.
Table IV shows the F>aC02 measurements obtained
at the time of the injection of fentanyl and 10 min
after the injection. These values showed little change
during the period ofmeasurement. Although most of
the PaC02 values were between 2.7 and 4.0 kPa
(the range aimed for), one was 5.5 kPa and another
2.5 kPa. In each patient the end-tidal carbon dioxide
concentration remained constant during the period
of the study.
Table IV. P&co% values at the time of injection of fentanyl

















The original report of the effects ofneuroleptanalgesic
drugs on i.c.p. was that of Fitch and colleagues
(1969a), who reported that, in patients with space-
occupying lesions ventilated with nitrous oxide and
oxygen at normocapnia, the i.v. administration of
droperidol 5 mg and fentanyl 0.1 mg led to small
decreases in i.c.p. in eight out of nine patients. The
effect of these drugs on i.c.p. was re-assessed by
Misfeldt and colleagues (1976) who also studied
patients with space-occupying lesions at normo¬
capnia and reported that fentanyl 0.2 mg given after
droperidol 7.5-12.5 mg resulted in increases in i.c.p.
in five patients and decreases in three. These latter
authors concluded that they could not explain the lack
of agreement between their results and those of
Fitch and colleagues. However, the disagreements do
not seem large to us since, of the five patients with
increases in i.c.p. reported by Misfeldt and colleagues,
three had very small increases indeed (1, 2 and 3 mm
Hg). In the other two patients the increases were
greater (8 and 9 mm Hg), but the methodology
employed by these workers would bias the results
towards the finding of increases in i.c.p., since they
measured the highest i.c.p. achieved at an undefined
time more than 10 min after the administration of the
drugs. Patients with space-occupying pathology
show "spontaneous" variations in i.c.p., so that in
any group of such patients a method which selects
the highest i.c.p. value reached will include increases
in i.c.p. which are not a result of the previous drug
administration, and the effect will increase the longer
the post-administration period of observation. This
consideration is reinforced by the fact that, in five of
Misfeldt's patients, plateau waves were recorded
before the induction of anaesthesia, and these five
patients included the two with the greatest increases
in i.c.p. following the injection of fentanyl. Therefore
i.c.p. in these patients was unstable before the
administration of fentanyl.
To conclude this discussion of the i.c.p. changes
during controlled ventilation at normocapnia, it is
worth emphasizing that supplementation of nitrous
oxide/oxygen anaesthesia with neuroleptanalgesic
drugs produces small changes in i.c.p., while the
administration of volatile anaesthetics produces large
and consistent increases in i.c.p. (Jennett et al., 1969;
Adams et al., 1972).
However, most neurosurgical operations are
conducted during hypocapnia and not normocapnia,
and the present study extends the information
available on neuroleptanalgesic drugs by reporting
measurements made at hypocapnia. Furthermore,
since fentanyl is a short-acting drug with a serum
half-life of 2 min (Schleimer et al., 1978), the
measurements were made during the first 10 min
after drug administration at a time when the maxi¬
mum effect of the drug is seen clinically, although of
course some lesser effect persists for a longer time.
Under hypocapnic conditions fentanyl 0.2 mg pro¬
duced small changes in i.c.p. which could be in
either direction. The mean i.c.p. decreased for 4 min
after the administration of fentanyl, but this decrease
did not reach statistical significance.
By comparison, in the study of Adams and
colleagues (1972), in which the i.c.p. response to
0.5-1% halothane was measured during hypocapnia
at a mean PaCOa of 3.5 kPa, i.c.p. increased in 10 out
of 17 patients, but only one patient showed an
increase greater than 4 mm Hg. In the studies of
Fitch and colleagues, no deliberate attempt to
hyperventilate was made, but inadvertent hypocapnia
occurred in some patients in their series. They noted
that large increases in i.c.p. were produced by
volatile anaesthetics in patients with space-occupying
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lesions, despite Pac<h values of about 4.5 kPa
(Fitch et al., 1969b).
The clinical question about the choice between
NLA supplementation and supplementation with
volatile anaesthetics during hypocapnia remains
unresolved, for there are two conflicting points of
view: (i) that previous hypocapnia renders increases in
i.c.p. with volatile anaesthetics so small as to be
clinically unimportant (Adams et al., 1972); or
(ii) that, although hypocapnia reduces the changes in
i.c.p. produced by volatile anaesthetics, major
changes in i.c.p. occur still in patients whose intra¬
cranial compression is advanced (Jennett et al., 1969;
Gordon, 1970). If the second view is correct, then
NLA supplementation may be preferable.
Another method of supplementing nitrous oxide
relaxant anaesthesia for neurosurgery employs infu¬
sions of thiopentone or methohexitone, as described
by Hunter (1972a, b). Thiopentone, methohexitone,
Althesin and etomidate have all been shown to
decrease i.c.p. (Horsley,1937; Hunter, 1972b; Turner
et al., 1973; E. Moss and colleagues, 1978, un¬
published observations) and cerebral blood flow
(Pierce et al., 1962; Herrschaft et al., 1975; Sari et al.,
1976) and thus an infusion containing any one of
these agents would decrease i.c.p. and consequently
be useful in patients in whom a decrease in i.c.p. is
considered necessary.
The present results on the effect of fentanyl on
m.a.p. and c.p.p. are in complete agreement with
those of Misfeldt and colleagues (1976) and we wish
to emphasize the point made by these authors, that
fentanyl should not be given to patients who are
hypotensive already, otherwise low cerebral perfusion
pressures may result. In the present study, cerebral
perfusion pressures of less than 50 mm Hg were
observed in two patients, both of whom were moder¬
ately hypotensive when the drug was given (m.a.p. =
73 and 63 mm Hg).
Therefore we would conclude that:
(1) In hypocapnic patients with intracranial space-
occupying lesions, changes in i.c.p. following fentanyl
are small and may be in either direction.
(2) Fentanyl causes decreases in m.a.p. and in c.p.p.,
but unless the patient is already hypotensive the
changes are small.
(3) The establishment of hypocapnia before the
administration of fentanyl does not provide complete
protection against a decrease in c.p.p. to less than
50 mm Hg if the patient is already hypotensive (see
patients D and G).
(4) In our view fentanyl continues to be a valuable
adjunct to nitrous oxide oxygen relaxant anaesthesia
in patients with intracranial space-occupying lesions,
provided that it is not used in patients who are
hypotensive. Its effect on i.c.p. in hypocapnic patients
is small and, both clinically and statistically, in¬
significant.
ACKNOWLEDGEMENTS
The authors wish to acknowledge the co-operation and
assistance of the neurosurgical theatre staff at Leeds
General Infirmary in these studies.
REFERENCES
Adams, R. W., Gronert, G. A., Sundt, T. M., and
Michenfelder, J. D. (1972). Halothane, hypocapnia and
cerebrospinal fluid pressure in neurosurgery. Anes¬
thesiology, 37, 510.
Fitch, W., Barker, J., Jennett, W. B., and McDowall,
D. G. (1969a). The influence of neuroleptanalgesic drugs
on cerebrospinal fluid pressure. Br. J. Anaesth., 41, 800.
McDowall, D. G., and Jennett, W. B. (1969b).
The effect of methoxyflurane on cerebrospinal fluid
pressure in patients with and without intracranial space-
occupying lesions. Br. J. Anaesth., 41, 564.
Gordon, E. (1970). The action of drugs on intracranial
contents; in Progress in Anesthesiology (eds T. B.
Boulton, R. Bryse-Smith, M. K. Sykes, G. B. Gillett
and A. L. Revell), p. 60. Amsterdam: Excerpta Medica.
Herrschaft, H., Schmidt, H., Gleim, F., and Albus, G.
(1975). The response of human cerebral blood flow to
thiopental, methohexital, propanidid, ketamine and
etomidate; in Advances in Neurosurgery, Vol. 3, Brain
Hypoxia—Pain (eds H. Penzholz, M. Brock, J. Hamer,
M. Klinger and O. Spoerri). p. 120. Berlin: Springer-
Verlag.
Horsley, J. S. (1937). The intracranial pressure during
barbital narcosis. Lancet, 1, 141.
Hunter, A. R. (1972a). Thiopentone supplemented
anaesthesia for neurosurgery. Br. J. Anaesth., 44, 506.
(1972b). Methohexitone as a supplement to nitrous
oxide during intracranial surgery. Br. J. Anaesth., 44,
1188.
Jennett, W. B., Barker, J., Fitch, W., and McDowall, D. G.
(1969). Effect of anaesthesia on intracranial pressure in
patients with space-occupying lesions. Lancet, 1, 61.
Midfeldt, B. B., Jorgensen, P. B., Spotoft, H., and Ronde,
F. (1976). The effects of droperidol and fentanyl on
intracranial pressure and cerebral perfusion pressure in
neurosurgical patients. Br. J. Anaesth., 48, 963.
Pierce, E. C., Lambertsen, C. J., Deutsch, S., Chase, P. E.,
Linde, H. W., Dripps, R. D., and Price, H. L. (1962).
Cerebral circulation and metabolism during thiopental
anesthesia and hyperventilation in man. J. Clin. Invest.,
41, 1664.
Sari, A., Maekawa, T., Tohjo, M., Okuda, Y., and
Takeshita, H. (1976). Effects of Althesin on cerebral
blood flow and oxygen consumption in man. Br. J.
Anaesth., 48, 545.
Okuda, Y., and Takeshita, H. (1972). The effects of
Thalamonal on cerebral circulation and oxygen consump¬
tion in man. Br. J. Anaesth., 44, 330.
784 BRITISH JOURNAL OF ANAESTHESIA
Schleimer, R., Benjamini, E., Eisele, J., and Henderson, G.
(1978). Pharmacokinetics of fentanyl as determined by
radioimmunoassay. Clin. Pharmacol. Ther. (in press).
Turner, J. M., Coroneos, N. J., Gibson, R. M., Powell, D.,
Ness, M. A., and McDowall, D. G. (1973). The effects of
Althesin on intracranial pressure in man. Br. J. Anaesth.,
45, 168.
EFFETS DU FENTANYL SUR LA PRESSION




On a examine 10 malades se presentant pour une cranio-
tomie. Chacun avait ete anesthesie a l'aide de thio¬
pentone ou d'althesine puis tubocurarine, et leurs poumons
etaient hyperventiles par du protoxyde d'azote dans de
l'oxygene. Le fentanyl a ete administre par voie intra-
veineuse a raison de 0,2 mg et on a enregistre par la
suite, pendant 10 min et d'une maniere continue 1'I.C.P.
(pression intracranienne) ainsi que la tension arterielle
moyenne. Au moment oil l'on a administre le fentanyl,
neuf malades sur 10 etaient en etat d'hypocapnie (Paco,
inferieure a 4 kPa). Les variations de 1'I.C.P. ont ete
faibles. On a observe sur deux malades que les
pressions de perfusion cerebrale etaient inferieures a 50
mm Hg, ces malades ayant tous deux une hypotension
moderee avant l'injection du medicament. Nous en con-
cluons que le fentanyl est un agent utile pour la technique
d'hyperventilation pour les malades ayant des lesions
intracraniennes envahissantes, a la condition toutefois que
ceux-ci ne soient pas hypotendus.





Studiert wurden 10 Patienten fur Gehirnchirurgie. Alle
waren entwedermit Thiopenton Odermit Althesin, dannmit
Tubocurarin narkotisiert und mit Stickoxyd in Sauerstoff
hyperventiliert. Dann wurden 0,2 mg Fentanyl intravenos
verabreicht, worauf der intrakranielle und der mittlere
arterielle Druck 10 min lang kontinuierlich gemessen wur¬
den. Bei der Verabreichung von Fentanyl waren neun der
10 Patienten hypokapnisch (PaCOj unter 4 kPa). Die
Veranderung des intrakraniellen Drucks waren gering.
Zerebraler Durchblutungsdruck von unter 50 mm Hg
wurde bei zwei Patienten beobachtet, bei denen vor Vera¬
breichung von Fentanyl eine massige Hypotension bestand.
Wir schliessen daraus, dass Fentanyl fur die Hyper-
ventilationstechnik sehr wertvoll bei Patienten ist, bei
denen intrakranielle Verletzungen bestehen—vorausgesetzt,
dass bei diesen Patienten keine Hypotension vorhanden ist.
LOS EFECTOS QUE EJERCE FENTANIL SOBRE
LA PRESION INTRACRANEAL Y LA PRESION
DE PERFUSION CEREBRAL DURANTE
HIPOCAPNIA
SUMARIO
Se estudiaron 10 pacientes que sufrian de craneotomia. Cada
uno fueanestesiado con tiopentonaoAltesina pues tubocurarin
y sus pulmones fueron hiperventilados con oxido nitroso en
oxigeno. El fentanil 0,2 mg fue administrado intravenosa-
mente y posteriormente se anoto continuamente durante
10 min la presion intracraneal (i.c.p.) y la presion arterial
media. En el momento de la administration de fentanil,
nueve de los 10 pacientes fueron hipocapnicos (Paco,
inferior a 4 kPa). Los cambios en la i.c.p. fueron escasos. Se
observaron presiones de perfusion cerebral inferiores a
50 mm Hg en dos pacientes quienes sufrian de una hipo-
tension moderada antes de suministrarse la droga. Con-
cluimos que el fentanil es un valioso agente en la tecnica de
hiperventilacion en pacientes con lesiones intracraneales




I.C.P. INCREASES WITH 50% NITROUS OXIDE IN OXYGEN IN
SEVERE HEAD INJURIES DURING CONTROLLED VENTILATION
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I.C.P. INCREASES WITH 50% NITROUS OXIDE IN OXYGEN IN
SEVERE HEAD INJURIES DURING CONTROLLED VENTILATION
E. Moss and D. G. McDowall
summary
In a randomized trial nitrous oxide 50% in oxygen (Entonox) or oxygen 100% was given during chest
physiotherapy on 23 occasions to three mechanically ventilated patients with severe head injuries.
Intracranial pressure (i.c.p.) increased by 22.7 mm Hg (SD 10.62) during chest physiotherapy with
Entonox, compared with 10.5 mm Hg (SD 10.4) with oxygen 100% (P> 0.02). A further nine
mechanically ventilated patients with severe head injuries were given Entonox without chest physio¬
therapy. There was a mean increase in i.c.p. of 3.8 mm Hg (SD 2.4) (P < 0.001) when Entonox was
given, and a mean decrease of 4.6 mm Hg (SD 2.8) when the nitrous oxide was withdrawn. End-tidal
carbon dioxide concentration showed almost no change during nitrous oxide administration (decrease
of 0-0.1%). We conclude that nitrous oxide causes an increase in i.c.p. in patients with severe head
injuries and exacerbates the increases in i.c.p. occurring during chest physiotherapy.
Nitrous oxide is used widely in intensive care units as
a 50% mixture with oxygen (Entonox) to produce
analgesia during chest physiotherapy and other
painful procedures. The aim of this study was to
determine whether the administration ofnitrous oxide
50% in oxygen would prevent or decrease the
increases in intracranial pressure (i.c.p.) which occur
normally during chest physiotherapy in patients with
severe head injuries (Gibson et al., 1975). The results
obtained prompted a second investigation into the
effects of nitrous oxide in oxygen on i.c.p. in the
absence of chest physiotherapy.
methods
The changes in i.c.p. which occurred during chest
physiotherapy were compared during administration
of either oxygen 100% or nitrous oxide 50% in
oxygen (Entonox).
Random number tables were used to determine the
treatment for each episode of chest physiotherapy.
There were three patients in the trial, all ofwhom had
severe head injury and whose lungs were being
ventilated mechanically. During chest physiotherapy
the lungs were "bagged" by an anaesthetist, using a
Mapleson C system (Mapleson, 1954) (fresh gas flow
of greater than twice the minute volume of the
patient). I.c.p. was recorded continuously from a
subdural catheter or device, or an extradural device
(Coroneos et al., 1973) connected to a transducer, the
E. Moss, m.b., ch.b., f.f.a.r.c.s.j d. G. mcdowall, m.d.,
f.f.a.r.c.s.; Departments of Anaesthesia, Leeds General
Infirmary and The University of Leeds.
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signal from which was amplified and recorded on a
Devices chart recorder. The maximum increase in
mean i.c.p. occurring during the period of chest
physiotherapy was obtained from the chart recordings.
This trial was terminated prematurely when it was
found that the administration of Entonox was
accentuating the changes in i.c.p. produced by chest
physiotherapy.
In a second study, the effect of Entonox on i.c.p.
was studied in a further nine patients with severe
head injury during mechanical ventilation. However,
in these patients physiotherapy was not undertaken.
In these patients IPPV had been established for at
least 6 h with PaC02 values between 3.3 and 4.0 kPa.
No patient was included who required an inspired
oxygen concentration greater than 50%. I.c.p. was
measured as described above, and was recorded at a
fast chart speed for 10 min before the administration
of Entonox, for either 5 min (two administrations) or
10 min (14 administrations) during the administration
of Entonox (through the oxygen inlet of the Cape
ventilator), and for 10 min after the discontinuation of
the Entonox. During the last six administrations of
Entonox, end-tidal carbon dioxide concentration was
measured bymass spectrometry (Medishield). Arterial
blood-gas tensions were measured within 4 h of the
administration of the Entonox as part of the routine
management of the patient in the intensive care ward.
results
Mean i.c.p. before chest physiotherapy was the same
in the 100% oxygen group as in the Entonox group.
© Macmillan Journals Ltd 1979
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I.c.p. increased by 22.7 mm Hg (SD 10.6) when
physiotherapy was performed with Entonox com¬
pared with 10.5 mm Hg (SD 10.4) during the
administration of oxygen (0.02 > P> 0.01) (table I and
fig. 1). In two patients A-waves (Lundberg, 1960)
were precipitated by Entonox and physiotherapy, but
this occurred also in one patient when physiotherapy
was being carried out with oxygen alone.
Table I. Comparison of increases in i.c.p. produced by chest
physiotherapy during 100% oxygen and during Entonox
administration. Control values are those of mean i.c.p. before
physiotherapy. *0.02>P>0.01
Oxygen Entonox
Change from Change from
Control control Control control
(mm Hg) (mm Hg) (mm Hg) (mm Hg)
7 + 10 19 + 16
15 + 40 15 + 40
26 + 15 16 + 40
18 + 3 7 + 6
9 + 4 10 + 11
13 + 4 8 + 23
14 + 10 10 + 23
7 + 5 12 + 19
13 + 9 10 + 22
9 + 7 13 + 33
10 + 8 12 + 15
14 + 24
n 11 12
x 12.8 + 10.5* 12.2 + 22.7*
SD 5.6 10.4 3.5 10.6
When Entonox was administered to patients not
undergoing chest physiotherapy there was a mean
increase in i.c.p. of 3.8. mm Hg (SD 2.4) (range
0-8.5 mm Hg) (P< 0.001). After the withdrawal of
nitrous oxide there was a mean decrease in i.c.p. of
4.6 mm Hg (SD 2.8) (P< 0.001) (table II and fig. 2).
There was a mean decrease in end-tidal carbon
dioxide concentration of less than 0.1% (range
0-0.1%) when nitrous oxide was given.
DISCUSSION
Reports on the effect of nitrous oxide on i.c.p. are
contradictory. In dogs, Saidman and Eger (1965)
showed no change in i.c.p. with 70-75% nitrous
oxide, whereas Sakabe and colleagues (1978) found
an increase in i.c.p. In man, increases in i.c.p. have
been reported during the induction of anaesthesia in
patients with intracranial tumours and aneurysms
physiotherapy during Entonox and 100% oxygen adminis¬
tration in patients with severe head injuries. The bars
represent the standard errors of the means.
(Sondergard, 1961; Hulme and Cooper, 1972;
Henriksen and Jorgensen, 1973; Greenbaum et al.,
1975; Phirman and Shapiro, 1977), and during
established anaesthesia with hypocapnia in patients
with cerebral tumours (Misfeldt, Jorgensen and
Rishoj, 1974). However, Gordon and Greitz (1970)
found no increase in lumbar cerebrospinal fluid
pressure when nitrous oxide was administered with
the anaesthetic gases to patients with normal i.c.p.
Increases in cerebral blood flow (c.b.f.) occur on the
administration of nitrous oxide to dogs (McDowall
and Harper, 1965; Theye and Michenfelder, 1968;
Sakabe et al., 1978), but the reports in man are
conflicting. Wollman and others (1965) reported no
change in c.b.f. when 70% nitrous oxide was given to
healthy male volunteers, whereas Sakabe and others
(1976) found an increase in c.b.f. with 60% nitrous
oxide in human volunteers. There has been no report
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Table II. I.e.p. {mm Hg) before, during and after Entonox.
The peak values reached during Entonox administration were
used in calculating the changes
Change after Change after
n2o n2o
Patient Control administration withdrawal
A 4 + 1 -2
13 + 5 -1
6.5 + 4.5 -5
b 13.5 + 2 -3.5
C 6 + 1 -1
D 16 + 2 -4
e 3 + 7 -4
3 + 2 -4
1 + 6 -6
f 22 + 4 -11
g 1 + 6 -6
6 + 5 -8
h 5 0 -0.5
i 25.5 + 8.5 -8
21 + 3 -5
23 + 3 -5
(n = 16)
X 10.6 </= +3.8 d = —4.6
SD 8.53 2.40 2.83
P< 0.001 P< 0.001
of the effect of nitrous oxide on i.c.p. or c.b.f. in
patients with severe head injury, although it has been
suggested that increases may occur (Henriksen and
Jorgensen, 1973).
Gibson and co-workers (1975) reported increases in
i.c.p. during chest physiotherapy in patients with
severe head injuries, whichwere thought to be partly a
result of systemic hypertension and partly a result of
cerebral activation produced by noxious stimulation.
As Entonox is an analgesic, it might be expected to
decrease such increases in i.c.p. However, after
Entonox had been given on 12 occasions during chest
physiotherapy, it was clear that the increases in i.c.p.
were exacerbated.
The increase in i.c.p. with Entonox in the absence
of chest physiotherapy is almost certainly a result of a
cerebral vasodilatory action of the drug. An increase
in end-tidal carbon dioxide concentration, which was
expected because of the initial rapid uptake of nitrous
oxide, was not seen and therefore cannot account for
the increase in i.c.p. The increases in i.c.p. recorded
here, in the absence of chest physiotherapy, were
small but might be greater in patients with severe
head injury breathing spontaneously, especially when
the volume of the intracranial contents is on the steep
part of the pressure-volume curve.
The use of nitrous oxide for general anaesthesia in














Fig. 2. The effect of Entonox on i.c.p. in nine patients with severe head injuries. The control value
represents the mean i.c.p. in the 10 min before administration of Entonox. The bars represent the
standard errors of the means.
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hypocapnia should probably be induced first by
hyperventilation with oxygen 100%.
Misfeldt and colleagues (1974) showed that prior
hyperventilation for 10 min or more with oxygen
100% prevented any marked increase in i.c.p. during
the administration of nitrous oxide. However, when
controlled hyperventilation has been in use for some
hours, as in the management of severe head injury,
any protective effect of hypocapnia against the
increases in i.c.p. induced by nitrous oxide may be
lost because of the adaptation of c.b.f. and i.c.p. with
time to the low PaCo2 values.
Finally, the results obtained here suggest that
Entonox should be avoided in spontaneously-breath¬
ing head-injured patients during transport and
admission to hospital.
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AUGMENTATIONS DE LA PRESSION
INTRA-CRANIENNE AVEC 50% DE PROTOXYDE
D'AZOTE DANS L'OXYGENE DANS LES CAS DE
BLESSURES GRAVES A LA TETE PENDANT
UNE VENTILATION CONTROLEE
RESUME
Au cours d'essais effectues au hasard, on a administre soit
50% de protoxyde d'azote dans l'oxygene (Entonox), soit
100% d'oxygene pendant une physiotherapie de la poitrine
et ce a 23 reprises a trois patients ventiles mecaniquement
et souffrant de blessures graves a la tete. La pression intra-
cranienne (i.c.p.) a augmente de 22,5 mm Hg (ecart type
10,62) pendant la physiotherapie de la poitrine a l'aide
d'Entonox, par rapport a 10,5 mm Hg (ecart type 10,4)
lorsqu'on a utilise de l'oxygene a 100% (P>0,02). Neuf
autres malades ventiles mecaniquement et souffrant egale-
ment de blessures graves a la tete se sont vus admi-
nistrer de l'Entonox sans physiotherapie de la poitrine.
II s'est produit une augmentation moyenne de l'i.c.p. de
3,8 mm Hg (ecart type 2,4) (P< 0,001) lorsque
l'Entonox a ete administre et une diminution moyenne de
4,6 mm Hg (ecart type 2,8) lorsque le protoxyde d'azote a
ete arrete. La concentration d'acide carbonique en fin
d'expiration n'a virtuellement accuse aucun changement
pendant l'administration de protoxyde d'azote (diminution
de 0-0, 1%). Nous en concluons que le protoxyde d'azote
provoque une augmentation de l'i.c.p. chez les malades
souffrant de blessures graves a la tete et aggrave l'augmenta-
tion de l'i.c.p. qui se produit pendant la physiotherapie de
la poitrine.
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VON 50% STICKOXYD IN SAUERSTOFF
ZUSAMMENFASSUNG
Bei einem wahllos durchgefiihrten Versuch wurden 50%
Stickoxyd in Sauerstoff (Entonox) oder 100% Sauerstoff
bei 23 Gelegenheiten wahrend Brust-Physiotherapie an
drei mechanisch beliiftete Patienten mit schweren Kopf-
verletzungen verabreicht. I.e.p. stieg um 22,7 mm Hg
(SD 10,62) wahrend der Brust-Physiotherapie mit Entonox,
verglichen mit 10,5 mm Hg (SD 10,4) mit 100% Sauerstoff
(P < 0,02). Weiter neun mechanisch beliiftete Patienten mit
schweren Kopfverletzungen erhielten Entonox ohne
Brust-Physiotherapie. Es kam zu einem mittleren Anstieg
von i.c.p. von 3,8 mm Hg (SD 2,4) (JP < 0,001), wenn
Entonox verabreicht wurde, und zu einem mittleren
Abstieg von 4,6 mm Hg (SD 2,8) bei Entzug von Stickoxyd.
Die Endausatmungskonzentration von Kohlendioxyd zeigte
fast keine Veranderung wahrend der Verabreichung
von Stickoxyd (Abstieg von 0-0,1%). Wir schliessen
daraus, dass Stickoxyd einen Anstieg von i.c.p. bei
Patienten mit schweren Kopfverletzungen bewirkt, und
den Anstieg von i.c.p., zu dem es wahrend Brust-Physio¬
therapie kommt, verschlechtert.
AUMENTOS EN LA PRESION INTRACRANEAL
CON 50% DE OXIDO NITROSO EN OXIGENO
PARA SERIAS LESIONES A LA CABEZA
DURANTE VENTILACION CONTROLADA
SUMARIO
En una prueba aleatoria, se administro oxido nitroso 50% en
oxigeno (Entonox) u oxigeno 100% durante la fisioterapia
del pecho, en 23 ocasiones, a tres pacientes ventilados
mecanicamente que habian sufrido serias lesiones a la
cabeza. La presion intracraneal (p.i.e.) aumento en un
22,7 mm Hg (SD 10,62) durante la fisioterapia del pecho
con Entronox, en comparacion con 10,5 mm Hg (SD 10,4)
con oxigeno 100% (P< 0,02). Otros nueve pacientes
mecanicamente ventilados con lesiones severas a la cabeza
recibieron Entonox sin fisioterapia del pecho. Se produjo
una p.i.e. media de 3,8 mm Hg (SD 2,4) (P< 0,001)
cuando se administro Entonox, y una disminucion media de
4,6 mm Hg (SD 2,8) cuando se suspendio la administracion
de oxido nitroso. La concentration de dioxido de carbono
al fin mareal practicamente no acuso cambio alguno
durante la administracion de oxido nitroso (disminucion de
0-0,1%). Concluimos que el oxido nitroso produce un
aumento en la p.i.e. en aquellos pacientes con serias
lesiones a la cabeza y exacerba los aumentos de p.i.e. que
se producen durante la fisioterapia del pecho.
